CDK2
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A0A2R8Y4L2 | S95 | Sugiyama | HNRNPA1L3 HNRNPA1P48 | RPHKVDGRVVEPKRAVSREDsQRPDAHLTVKKIFVGGIKED |
| A1KXE4 | T57 | EPSD|PSP | FAM168B KIAA0280L MANI | YSPNMYPGANPTFQTGYTPGtPYKVsCsPTSGAVPPYSSSP |
| A5A3E0 | S1068 | Sugiyama | POTEF A26C1B | SLSTFQQMWISKQEyDEsGPsIVHRKCL_____________ |
| A5A3E0 | Y940 | Sugiyama | POTEF A26C1B | ALDFEQEMATVAsSSSLEKsyELPDGQVItIGNERFRCPEA |
| O00115 | S70 | Sugiyama | DNASE2 DNASE2A DNL2 | QYKyLDEssGGWRDGRALINsPEGAVGRSLQPLyRSNTSQL |
| O00267 | S666 | EPSD|PSP | SUPT5H SPT5 SPT5H | AGGSKPRDVtNFtVGGFAPMsPRIssPMHPSAGGQRGGFGs |
| O00267 | T775 | EPSD|PSP | SUPT5H SPT5 SPT5H | sRRPGGMTsTYGRtPMYGsQtPMYGsGsRtPMYGsQtPLQD |
| O00267 | T791 | EPSD|PSP | SUPT5H SPT5 SPT5H | YGsQtPMYGsGsRtPMYGsQtPLQDGsRtPHyGsQtPLHDG |
| O00311 | T376 | SIGNOR|EPSD|PSP | CDC7 CDC7L1 | TDKVCSICLSRRQQVAPRAGtPGFRAPEVLTKCPNQTTAID |
| O00429 | S126 | Sugiyama | DNM1L DLP1 DRP1 | EIRQEIENETERISGNNKGVsPEPIHLKIFSPNVVNLTLVD |
| O00429 | S616 | EPSD|PSP | DNM1L DLP1 DRP1 | SKAEELLAEEKsKPIPIMPAsPQKGHAVNLLDVPVPVARKL |
| O00499 | T348 | PSP | BIN1 AMPHL | LPKsPsQLRKGPPVPPPPKHtPSKEVKQEQILSLFEDTFVP |
| O00571 | T204 | EPSD|PSP | DDX3X DBX DDX3 | DVEMGEIIMGNIELTRYTRPtPVQKHAIPIIKEKRDLMACA |
| O14497 | S1320 | EPSD | ARID1A BAF250 BAF250A C1orf4 OSA1 SMARCF1 | MSTGAPQPNLMPSNPDSGMYsPsRYPPQQQQQQQQRHDsYG |
| O14497 | S1322 | EPSD | ARID1A BAF250 BAF250A C1orf4 OSA1 SMARCF1 | TGAPQPNLMPSNPDSGMYsPsRYPPQQQQQQQQRHDsYGNQ |
| O14497 | S363 | EPSD|PSP|Sugiyama | ARID1A BAF250 BAF250A C1orf4 OSA1 SMARCF1 | AAAAAAASGGAQQRsHHAPMsPGssGGGGQPLARtPQPssP |
| O14686 | T5374 | EPSD|PSP | KMT2D ALR MLL2 MLL4 | TLNSTSMSKAYQSTFTGETNtPYSKQFVHSKSSQYRRLRTE |
| O14757 | S286 | GPS6|SIGNOR|EPSD|PSP | CHEK1 CHK1 | NKPLKKGAKRPRVtsGGVsEsPsGFsKHIQsNLDFsPVNsA |
| O14757 | S301 | GPS6|SIGNOR|EPSD|PSP | CHEK1 CHK1 | GGVsEsPsGFsKHIQsNLDFsPVNsAssEENVKYsssQPEP |
| O14929 | S361 | Sugiyama | HAT1 KAT1 | DMsDAEQyRSYRLDIKRRLIsPYKKKQRDLAKMRKCLRPEE |
| O15014 | T722 | EPSD|PSP | ZNF609 KIAA0295 | KPIQPKPTVMGEPFTVNPALtPAKDKKKKDKKKKESSKELE |
| O15350 | T86 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | TP73 P73 | NLLSSTMDQMSSRAASASPYtPEHAASVPTHSPyAQPSSTF |
| O43237 | S194 | Sugiyama | DYNC1LI2 DNCLI2 LIC2 | ERKFVKDFQDyMEPEEGCQGsPQRRGPLtsGsDEENVALPL |
| O43303 | S170 | SIGNOR|PSP | CCP110 CEP110 CP110 KIAA0419 | NEDQCKTDGIDLARDsEGFNsPKQCDSSNISHVENEAFPKT |
| O43303 | S366 | SIGNOR|PSP | CCP110 CEP110 CP110 KIAA0419 | TFVTENNVIKSLTGSYAKLPsPEPsMsPKMHRRRsRtssAC |
| O43303 | S372 | SIGNOR|PSP | CCP110 CEP110 CP110 KIAA0419 | NVIKSLTGSYAKLPsPEPsMsPKMHRRRsRtssACHILINN |
| O43303 | S400 | SIGNOR|PSP | CCP110 CEP110 CP110 KIAA0419 | sRtssACHILINNPINACELsPKGKEQAMDLIIQDTDENTN |
| O43303 | S45 | SIGNOR|PSP | CCP110 CEP110 CP110 KIAA0419 | FLPAQSESISLIRFHGVAILsPLLNIEKRKEMQQEKQKALD |
| O43303 | S516 | SIGNOR|PSP | CCP110 CEP110 CP110 KIAA0419 | STCAAMPKLHEPYAssQCIAsPNFGTVSGLKPASMLEKNCS |
| O43303 | T194 | SIGNOR|PSP | CCP110 CEP110 CP110 KIAA0419 | CDSSNISHVENEAFPKTSSAtPQETLISDGPFSVNEQQDLP |
| O43303 | T566 | SIGNOR|PSP | CCP110 CEP110 CP110 KIAA0419 | DVKNPsPLLMQNQNTRQQMDtPMVSCGNEQFLDNsFEKVKR |
| O43395 | T167 | EPSD|PSP | PRPF3 HPRP3 PRP3 | EAATRQIEERKKQLsFIsPPtPQPKtPsssQPERLPIGNTI |
| O43463 | S391 | PSP | SUV39H1 KMT1A SUV39H | PVDMESTRMDsNFGLAGLPGsPKKRVRIECKCGTESCRKYL |
| O43583 | S73 | PSP|Sugiyama | DENR DRP1 H14 | CRQWLEKNFPNEFAKLtVENsPKQEAGIsEGQGtAGEEEEK |
| O43583 | T69 | PSP | DENR DRP1 H14 | DVAKCRQWLEKNFPNEFAKLtVENsPKQEAGIsEGQGtAGE |
| O43623 | S104 | SIGNOR|PSP | SNAI2 SLUG SLUGH | GRVsPPPPsDTSsKDHsGSEsPIsDEEERLQSKLSDPHAIE |
| O43623 | S54 | SIGNOR|PSP | SNAI2 SLUG SLUGH | YESYSMPVIPQPEILSSGAYsPITVWTTAAPFHAQLPNGLS |
| O43663 | T470 | SIGNOR|iPTMNet | PRC1 | RQLKNKKQTEtEMLyGsAPRtPsKRRGLAPNtPGKARKLNT |
| O43663 | T481 | SIGNOR|iPTMNet | PRC1 | EMLyGsAPRtPsKRRGLAPNtPGKARKLNTttMsNAtANss |
| O43765 | S77 | Sugiyama | SGTA SGT SGT1 | TLPEIFEAAATGKEMPQDLRsPARtPPsEEDsAEAERLKTE |
| O43852 | T65 | Sugiyama | CALU | FDyDHDAFLGAEEAKtFDQLtPEEsKERLGKIVSKIDGDKD |
| O60271 | T586 | EPSD|PSP | SPAG9 HSS KIAA0516 MAPK8IP4 SYD1 HLC6 | TTKKPEPPVNLKYNAPTSHVtPsVKKRsstLsQLPGDKSKA |
| O60292 | S158 | Sugiyama | SIPA1L3 KIAA0545 SPAL3 | FHRLSRRRsKDVEFQDGWPRsPGRAFLPLRHRsssEItLSE |
| O60318 | S508 | SIGNOR | MCM3AP GANP KIAA0572 MAP80 | RKKGKSLHKDMAIFWHRKKIsPNKKPFSLKEKKPGDGEVsP |
| O60504 | S563 | EPSD | SORBS3 SCAM1 | PSSPSALRSPADPIDLGGQtsPRRTGFSFPTQEPRPQTQNL |
| O60504 | T562 | EPSD | SORBS3 SCAM1 | HPSSPSALRSPADPIDLGGQtsPRRTGFSFPTQEPRPQTQN |
| O60716 | S252 | Sugiyama | CTNND1 KIAA0384 | sRVtRIEERyRPsMEGyRAPsRQDVyGPQPQVRVGGssVDL |
| O60841 | S214 | Sugiyama | EIF5B IF2 KIAA0741 | LQsRKGQKKNQKNKPGPNIEsGNEDDDAsFKIKTVAQKKAE |
| O60841 | S295 | Sugiyama | EIF5B IF2 KIAA0741 | KFEEETVKSKVTVDtGVIPAsEEKAEtPtAAEDDNEGDKKK |
| O60934 | S432 | EPSD|PSP | NBN NBS NBS1 P95 | NNNSMVSNTLAKMRIPNyQLsPtKLPSINKSKDRAsQQQQT |
| O60941 | S465 | Sugiyama | DTNB | NKNREILQEIQRLRLEHEQAsQPtPEKAQQNPTLLAELRLL |
| O60941 | T468 | Sugiyama | DTNB | REILQEIQRLRLEHEQAsQPtPEKAQQNPTLLAELRLLRQR |
| O75152 | T321 | EPSD|PSP | ZC3H11A KIAA0663 ZC3HDC11A | RSLAQRLGKKVEAPETNIDKtPKKAQVSKSLKERLGMsADP |
| O75179 | S2042 | EPSD|PSP|Sugiyama | ANKRD17 GTAR KIAA0697 | TAPTNATYPMPTAKEHyPVssPssPsPPAQPGGVsRNsPLD |
| O75179 | S2044 | EPSD | ANKRD17 GTAR KIAA0697 | PTNATYPMPTAKEHyPVssPssPsPPAQPGGVsRNsPLDCG |
| O75179 | S2045 | EPSD|PSP|Sugiyama | ANKRD17 GTAR KIAA0697 | TNATYPMPTAKEHyPVssPssPsPPAQPGGVsRNsPLDCGs |
| O75179 | S2401 | EPSD|PSP | ANKRD17 GTAR KIAA0697 | CSSASNDSSAQSVSSGVRAPsPAPssVPLGSEKPSNVSQDR |
| O75223 | S136 | Sugiyama | GGCT C7orf24 CRF21 | EGKEITCRSYLMTNYESAPPsPQYKKIICMGAKENGLPLEy |
| O75369 | Y1604 | Sugiyama | FLNB FLN1L FLN3 TABP TAP | KtGRYMIGVTYGGDDIPLsPyRIRAtQTGDASKCLAtGPGI |
| O75390 | Y345 | Sugiyama | CS | DEKLRDYIWNtLNSGRVVPGyGHAVLRKTDPRYTCQREFAL |
| O75469 | S114 | EPSD|PSP | NR1I2 PXR | CQACRLRKCLESGMKKEMIMsDEAVEERRALIKRKKSERtG |
| O75469 | S167 | EPSD|PSP | NR1I2 PXR | QRMMIRELMDAQMKTFDTTFsHFKNFRLPGVLSSGCELPES |
| O75469 | S200 | EPSD|PSP | NR1I2 PXR | SGCELPESLQAPSREEAAKWsQVRKDLCsLKVSLQLRGEDG |
| O75469 | S350 | EPSD|PSP | NR1I2 PXR | LKKLQLHEEEYVLMQAISLFsPDRPGVLQHRVVDQLQEQFA |
| O75469 | T133 | EPSD|PSP | NR1I2 PXR | MsDEAVEERRALIKRKKSERtGtQPLGVQGLTEEQRMMIRE |
| O75469 | T135 | EPSD|PSP | NR1I2 PXR | DEAVEERRALIKRKKSERtGtQPLGVQGLTEEQRMMIRELM |
| O75533 | S259 | EPSD | SF3B1 SAP155 | AKGsEtPGAtPGSKIWDPtPsHtPAGAAtPGRGDtPGHAtP |
| O75533 | T142 | EPSD|PSP | SF3B1 SAP155 | HRRtMIIsPERLDPFADGGKtPDPKMNARTyMDVMREQHLT |
| O75533 | T211 | EPSD|PSP | SF3B1 SAP155 | QPPsKRKRRWDQtADQtPGAtPKKLssWDQAEtPGHtPsLR |
| O75533 | T244 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | SF3B1 SAP155 | PGHtPsLRWDEtPGRAKGsEtPGAtPGSKIWDPtPsHtPAG |
| O75533 | T248 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | SF3B1 SAP155 | PsLRWDEtPGRAKGsEtPGAtPGSKIWDPtPsHtPAGAAtP |
| O75533 | T261 | EPSD | SF3B1 SAP155 | GsEtPGAtPGSKIWDPtPsHtPAGAAtPGRGDtPGHAtPGH |
| O75533 | T267 | EPSD | SF3B1 SAP155 | AtPGSKIWDPtPsHtPAGAAtPGRGDtPGHAtPGHGGAtss |
| O75533 | T313 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | SF3B1 SAP155 | WDEtPKtERDtPGHGsGWAEtPRtDRGGDsIGEtPtPGAsK |
| O75533 | T354 | EPSD|PSP | SF3B1 SAP155 | RKsRWDEtPAsQMGGstPVLtPGKTPIGTPAMNMAtPTPGH |
| O75533 | T426 | EPSD|PSP | SF3B1 SAP155 | AMFPEGyKVLPPPAGYVPIRtPARKLtAtPtPLGGMtGFHM |
| O75533 | T432 | EPSD | SF3B1 SAP155 | yKVLPPPAGYVPIRtPARKLtAtPtPLGGMtGFHMQTEDRT |
| O75533 | T434 | EPSD | SF3B1 SAP155 | VLPPPAGYVPIRtPARKLtAtPtPLGGMtGFHMQTEDRTMK |
| O75533 | T436 | EPSD | SF3B1 SAP155 | PPPAGYVPIRtPARKLtAtPtPLGGMtGFHMQTEDRTMKSV |
| O75553 | S524 | ELM | DAB1 | PVTSTTPSTNSPPTPAPRQSsPSKSSASHASDPTTDDIFEE |
| O75553 | S548 | ELM | DAB1 | SSASHASDPTTDDIFEEGFEsPSKSEEQEAPDGSQASSNSD |
| O75616 | S173 | EPSD|PSP | ERAL1 HERA | LGVITEKETQVILLDTPGIIsPGKQKRHHLELSLLEDPWKS |
| O75683 | S138 | Sugiyama | SURF6 SURF-6 | RQRLHEKIQEARGQGSAKELsPAALEKRRRRKQERDRKKRK |
| O75781 | S116 | Sugiyama | PALM KIAA0270 | EVLERGDSAPATAKENAAAPsPVRAPAPsPAKEERKTEVVM |
| O75781 | S124 | Sugiyama | PALM KIAA0270 | APATAKENAAAPsPVRAPAPsPAKEERKTEVVMNsQQtPVG |
| O75821 | S189 | Sugiyama | EIF3G EIF3S4 | CPYKDtLGPMQKELAEQLGLstGEKEKLPGELEPVQAtQNK |
| O75821 | T190 | Sugiyama | EIF3G EIF3S4 | PYKDtLGPMQKELAEQLGLstGEKEKLPGELEPVQAtQNKt |
| O75874 | T157 | SIGNOR | IDH1 PICD | DQYRATDFVVPGPGKVEITytPSDGTQKVTYLVHNFEEGGG |
| O94761 | S251 | SIGNOR|EPSD|PSP | RECQL4 RECQ4 | GAGSQGPEASAFQEVSIRVGsPQPSSSGGEKRRWNEEPWES |
| O94761 | S89 | EPSD | RECQL4 RECQ4 | AEEAPEPRCWGPHLNRAAtKsPQStPGRSRQGsVPDYGQRL |
| O94776 | S435 | EPSD|Sugiyama | MTA2 MTA1L1 PID | RGtTEPHSRGHLsRPEAQsLsPyttsANRAKLLAKNRQtFL |
| O94776 | S440 | EPSD | MTA2 MTA1L1 PID | PHSRGHLsRPEAQsLsPyttsANRAKLLAKNRQtFLLQtTK |
| O94776 | T438 | EPSD | MTA2 MTA1L1 PID | TEPHSRGHLsRPEAQsLsPyttsANRAKLLAKNRQtFLLQt |
| O94776 | T439 | EPSD | MTA2 MTA1L1 PID | EPHSRGHLsRPEAQsLsPyttsANRAKLLAKNRQtFLLQtT |
| O94826 | S91 | Sugiyama | TOMM70 KIAA0719 TOM70 TOMM70A | RGDASGLKRNSERKtPEGRAsPAPGsGHPEGPGAHLDMNsL |
| O94913 | S1493 | Sugiyama | PCF11 KIAA0824 | IYHPSCYEDYQNTSSFDCtPsPsKtPVENPLNIMLNIVKNE |
| O94979 | S799 | Sugiyama | SEC31A KIAA0905 SEC31L1 HSPC275 HSPC334 | IMQLRDRLCRAQGEPVAGHEsPKIPyEKQQLPKGRPGPVAG |
| O95251 | T88 | EPSD|PSP | KAT7 HBO1 HBOa MYST2 | EEPAYstRRVTRsQQQPtPVtPKKYPLRQtRssGsEtEQVV |
| O95295 | S133 | EPSD|PSP | SNAPIN BLOC1S7 SNAP25BP SNAPAP | VAKEtARRRAMLDsGIyPPGsPGK_________________ |
| O95297 | S210 | Sugiyama | MPZL1 PZR UNQ849/PRO1787 | LYRRKNSKRDyTGCstsEsLsPVKQAPRKsPsDtEGLVKSL |
| O95359 | S2317 | Sugiyama | TACC2 | MPLRRPKMKKtPEKLDNtPAsPPRsPAEPNDIPIAKGTYTF |
| O95359 | S2321 | Sugiyama | TACC2 | RPKMKKtPEKLDNtPAsPPRsPAEPNDIPIAKGTYTFDIDK |
| O95425 | S920 | Sugiyama | SVIL | LDHNAsAtDYKFSssIENsDsPVRSILKSQAWQPLVEGsEN |
| P00338 | S161 | Sugiyama | LDHA PIG19 | DILTYVAWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVH |
| P00558 | T168 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | EAFRAsLSKLGDVyVNDAFGtAHRAHssMVGVNLPQKAGGF |
| P01106 | S77 | PSP | MYC BHLHE39 | PPAPSEDIWKKFELLPtPPLsPsRRsGLCsPSyVAVTPFsL |
| P02545 | S22 | ELM | LMNA LMN1 | ETPsQRRAtRsGAQAsstPLsPtRItRLQEKEDLQELNDRL |
| P02545 | T19 | ELM | LMNA LMN1 | __METPsQRRAtRsGAQAsstPLsPtRItRLQEKEDLQELN |
| P03372 | S104 | GPS6|SIGNOR|ELM|EPSD|PSP | ESR1 ESR NR3A1 | SEAAAFGSNGLGGFPPLNsVsPsPLMLLHPPPQLsPFLQPH |
| P03372 | S106 | GPS6|SIGNOR|ELM|EPSD|PSP | ESR1 ESR NR3A1 | AAAFGSNGLGGFPPLNsVsPsPLMLLHPPPQLsPFLQPHGQ |
| P03372 | S118 | SIGNOR|EPSD|PSP | ESR1 ESR NR3A1 | PPLNsVsPsPLMLLHPPPQLsPFLQPHGQQVPYYLENEPSG |
| P03372 | S294 | SIGNOR|EPSD|PSP | ESR1 ESR NR3A1 | GEGRGEVGsAGDMRAANLWPsPLMIKRSKKNsLALSLtADQ |
| P03372 | S341 | PSP | ESR1 ESR NR3A1 | DAEPPILYSEYDPTRPFSEAsMMGLLTNLADRELVHMINWA |
| P04075 | S36 | Sugiyama | ALDOA ALDA | LsDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENR |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | T37 | Sugiyama | ALDOA ALDA | sDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRR |
| P04150 | S203 | SIGNOR | NR3C1 GRL | LYTTDQSTFDILQDLEFssGsPGKETNEsPWRSDLLIDENC |
| P04150 | S211 | SIGNOR | NR3C1 GRL | FDILQDLEFssGsPGKETNEsPWRSDLLIDENCLLsPLAGE |
| P04183 | S13 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | TK1 | ________MSCINLPTVLPGsPsKtRGQIQVILGPMFSGKS |
| P04406 | S210 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GPsGKLWRDGRGALQNIIPAstGAAKAVGKVIPELNGKLtG |
| P04406 | T211 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | PsGKLWRDGRGALQNIIPAstGAAKAVGKVIPELNGKLtGM |
| P04637 | S313 | EPSD | TP53 P53 | GEPHHELPPGStKRALPNNTsssPQPKKKPLDGEyFTLQIR |
| P04637 | S314 | EPSD | TP53 P53 | EPHHELPPGStKRALPNNTsssPQPKKKPLDGEyFTLQIRG |
| P04637 | S315 | GPS6|SIGNOR|iPTMNet|EPSD|PSP | TP53 P53 | PHHELPPGStKRALPNNTsssPQPKKKPLDGEyFTLQIRGR |
| P04637 | S33 | ELM | TP53 P53 | PLsQEtFsDLWKLLPENNVLsPLPsQAMDDLMLsPDDIEQW |
| P04637 | S392 | GPS6|SIGNOR|iPTMNet | TP53 P53 | KKGQstsRHKKLMFKtEGPDsD___________________ |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05187 | S177 | Sugiyama | ALPP PLAP | RAKKAGKSVGVVTTTRVQHAsPAGtyAHtVNRNWysDADVP |
| P05187 | S438 | Sugiyama | ALPP PLAP | GPGYVLKDGARPDVtEsEsGsPEyRQQSAVPLDEETHAGED |
| P05386 | S101 | Sugiyama | RPLP1 RRP1 | APstAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD_______ |
| P05387 | S102 | Sugiyama | RPLP2 D11S2243E RPP2 | PAAGsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD_______ |
| P05455 | S325 | Sugiyama | SSB | VLEGEVEKEALKKIIEDQQEsLNKWKSKGRRFKGKGKGNKA |
| P05455 | S92 | Sugiyama | SSB | LSKSKAELMEIsEDKTKIRRsPsKPLPEVTDEyKNDVKNRs |
| P06400 | S230 | iPTMNet | RB1 | DDLVISFQLMLCVLDYFIKLsPPMLLKEPYKTAVIPINGsP |
| P06400 | S249 | ELM|EPSD|PSP | RB1 | LsPPMLLKEPYKTAVIPINGsPRtPRRGQNRSARIAKQLEN |
| P06400 | S567 | GPS6|iPTMNet|EPSD|PSP | RB1 | IKHLERCEHRIMESLAWLSDsPLFDLIKQSKDREGPTDHLE |
| P06400 | S608 | SIGNOR|iPTMNet|EPSD|PSP | RB1 | sACPLNLPLQNNHtAADMyLsPVRsPKKKGSTTRVNstANA |
| P06400 | S612 | iPTMNet|EPSD|PSP | RB1 | LNLPLQNNHtAADMyLsPVRsPKKKGSTTRVNstANAETQA |
| P06400 | S780 | PSP | RB1 | FMQRLKtNILQyAstRPPtLsPIPHIPRsPyKFPssPLRIP |
| P06400 | S807 | ELM|iPTMNet|EPSD|PSP | RB1 | RsPyKFPssPLRIPGGNIyIsPLKsPYKIsEGLPtPtKMtP |
| P06400 | S811 | ELM|iPTMNet|EPSD|PSP | RB1 | KFPssPLRIPGGNIyIsPLKsPYKIsEGLPtPtKMtPRSRI |
| P06400 | T252 | ELM|EPSD|PSP | RB1 | PMLLKEPYKTAVIPINGsPRtPRRGQNRSARIAKQLENDTR |
| P06400 | T356 | EPSD|PSP | RB1 | FLDHDKTLQTDsIDsFEtQRtPRKsNLDEEVNVIPPHtPVR |
| P06400 | T373 | ELM|EPSD|PSP | RB1 | tQRtPRKsNLDEEVNVIPPHtPVRTVMNTIQQLMMILNSAS |
| P06400 | T821 | SIGNOR|iPTMNet|EPSD|PSP | RB1 | GGNIyIsPLKsPYKIsEGLPtPtKMtPRSRILVSIGEsFGt |
| P06400 | T826 | EPSD|PSP | RB1 | IsPLKsPYKIsEGLPtPtKMtPRSRILVSIGEsFGtsEKFQ |
| P06401 | S162 | GPS6|ELM|iPTMNet|EPSD|PSP | PGR NR3C3 | LFGPELPEDPPAAPATQRVLsPLMSRSGCKVGDSSGTAAAH |
| P06401 | S190 | GPS6|ELM|iPTMNet|EPSD|PSP | PGR NR3C3 | CKVGDSSGTAAAHKVLPRGLsPARQLLLPASESPHWSGAPV |
| P06401 | S20 | SIGNOR | PGR NR3C3 | _MTELKAKGPRAPHVAGGPPsPEVGsPLLCRPAAGPFPGSQ |
| P06401 | S213 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | PGR NR3C3 | RQLLLPASESPHWSGAPVKPsPQAAAVEVEEEDGSESEESA |
| P06401 | S25 | SIGNOR | PGR NR3C3 | KAKGPRAPHVAGGPPsPEVGsPLLCRPAAGPFPGSQTSDTL |
| P06401 | S294 | SIGNOR|EPSD|PSP | PGR NR3C3 | RFSAPRVALVEQDAPMAPGRsPLATTVMDFIHVPILPLNHA |
| P06401 | S400 | GPS6|ELM|iPTMNet|EPSD|PSP | PGR NR3C3 | FQPPALKIKEEEEGAEASARsPRSYLVAGANPAAFPDFPLG |
| P06401 | S554 | SIGNOR | PGR NR3C3 | LPQVYPPYLNYLRPDsEAsQsPQYsFEsLPQKICLICGDEA |
| P06401 | S676 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | PGR NR3C3 | LPQPVGVPNESQALSQRFTFsPGQDIQLIPPLINLLMSIEP |
| P06401 | T430 | SIGNOR | PGR NR3C3 | NPAAFPDFPLGPPPPLPPRAtPSRPGEAAVTAAPASASVSS |
| P06493 | T14 | Sugiyama | CDK1 CDC2 CDC28A CDKN1 P34CDC2 | _______MEDyTKIEKIGEGtyGVVyKGRHKTTGQVVAMKK |
| P06493 | Y15 | Sugiyama | CDK1 CDC2 CDC28A CDKN1 P34CDC2 | ______MEDyTKIEKIGEGtyGVVyKGRHKTTGQVVAMKKI |
| P06493 | Y19 | Sugiyama | CDK1 CDC2 CDC28A CDKN1 P34CDC2 | __MEDyTKIEKIGEGtyGVVyKGRHKTTGQVVAMKKIRLEs |
| P06733 | S272 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | FRsGKyDLDFKsPDDPsRyIsPDQLADLyKsFIKDyPVVsI |
| P06733 | T100 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | KKLNVtEQEKIDKLMIEMDGtENKsKFGANAILGVsLAVCK |
| P06733 | T205 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | GAEVyHNLKNVIKEKyGKDAtNVGDEGGFAPNILENKEGLE |
| P06744 | S455 | Sugiyama | GPI | ALMRGKSTEEARKELQAAGKsPEDLERLLPHKVFEGNRPTN |
| P06748 | S125 | GPS6|EPSD | NPM1 NPM | GsGPVHIsGQHLVAVEEDAEsEDEEEEDVKLLsIsGKRsAP |
| P06748 | S70 | SIGNOR|EPSD|PSP|Sugiyama | NPM1 NPM | GAGAKDELHIVEAEAMNyEGsPIKVtLAtLKMsVQPtVsLG |
| P06748 | T199 | GPS6|SIGNOR|iPTMNet|EPSD|PSP | NPM1 NPM | DDFDDEEAEEKAPVKKsIRDtPAKNAQKSNQNGKDsKPsst |
| P06748 | T234 | SIGNOR|EPSD|PSP | NPM1 NPM | sKPsstPRsKGQEsFKKQEKtPKtPKGPssVEDIKAKMQAs |
| P07195 | S162 | Sugiyama | LDHB | DILTYVTWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIH |
| P07195 | S303 | Sugiyama | LDHB | GIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsADt |
| P07195 | T302 | Sugiyama | LDHB | YGIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsAD |
| P07195 | T323 | Sugiyama | LDHB | sVINQKLKDDEVAQLKKsADtLWDIQKDLKDL_________ |
| P07205 | T168 | Sugiyama | PGK2 PGKB | EAFRAsLSKLGDVyVNDAFGtAHRAHSSMVGVNLPHKASGF |
| P07355 | S184 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | sGDFRKLMVALAKGRRAEDGsVIDyELIDQDARDLyDAGVK |
| P07437 | S168 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | GTLLISKIREEYPDRIMNtFsVVPsPKVSDTVVEPYNATLS |
| P07437 | S172 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | ISKIREEYPDRIMNtFsVVPsPKVSDTVVEPYNATLSVHQL |
| P07437 | T55 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | tyHGDsDLQLDRIsVyyNEAtGGKyVPRAILVDLEPGtMDs |
| P07814 | S886 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | EKTGKEyIPGQPPLsQssDssPtRNsEPAGLEtPEAKVLFD |
| P07814 | T737 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | EKTKVEATKNETSAPFKERPtPsLNNNCttsEDsLVLyNRV |
| P07858 | S216 | Sugiyama | CTSB CPSB | PPCTGEGDTPKCSKICEPGysPtyKQDKHYGYNSYSVSNSE |
| P07864 | S161 | Sugiyama | LDHC LDH3 LDHX | DILTYIVWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVH |
| P07900 | S263 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | EEKEKEEKEsEDKPEIEDVGsDEEEEKKDGDKKKKKKIKEK |
| P07900 | S543 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | EPIDEyCVQQLKEFEGKtLVsVTKEGLELPEDEEEKKKQEE |
| P07900 | T109 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | LtIVDtGIGMTKADLINNLGtIAKSGtKAFMEALQAGADIS |
| P07900 | Y309 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | ELNKtKPIWtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHF |
| P08047 | S59 | SIGNOR | SP1 TSFP1 | RssstGsssstGGGGQEsQPsPLALLAATCSRIESPNENSN |
| P08195 | S296 | Sugiyama | SLC3A2 MDU1 | DLLQIDPNFGsKEDFDsLLQsAKKKSIRVILDLTPNYRGEN |
| P08195 | S598 | Sugiyama | SLC3A2 MDU1 | LQASDLPASASLPAKADLLLstQPGREEGsPLELERLKLEP |
| P08195 | S607 | Sugiyama | SLC3A2 MDU1 | ASLPAKADLLLstQPGREEGsPLELERLKLEPHEGLLLRFP |
| P08238 | S535 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | EPIDEyCVQQLKEFDGKsLVsVtKEGLELPEDEEEKKKMEE |
| P08238 | T104 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LtLVDtGIGMtKADLINNLGtIAKSGtKAFMEALQAGADIS |
| P08238 | T83 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | sKLDsGKELKIDIIPNPQERtLtLVDtGIGMtKADLINNLG |
| P08238 | T85 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LDsGKELKIDIIPNPQERtLtLVDtGIGMtKADLINNLGtI |
| P08238 | T89 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KELKIDIIPNPQERtLtLVDtGIGMtKADLINNLGtIAKSG |
| P08621 | S226 | EPSD|PSP | SNRNP70 RNPU1Z RPU1 SNRP70 U1AP1 | VNIRHSGRDDtsRyDERPGPsPLPHRDRDRDRERERRERSR |
| P08651 | S323 | Sugiyama | NFIC NFI | PssPtsSSRNWTEDMEGGIssPVKKtEMDKsPFNsPsPQDs |
| P08670 | S55 | EPSD | VIM | TRtYsLGsALRPstsRsLyAssPGGVyAtRssAVRLRssVP |
| P08670 | S56 | EPSD | VIM | RtYsLGsALRPstsRsLyAssPGGVyAtRssAVRLRssVPG |
| P08865 | T97 | Sugiyama | RPSA LAMBR LAMR1 | IssRNtGQRAVLKFAAAtGAtPIAGRFtPGTFTNQIQAAFR |
| P09382 | T58 | Sugiyama | LGALS1 | DsNNLCLHFNPRFNAHGDANtIVCNsKDGGAWGTEQREAVF |
| P09651 | S95 | Sugiyama | HNRNPA1 HNRPA1 | RPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| P09923 | S174 | Sugiyama | ALPI | RAKQAGKSVGVVTTTRVQHAsPAGtyAHtVNRNWysDADMP |
| P0CG38 | S1068 | Sugiyama | POTEI | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0CG39 | S1031 | Sugiyama | POTEJ | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0DPH7 | T56 | Sugiyama | TUBA3C TUBA2 | MPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtVVD |
| P10244 | S393 | SIGNOR|iPTMNet | MYBL2 BMYB | LDGHTISDLSRSSRGELIPIsPstEVGGsGIGtPPSVLKRQ |
| P10244 | S452 | SIGNOR|iPTMNet | MYBL2 BMYB | FLDSCNSLtPKStPVKtLPFsPsQFLNFWNKQDtLELESPs |
| P10244 | S577 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | MYBL2 BMYB | LIIEDDIRPEKQKRKPGLRRsPIKKVRKSLALDIVDEDVKL |
| P10244 | T266 | SIGNOR|iPTMNet | MYBL2 BMYB | AAATtsKEQEPIGTDLDAVRtPEPLEEFPKREDQEGsPPET |
| P10244 | T405 | SIGNOR|iPTMNet | MYBL2 BMYB | SRGELIPIsPstEVGGsGIGtPPSVLKRQRKRRVALsPVtE |
| P10244 | T440 | GPS6|SIGNOR|iPTMNet|EPSD | MYBL2 BMYB | LsPVtENSTSLSFLDSCNSLtPKStPVKtLPFsPsQFLNFW |
| P10244 | T444 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | MYBL2 BMYB | tENSTSLSFLDSCNSLtPKStPVKtLPFsPsQFLNFWNKQD |
| P10244 | T487 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | MYBL2 BMYB | ELESPsLTStPVCSQKVVVTtPLHRDKtPLHQKHAAFVtPD |
| P10244 | T494 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | MYBL2 BMYB | TStPVCSQKVVVTtPLHRDKtPLHQKHAAFVtPDQKYSMDN |
| P10244 | T515 | SIGNOR|iPTMNet|PSP | MYBL2 BMYB | PLHQKHAAFVtPDQKYSMDNtPHtPtPFKNALEKYGPLKPL |
| P10244 | T518 | SIGNOR|iPTMNet|PSP | MYBL2 BMYB | QKHAAFVtPDQKYSMDNtPHtPtPFKNALEKYGPLKPLPQt |
| P10244 | T520 | GPS6|SIGNOR|iPTMNet|EPSD|PSP | MYBL2 BMYB | HAAFVtPDQKYSMDNtPHtPtPFKNALEKYGPLKPLPQtPH |
| P10275 | S96 | EPSD|PSP | AR DHTR NR3C4 | QQQQQETsPRQQQQQQGEDGsPQAHRRGPTGYLVLDEEQQP |
| P10412 | T146 | PSP | H1-4 H1F4 HIST1H1E | AKAKKPAGAAKKPKKATGAAtPKKSAKKTPKKAKKPAAAAG |
| P10412 | T18 | EPSD|PSP|Sugiyama | H1-4 H1F4 HIST1H1E | ___MsEtAPAAPAAPAPAEKtPVKKKARKsAGAAKRKAsGP |
| P10636 | S519 | ELM | MAPT MAPTL MTBT1 TAU | PPsSGEPPKsGDRsGyssPGsPGtPGsRsRtPsLPtPPTRE |
| P10636 | S552 | ELM | MAPT MAPTL MTBT1 TAU | LPtPPTREPKKVAVVRtPPKsPssAKSRLQTAPVPMPDLKN |
| P10636 | S713 | ELM | MAPT MAPTL MTBT1 TAU | LTFRENAKAKTDHGAEIVyKsPVVsGDtsPRHLsNVsstGs |
| P10636 | S721 | ELM | MAPT MAPTL MTBT1 TAU | AKTDHGAEIVyKsPVVsGDtsPRHLsNVsstGsIDMVDsPQ |
| P10636 | T522 | ELM | MAPT MAPTL MTBT1 TAU | SGEPPKsGDRsGyssPGsPGtPGsRsRtPsLPtPPTREPKK |
| P10636 | T529 | ELM | MAPT MAPTL MTBT1 TAU | GDRsGyssPGsPGtPGsRsRtPsLPtPPTREPKKVAVVRtP |
| P10636 | T534 | ELM | MAPT MAPTL MTBT1 TAU | yssPGsPGtPGsRsRtPsLPtPPTREPKKVAVVRtPPKsPs |
| P10636 | T548 | ELM | MAPT MAPTL MTBT1 TAU | RtPsLPtPPTREPKKVAVVRtPPKsPssAKSRLQTAPVPMP |
| P10636 | T690 | ELM | MAPT MAPTL MTBT1 TAU | KIGsLDNITHVPGGGNKKIEtHKLTFRENAKAKTDHGAEIV |
| P10644 | S83 | SIGNOR|iPTMNet|EPSD|PSP | PRKAR1A PKR1 PRKAR1 TSE1 | KQIQNLQKAGtRtDsREDEIsPPPPNPVVKGRRRRGAIsAE |
| P10644 | T209 | iPTMNet | PRKAR1A PKR1 PRKAR1 TSE1 | EWATSVGEGGSFGELALIYGtPRAATVKAKTNVKLWGIDRD |
| P10696 | S435 | Sugiyama | ALPG ALPPL ALPPL2 | GPGYVLKDGARPDVtEsEsGsPEyRQQSAVPLDGETHAGED |
| P10809 | S247 | Sugiyama | HSPD1 HSP60 | yFINtsKGQKCEFQDAyVLLsEKKIssIQsIVPALEIANAH |
| P10809 | S70 | Sugiyama | HSPD1 HSP60 | AVAVTMGPKGRtVIIEQsWGsPKVTKDGVtVAKsIDLKDKY |
| P11142 | S40 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P11142 | S85 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | NtVFDAKRLIGRRFDDAVVQsDMKHWPFMVVNDAGRPKVQV |
| P11142 | T226 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVNHFIAEFK |
| P11142 | T38 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQ |
| P11142 | T45 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPtN |
| P11142 | T64 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | FtDtERLIGDAAKNQVAMNPtNtVFDAKRLIGRRFDDAVVQ |
| P11142 | T66 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DtERLIGDAAKNQVAMNPtNtVFDAKRLIGRRFDDAVVQsD |
| P11142 | Y41 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P12268 | S122 | EPSD|PSP | IMPDH2 IMPD2 | NEVRKVKKyEQGFITDPVVLsPKDRVRDVFEAKARHGFCGI |
| P12270 | S1676 | EPSD | TPR | RGIAstsDPPtANIKPtPVVstPsKVTAAAMAGNKstPRAS |
| P12270 | S1679 | EPSD | TPR | AstsDPPtANIKPtPVVstPsKVTAAAMAGNKstPRASIRP |
| P12270 | T1677 | EPSD | TPR | GIAstsDPPtANIKPtPVVstPsKVTAAAMAGNKstPRASI |
| P12272 | T108 | iPTMNet | PTHLH PTHRP | TKNHPVRFGSDDEGRYLTQEtNKVETYKEQPLKtPGKKKKG |
| P12272 | T121 | SIGNOR|EPSD|PSP | PTHLH PTHRP | GRYLTQEtNKVETYKEQPLKtPGKKKKGKPGKRKEQEKKKR |
| P12830 | S36 | SIGNOR | CDH1 CDHE UVO | QVSSWLCQEPEPCHPGFDAEsYTFtVPRRHLERGRVLGRVN |
| P12830 | T40 | SIGNOR | CDH1 CDHE UVO | WLCQEPEPCHPGFDAEsYTFtVPRRHLERGRVLGRVNFEDC |
| P12931 | S75 | ELM | SRC SRC1 | APAAAEPKLFGGFNssDtVtsPQRAGPLAGGVTTFVALyDY |
| P12956 | T455 | EPSD|PSP | XRCC6 G22P1 | VFLPFADDKRKMPFTEKIMAtPEQVGKMKAIVEKLRFtYRs |
| P13051 | S12 | SIGNOR|EPSD|PSP | UNG DGU UNG1 UNG15 | _________MIGQKtLysFFsPsPARKRHAPsPEPAVQGtG |
| P13051 | S14 | SIGNOR | UNG DGU UNG1 UNG15 | _______MIGQKtLysFFsPsPARKRHAPsPEPAVQGtGVA |
| P13051 | S23 | SIGNOR|PSP | UNG DGU UNG1 UNG15 | GQKtLysFFsPsPARKRHAPsPEPAVQGtGVAGVPEESGDA |
| P13051 | S64 | SIGNOR|PSP | UNG DGU UNG1 UNG15 | AAIPAKKAPAGQEEPGtPPssPLsAEQLDRIQRNKAAALLR |
| P13051 | T60 | SIGNOR|PSP | UNG DGU UNG1 UNG15 | SGDAAAIPAKKAPAGQEEPGtPPssPLsAEQLDRIQRNKAA |
| P13639 | S593 | Sugiyama | EEF2 EF2 | SDPVVsyREtVsEEsNVLCLsKsPNKHNRLyMKARPFPDGL |
| P13639 | S595 | EPSD|PSP|Sugiyama | EEF2 EF2 | PVVsyREtVsEEsNVLCLsKsPNKHNRLyMKARPFPDGLAE |
| P13639 | T435 | EPSD|PSP | EEF2 EF2 | RVFsGLVsTGLKVRIMGPNytPGKKEDLyLKPIQRTILMMG |
| P13667 | S379 | Sugiyama | PDIA4 ERP70 ERP72 | QPEKFQSKYEPRSHMMDVQGstQDsAIKDFVLKyALPLVGH |
| P13667 | S383 | Sugiyama | PDIA4 ERP70 ERP72 | FQSKYEPRSHMMDVQGstQDsAIKDFVLKyALPLVGHRKVS |
| P13667 | S482 | Sugiyama | PDIA4 ERP70 ERP72 | VKDLGLsEsGEDVNAAILDEsGKKFAMEPEEFDsDtLREFV |
| P13861 | S99 | Sugiyama | PRKAR2A PKR2 PRKAR2 | EsEEDEDLEVPVPsRFNRRVsVCAEtyNPDEEEEDTDPRVI |
| P14625 | S552 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | KEKQDKIyFMAGsSRKEAEssPFVERLLKKGyEVIyLTEPV |
| P14859 | S269 | EPSD | POU2F1 OCT1 OTF1 | PATPTRTIAAtPIQTLPQsQstPKRIDtPsLEEPsDLEELE |
| P14859 | T270 | EPSD | POU2F1 OCT1 OTF1 | ATPTRTIAAtPIQTLPQsQstPKRIDtPsLEEPsDLEELEQ |
| P14866 | S101 | Sugiyama | HNRNPL HNRPL P/OKcl.14 | GAAGGGGGGENyDDPHKtPAsPVVHIRGLIDGVVEADLVEA |
| P14868 | S369 | Sugiyama | DARS1 DARS PIG40 | CEALAMLREAGVEMGDEDDLstPNEKLLGHLVKEKyDTDFy |
| P15172 | S200 | SIGNOR|ELM|iPTMNet | MYOD1 BHLHC1 MYF3 MYOD | APGPLPPGRGGEHYSGDSDAssPRSNCSDGMMDYSGPPSGA |
| P15336 | T116 | EPSD|PSP | ATF2 CREB2 CREBP1 | FKKASEDDIKKMPLDLsPLAtPIIRsKIEEPsVVEttHQDs |
| P15531 | S125 | Sugiyama | NME1 NDPKA NM23 | RGDFCIQVGRNIIHGsDsVEsAEKEIGLWFHPEELVDyTsC |
| P15923 | S139 | EPSD|PSP | TCF3 BHLHB21 E2A ITF1 | GLTQAGFLSGELALNSPGPLsPsGMKGTSQYYPSYsGssRR |
| P15923 | S154 | GPS6 | TCF3 BHLHB21 E2A ITF1 | SPGPLsPsGMKGTSQYYPSYsGssRRRAADGSLDTQPKKVR |
| P15923 | S245 | EPSD|PSP | TCF3 BHLHB21 E2A ITF1 | AELWsPPGQAGFGPMLGGGSsPLPLPPGSGPVGSSGSSSTF |
| P15923 | S48 | GPS6 | TCF3 BHLHB21 E2A ITF1 | LPVTNGKGRPAsLAGAQFGGsGLEDRPssGSWGSGDQSSSS |
| P15927 | S23 | EPSD|PSP | RPA2 REPA2 RPA32 RPA34 | NsGFEsYGsssYGGAGGYtQsPGGFGsPAPsQAEKKSRARA |
| P15927 | S29 | EPSD|PSP | RPA2 REPA2 RPA32 RPA34 | YGsssYGGAGGYtQsPGGFGsPAPsQAEKKSRARAQHIVPC |
| P15927 | S33 | EPSD|PSP | RPA2 REPA2 RPA32 RPA34 | sYGGAGGYtQsPGGFGsPAPsQAEKKSRARAQHIVPCTIsQ |
| P16278 | S434 | Sugiyama | GLB1 ELNR1 | GFVLYRTTLPQDCSNPAPLssPLNGVHDRAyVAVDGIPQGV |
| P16949 | S25 | EPSD|PSP|Sugiyama | STMN1 C1orf215 LAP18 OP18 | DIQVKELEKRAsGQAFELILsPRsKEsVPEFPLsPPKKKDL |
| P16949 | S38 | ELM|EPSD|PSP|Sugiyama | STMN1 C1orf215 LAP18 OP18 | QAFELILsPRsKEsVPEFPLsPPKKKDLsLEEIQKKLEAAE |
| P17096 | S36 | SIGNOR|EPSD|PSP | HMGA1 HMGIY | QEKDGTEKRGRGRPRKQPPVsPGtALVGsQKEPsEVPtPKR |
| P17174 | S93 | Sugiyama | GOT1 | PILGLAEFRsCAsRLALGDDsPALKEKRVGGVQsLGGtGAL |
| P17480 | S389 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | UBTF UBF UBF1 | EQQRVLGEEKMLNINKKQAtsPASKKPAQEGGKGGSEKPKR |
| P17480 | S484 | SIGNOR|iPTMNet | UBTF UBF UBF1 | KAQSERKPGGEREERGKLPEsPKRAEEIWQQSVIGDYLARF |
| P17600 | S551 | ELM | SYN1 | RQSRPVAGGPGAPPAARPPAsPsPQRQAGPPQATRQTsVSG |
| P17676 | T235 | SIGNOR | CEBPB TCF5 PP9092 | AVPsGssGsLstsssssPPGtPsPADAKAPPTACyAGAAPA |
| P17706 | S304 | SIGNOR|iPTMNet|PSP|Sugiyama | PTPN2 PTPT | SIQKRWKELsKEDLsPAFDHsPNKIMtEKYNGNRIGLEEEK |
| P17812 | S575 | Sugiyama | CTPS1 CTPS | LQKGCRLsPRDtysDRsGsssPDsEItELKFPsINHD____ |
| P17980 | S376 | Sugiyama | PSMC3 TBP1 | MPNEEARARIMQIHSRKMNVsPDVNyEELARCTDDFNGAQC |
| P18031 | S386 | ELM | PTPN1 PTP1B | QDtEVRSRVVGGsLRGAQAAsPAKGEPsLPEKDEDHALSYW |
| P18124 | T17 | Sugiyama | RPL7 | ____MEGVEEKKKEVPAVPEtLKKKRRNFAELKIKRLRKKF |
| P18669 | S31 | Sugiyama | PGAM1 PGAMA CDABP0006 | HGEsAWNLENRFsGWyDADLsPAGHEEAKRGGQALRDAGyE |
| P18754 | S11 | Sugiyama | RCC1 CHC1 | __________MsPKRIAKRRsPPADAIPKsKKVKVsHRsHs |
| P18858 | S49 | Sugiyama | LIG1 | RETEPPPKAALKEWNGVVsEsDsPVKRPGRKAARVLGsEGE |
| P18858 | S51 | SIGNOR|EPSD|PSP|Sugiyama | LIG1 | TEPPPKAALKEWNGVVsEsDsPVKRPGRKAARVLGsEGEEE |
| P18858 | S76 | SIGNOR|EPSD|PSP|Sugiyama | LIG1 | PGRKAARVLGsEGEEEDEALsPAKGQKPALDCsQVsPPRPA |
| P18858 | S91 | SIGNOR|EPSD|PSP | LIG1 | EDEALsPAKGQKPALDCsQVsPPRPAtsPENNAsLsDtsPM |
| P18858 | T195 | EPSD | LIG1 | GEDGDQPttPPKPLKTSKAEtPtEsVsEPEVAtKQELQEEE |
| P18858 | T197 | EPSD | LIG1 | DGDQPttPPKPLKTSKAEtPtEsVsEPEVAtKQELQEEEEQ |
| P18858 | T233 | EPSD|PSP | LIG1 | EEEEQTKPPRRAPKTLsSFFtPRKPAVKKEVKEEEPGAPGK |
| P18887 | S226 | EPSD | XRCC1 | PAGPsyAAAtLQAsSAAssAsPVsRAIGstsKPQEsPKGKR |
| P18887 | S229 | EPSD | XRCC1 | PsyAAAtLQAsSAAssAsPVsRAIGstsKPQEsPKGKRKLD |
| P18887 | S446 | Sugiyama | XRCC1 | PKLPQKQPQTKtKPtQAAGPssPQKPPtPEEtKAAsPVLQE |
| P18887 | T453 | Sugiyama | XRCC1 | PQTKtKPtQAAGPssPQKPPtPEEtKAAsPVLQEDIDIEGV |
| P19338 | S563 | Sugiyama | NCL | CNKREIEGRAIRLELQGPRGsPNARSQPSKTLFVKGLsEDt |
| P19338 | S67 | EPSD | NCL | VIPQKKGKKAAATsAKKVVVsPtKKVAVAtPAKKAAVtPGK |
| P19338 | T121 | EPSD|PSP | NCL | AKAVTtPGKKGAtPGKALVAtPGKKGAAIPAKGAKNGKNAK |
| P19338 | T76 | EPSD|PSP | NCL | AAATsAKKVVVsPtKKVAVAtPAKKAAVtPGKKAAAtPAKK |
| P20248 | S130 | Sugiyama | CCNA2 CCN1 CCNA | AQKKPAESQKIEREDALAFNsAIsLPGPRKPLVPLDYPMDG |
| P20248 | S133 | Sugiyama | CCNA2 CCN1 CCNA | KPAESQKIEREDALAFNsAIsLPGPRKPLVPLDYPMDGSFE |
| P20248 | S154 | GPS6|SIGNOR|EPSD|PSP | CCNA2 CCN1 CCNA | LPGPRKPLVPLDYPMDGSFEsPHTMDMSIILEDEKPVSVNE |
| P20248 | S16 | Sugiyama | CCNA2 CCN1 CCNA | _____MLGNSAPGPATREAGsALLALQQtALQEDQENINPE |
| P20248 | T100 | Sugiyama | CCNA2 CCN1 CCNA | VNDEHVTVPPWKANSKQPAFtIHVDEAEKEAQKKPAESQKI |
| P20248 | T24 | Sugiyama | CCNA2 CCN1 CCNA | NSAPGPATREAGsALLALQQtALQEDQENINPEKAAPVQQP |
| P20700 | S23 | ELM|Sugiyama | LMNB1 LMN2 LMNB | TAtPVPPRMGsRAGGPttPLsPtRLsRLQEKEELRELNDRL |
| P20700 | S393 | ELM | LMNB1 LMN2 LMNB | EIsAYRKLLEGEEERLKLsPsPssRVtVsRAsssRsVRTTR |
| P21333 | S1084 | Sugiyama | FLNA FLN FLN1 | PTKPSKVKAFGPGLQGGsAGsPARFtIDTKGAGTGGLGLTV |
| P21333 | S1533 | Sugiyama | FLNA FLN FLN1 | PSREGPysIsVLyGDEEVPRsPFKVKVLPTHDASKVKAsGP |
| P21333 | S2640 | Sugiyama | FLNA FLN FLN1 | LKDKGEYTLVVKWGDEHIPGsPYRVVVP_____________ |
| P22234 | S27 | EPSD|PSP|Sugiyama | PAICS ADE2 AIRC PAIS | LNIGKKLYEGKtKEVyELLDsPGKVLLQsKDQItAGNAARK |
| P22626 | S225 | Sugiyama | HNRNPA2B1 HNRPA2B1 | GNFGFGDsRGGGGNFGPGPGsNFRGGsDGyGsGRGFGDGyN |
| P22626 | S259 | Sugiyama | HNRNPA2B1 HNRPA2B1 | GFGDGyNGyGGGPGGGNFGGsPGyGGGRGGYGGGGPGYGNQ |
| P22674 | S81 | SIGNOR|EPSD|PSP | CCNO | FESPSSGSDGAESPSAARGGsPLPGPAQPVAQLDLQTFRDY |
| P23258 | S80 | EPSD|PSP | TUBG1 TUBG | yIPRAVLLDLEPRVIHSILNsPYAKLYNPENIYLSEHGGGA |
| P23284 | T81 | Sugiyama | PPIB CYPB | IFGLFGKTVPKTVDNFVALAtGEKGFGYKNSKFHRVIKDFM |
| P23396 | T220 | EPSD | RPS3 OK/SW-cl.26 | PKKPLPDHVsIVEPKDEILPttPIsEQKGGKPEPPAMPQPV |
| P23396 | T221 | EPSD|Sugiyama | RPS3 OK/SW-cl.26 | KKPLPDHVsIVEPKDEILPttPIsEQKGGKPEPPAMPQPVP |
| P23511 | S320 | GPS6|SIGNOR | NFYA | HESRHRHAMARKRGEGGRFFsPKEKDsPHMQDPNQADEEAM |
| P23511 | S326 | GPS6|SIGNOR | NFYA | HAMARKRGEGGRFFsPKEKDsPHMQDPNQADEEAMTQIIRV |
| P23526 | S183 | Sugiyama | AHCY SAHH | NLyKMMANGILKVPAINVNDsVtKsKFDNLyGCRESLIDGI |
| P23588 | S406 | Sugiyama | EIF4B | KLQRQLDEPKLERRPRERHPsWRsEEtQERERsRtGsEssQ |
| P23588 | S409 | Sugiyama | EIF4B | RQLDEPKLERRPRERHPsWRsEEtQERERsRtGsEssQtGt |
| P23771 | T156 | SIGNOR|EPSD|PSP | GATA3 | ASSSSLSGGHASPHLFTFPPtPPKDVsPDPSLSTPGSAGSA |
| P23921 | S559 | SIGNOR|PSP|Sugiyama | RRM1 RR1 | ALEASCDLAKEQGPyEtyEGsPVsKGILQYDMWNVTPTDLW |
| P24864 | S387 | SIGNOR|EPSD|PSP | CCNE1 CCNE | LDLLDKARAKKAMLsEQNRAsPLPsGLLtPPQsGKKQSSGP |
| P24864 | S399 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | CCNE1 CCNE | MLsEQNRAsPLPsGLLtPPQsGKKQSSGPEMA_________ |
| P24864 | T395 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | CCNE1 CCNE | AKKAMLsEQNRAsPLPsGLLtPPQsGKKQSSGPEMA_____ |
| P24928 | S1882 | EPSD | POLR2A POLR2 | PtsPKysPtsPKysPtsPtysPttPKysPtsPtysPtsPVy |
| P24928 | S1917 | EPSD | POLR2A POLR2 | PtsPVytPtsPKysPtsPtysPtsPKysPtsPtysPtsPKG |
| P24928 | T1884 | EPSD | POLR2A POLR2 | sPKysPtsPKysPtsPtysPttPKysPtsPtysPtsPVytP |
| P24928 | T1885 | EPSD | POLR2A POLR2 | PKysPtsPKysPtsPtysPttPKysPtsPtysPtsPVytPt |
| P24928 | T1915 | EPSD | POLR2A POLR2 | ysPtsPVytPtsPKysPtsPtysPtsPKysPtsPtysPtsP |
| P24941 | S46 | Sugiyama | CDK2 CDKN2 | TGEVVALKKIRLDtETEGVPstAIREIsLLKELNHPNIVKL |
| P24941 | T14 | Sugiyama | CDK2 CDKN2 | _______MENFQKVEKIGEGtyGVVyKARNKLTGEVVALKK |
| P24941 | T160 | SIGNOR|EPSD|PSP|Sugiyama | CDK2 CDKN2 | AIKLADFGLARAFGVPVRtytHEVVtLWyRAPEILLGCKYY |
| P24941 | T39 | Sugiyama | CDK2 CDKN2 | yKARNKLTGEVVALKKIRLDtETEGVPstAIREIsLLKELN |
| P24941 | T47 | Sugiyama | CDK2 CDKN2 | GEVVALKKIRLDtETEGVPstAIREIsLLKELNHPNIVKLL |
| P24941 | Y15 | Sugiyama | CDK2 CDKN2 | ______MENFQKVEKIGEGtyGVVyKARNKLTGEVVALKKI |
| P24941 | Y19 | iPTMNet|Sugiyama | CDK2 CDKN2 | __MENFQKVEKIGEGtyGVVyKARNKLTGEVVALKKIRLDt |
| P25054 | S1360 | EPSD|PSP | APC DP2.5 | ssLssEsARHKAVEFssGAKsPsKSGAQtPKsPPEHYVQET |
| P25098 | S670 | SIGNOR|EPSD|PSP | GRK2 ADRBK1 BARK BARK1 | AYREAQQLVQRVPKMKNKPRsPVVELsKVPLVQRGsANGL_ |
| P25205 | T722 | SIGNOR|EPSD|PSP | MCM3 | GDsyDPyDFsDtEEEMPQVHtPKTADsQEtKEsQKVELsES |
| P25786 | S14 | Sugiyama | PSMA1 HC2 NU PROS30 PSC2 | _______MFRNQyDNDVtVWsPQGRIHQIEYAMEAVKQGSA |
| P26038 | S576 | Sugiyama | MSN | YKtLRQIRQGNTKQRIDEFEsM___________________ |
| P26358 | S154 | SIGNOR|EPSD|PSP | DNMT1 AIM CXXC9 DNMT | KPRTPRRsKsDGEAKPEPsPsPRITRKSTRQttITSHFAKG |
| P26373 | S181 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | YKKEKARVItEEEKNFKAFAsLRMARANARLFGIRAKRAKE |
| P26373 | S77 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PIVRCPTVRYHTKVRAGRGFsLEELRVAGIHKKVARTIGIs |
| P27708 | S1859 | Sugiyama | CAD | RGIPGLPDGRFHLPPRIHRAsDPGLPAEEPKEKSSRKVAEP |
| P27797 | S52 | Sugiyama | CALR CRTC | GWtsRWIEsKHKSDFGKFVLssGKFyGDEEKDKGLQTSQDA |
| P27797 | T34 | Sugiyama | CALR CRTC | LAVAEPAVYFKEQFLDGDGWtsRWIEsKHKSDFGKFVLssG |
| P27816 | T571 | Sugiyama | MAP4 | ALKTEAPLAKDGVLtLANNVtPAKDVPPLsEtEAtPVPIKD |
| P27824 | S362 | Sugiyama | CANX | WDEDMDGEWEAPQIANPRCEsAPGCGVWQRPVIDNPNyKGK |
| P27824 | S583 | Sugiyama | CANX | VsQEEEDRKPKAEEDEILNRsPRNRKPRRE___________ |
| P28324 | S387 | EPSD|PSP | ELK4 SAP1 | PSPLLSSIHFWSTLsPVAPLsPARLQGANTLFQFPSVLNSH |
| P28324 | T194 | EPSD|PSP | ELK4 SAP1 | KLAEKKsPQEPTPSVIKFVTtPSKKPPVEPVAATISIGPsI |
| P28749 | S1009 | GPS6|EPSD | RBL1 | PHKNGSGLtPRSALLYKFNGsPSKSLKDINNMIRQGEQRTK |
| P28749 | S615 | PSP | RBL1 | NNFETGNGGNVQGHLPLMPMsPLMHPRVKEVRTDSGSLRRD |
| P28749 | S640 | GPS6|EPSD|PSP | RBL1 | PRVKEVRTDSGSLRRDMQPLsPISVHERYSsPtAGSAKRRL |
| P28749 | S650 | EPSD|PSP | RBL1 | GSLRRDMQPLsPISVHERYSsPtAGSAKRRLFGEDPPKEML |
| P28749 | S762 | GPS6|EPSD | RBL1 | NQESKVKsPVsLtAHSLIGAsPKQTNLTKAQEVHsTGINRP |
| P28749 | S964 | GPS6|EPSD | RBL1 | SFALKYDLANQDHMMDAPPLsPFPHIKQQPGsPRRISQQHS |
| P28749 | S975 | GPS6|EPSD | RBL1 | DHMMDAPPLsPFPHIKQQPGsPRRISQQHSIYIsPHKNGSG |
| P28749 | S988 | GPS6|EPSD | RBL1 | HIKQQPGsPRRISQQHSIYIsPHKNGSGLtPRSALLYKFNG |
| P28749 | T332 | GPS6|EPSD | RBL1 | TVGDFDERIFLGADAEEEIGtPRKFTRDTPLGKLTAQANVE |
| P28749 | T385 | GPS6|EPSD | RBL1 | FAPstPLTGRRYLREKEAVItPVASATQSVSRLQSIVAGLK |
| P28749 | T997 | GPS6|EPSD | RBL1 | RRISQQHSIYIsPHKNGSGLtPRSALLYKFNGsPSKSLKDI |
| P29374 | S1007 | SIGNOR|EPSD|PSP | ARID4A RBBP1 RBP1 | SLVSIPPALPPVVQHNFSVAsPLTLSQDESRSVKSESDITI |
| P29374 | S1140 | EPSD|PSP | ARID4A RBBP1 RBP1 | SSKCtPVKHLNVSKPQKLARsPARIsPHIKDGEKDKHREKH |
| P29374 | S1145 | EPSD|PSP | ARID4A RBBP1 RBP1 | PVKHLNVSKPQKLARsPARIsPHIKDGEKDKHREKHPNSSP |
| P29374 | S864 | SIGNOR|EPSD|PSP | ARID4A RBBP1 RBP1 | DEIDQCVKEKKLKRKILGQssPEKKIRIENGMEMTNTVSQE |
| P29374 | T1124 | EPSD|PSP | ARID4A RBBP1 RBP1 | GtGQssDsEDLPVLDNSSKCtPVKHLNVSKPQKLARsPARI |
| P29401 | S295 | Sugiyama | TKT | ysQIQsKKKILAtPPQEDAPsVDIANIRMPsLPsyKVGDKI |
| P29401 | T287 | Sugiyama | TKT | AEQIIQEIysQIQsKKKILAtPPQEDAPsVDIANIRMPsLP |
| P29590 | S518 | EPSD|PSP | PML MYL PP8675 RNF71 TRIM19 | EARLARssPEQPRPstsKAVsPPHLDGPPsPRsPVIGsEVF |
| P29692 | S133 | Sugiyama | EEF1D EF1D | NVLEKssPGHRAtAPQtQHVsPMRQVEPPAKKPAtPAEDDE |
| P29692 | S162 | Sugiyama | EEF1D EF1D | AKKPAtPAEDDEDDDIDLFGsDNEEEDKEAAQLREERLRQY |
| P29692 | T147 | Sugiyama | EEF1D EF1D | PQtQHVsPMRQVEPPAKKPAtPAEDDEDDDIDLFGsDNEEE |
| P29966 | S118 | EPSD | MARCKS MACS PRKCSL | AGAsPVEKEAPAEGEAAEPGsPtAAEGEAAsAAsstssPKA |
| P29966 | S131 | EPSD | MARCKS MACS PRKCSL | GEAAEPGsPtAAEGEAAsAAsstssPKAEDGAtPsPsNEtP |
| P29966 | S132 | EPSD | MARCKS MACS PRKCSL | EAAEPGsPtAAEGEAAsAAsstssPKAEDGAtPsPsNEtPK |
| P29966 | S134 | EPSD | MARCKS MACS PRKCSL | AEPGsPtAAEGEAAsAAsstssPKAEDGAtPsPsNEtPKKK |
| P29966 | S135 | EPSD | MARCKS MACS PRKCSL | EPGsPtAAEGEAAsAAsstssPKAEDGAtPsPsNEtPKKKK |
| P29966 | S147 | EPSD | MARCKS MACS PRKCSL | AsAAsstssPKAEDGAtPsPsNEtPKKKKKRFsFKKsFKLs |
| P29966 | S26 | EPSD|Sugiyama | MARCKS MACS PRKCSL | SKTAAKGEAAAERPGEAAVAssPsKANGQENGHVKVNGDAs |
| P29966 | S27 | GPS6|EPSD|Sugiyama | MARCKS MACS PRKCSL | KTAAKGEAAAERPGEAAVAssPsKANGQENGHVKVNGDAsP |
| P29966 | T133 | EPSD | MARCKS MACS PRKCSL | AAEPGsPtAAEGEAAsAAsstssPKAEDGAtPsPsNEtPKK |
| P29966 | T150 | GPS6|EPSD | MARCKS MACS PRKCSL | AsstssPKAEDGAtPsPsNEtPKKKKKRFsFKKsFKLsGFs |
| P30050 | S165 | Sugiyama | RPL12 | GRHPHDIIDDINsGAVECPAs____________________ |
| P30050 | S38 | GPS6|SIGNOR|EPSD|PSP | RPL12 | tGGEVGAtsALAPKIGPLGLsPKKVGDDIAKATGDWKGLRI |
| P30101 | S443 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | LsKDPNIVIAKMDAtANDVPsPyEVRGFPtIyFsPANKKLN |
| P30291 | S123 | SIGNOR | WEE1 | DEAGGGAEGDSWEEEGFGsSsPVKsPAAPyFLGssFsPVRC |
| P30304 | S263 | SIGNOR | CDC25A | APLVMRTTNLDNRCKLFDsPsLCssSTRSVLKRPERsQEEs |
| P30304 | S283 | EPSD|PSP | CDC25A | sLCssSTRSVLKRPERsQEEsPPGSTKRRKsMsGASPKEST |
| P30307 | S214 | SIGNOR|EPSD|PSP | CDC25C | LMEFsLKDQEAKVSRsGLYRsPsMPENLNRPRLKQVEKFKD |
| P30533 | S242 | Sugiyama | LRPAP1 A2MRAP | TELKEKLRsINQGLDRLRRVsHQGystEAEFEEPRVIDLWD |
| P30566 | S412 | Sugiyama | ADSL AMPS | AGGSRQDCHEKIRVLsQQAAsVVKQEGGDNDLIERIQVDAY |
| P31327 | S835 | Sugiyama | CPS1 | MCHPsIEGFTPRLPMNKEWPsNLDLRKELSEPSsTRIyAIA |
| P31350 | S20 | EPSD|PSP | RRM2 RR2 | _MLSLRVPLAPItDPQQLQLsPLKGLsLVDKENtPPALsGT |
| P31350 | T33 | EPSD|PSP | RRM2 RR2 | DPQQLQLsPLKGLsLVDKENtPPALsGTRVLASKTARRIFQ |
| P31749 | S477 | SIGNOR|PSP | AKT1 PKB RAC | SMECVDSERRPHFPQFsysAsGtA_________________ |
| P31749 | T479 | SIGNOR|PSP | AKT1 PKB RAC | ECVDSERRPHFPQFsysAsGtA___________________ |
| P31943 | S104 | EPSD|PSP|Sugiyama | HNRNPH1 HNRPH HNRPH1 | EVFKSNNVEMDWVLKHtGPNsPDtANDGFVRLRGLPFGCSK |
| P31948 | S481 | Sugiyama | STIP1 | CKEAADGYQRCMMAQyNRHDsPEDVKRRAMADPEVQQIMSD |
| P32322 | S301 | EPSD | PYCR1 | AIKKTILDKVKLDsPAGtALsPsGHTKLLPRSLAPAGKD__ |
| P32322 | S303 | EPSD | PYCR1 | KKTILDKVKLDsPAGtALsPsGHTKLLPRSLAPAGKD____ |
| P33316 | S99 | Sugiyama | DUT | KGELPKAGGsPAPGPEtPAIsPsKRARPAEVGGMQLRFARL |
| P33981 | S436 | PSP | TTK MPS1 MPS1L1 | VNTEQKHTTFEQPVFSVSKQsPPISTSKWFDPKSICKtPss |
| P33981 | T453 | PSP | TTK MPS1 MPS1L1 | SKQsPPISTSKWFDPKSICKtPssNtLDDYMsCFRtPVVKN |
| P33981 | T468 | GPS6|ELM|iPTMNet|PSP | TTK MPS1 MPS1L1 | KSICKtPssNtLDDYMsCFRtPVVKNDFPPACQLSTPYGQP |
| P33991 | S3 | iPTMNet | MCM4 CDC21 | __________________MssPAstPSRRGSRRGRAtPAQt |
| P33991 | S32 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | MCM4 CDC21 | GSRRGRAtPAQtPRsEDARssPsQRRRGEDSTSTGELQPMP |
| P33991 | S54 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | MCM4 CDC21 | sQRRRGEDSTSTGELQPMPtsPGVDLQSPAAQDVLFSsPPQ |
| P33991 | T110 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | MCM4 CDC21 | LTYGTPSSRVEGTPRSGVRGtPVRQRPDLGsAQKGLQVDLQ |
| P33991 | T19 | SIGNOR|iPTMNet | MCM4 CDC21 | __MssPAstPSRRGSRRGRAtPAQtPRsEDARssPsQRRRG |
| P33991 | T53 | EPSD | MCM4 CDC21 | PsQRRRGEDSTSTGELQPMPtsPGVDLQSPAAQDVLFSsPP |
| P33991 | T7 | iPTMNet | MCM4 CDC21 | ______________MssPAstPSRRGSRRGRAtPAQtPRsE |
| P33992 | S315 | Sugiyama | MCM5 CDC46 | RVLGIQVDTDGSGRSFAGAVsPQEEEEFRRLAALPNVYEVI |
| P33993 | S121 | EPSD|PSP | MCM7 CDC47 MCM2 | VyIEHRLMMEQRSRDPGMVRsPQNQYPAELMRRFELYFQGP |
| P33993 | S365 | EPSD|PSP | MCM7 CDC47 MCM2 | YGHEDVKKALLLLLVGGVDQsPRGMKIRGNINICLMGDPGV |
| P34897 | S266 | Sugiyama | SHMT2 | AHLLADMAHISGLVAAKVIPsPFKHADIVTtTTHKtLRGAR |
| P34931 | S42 | Sugiyama | HSPA1L | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P34931 | T40 | Sugiyama | HSPA1L | VGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQ |
| P34931 | T47 | Sugiyama | HSPA1L | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPQN |
| P34931 | Y43 | Sugiyama | HSPA1L | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P34932 | S408 | Sugiyama | HSPA4 APG2 HSPH2 | KVREFSITDVVPYPISLRWNsPAEEGssDCEVFSKNHAAPF |
| P35221 | S641 | Sugiyama | CTNNA1 | GIRDIRKAVLMIRtPEELDDsDFEtEDFDVRsRtsVQtEDD |
| P35269 | T445 | EPSD | GTF2F1 RAP74 | LDtGPQsLsGKstPQPPsGKttPNsGDVQVTEDAVRRYLTR |
| P35269 | T446 | EPSD | GTF2F1 RAP74 | DtGPQsLsGKstPQPPsGKttPNsGDVQVTEDAVRRYLTRK |
| P35579 | S1892 | Sugiyama | MYH9 | LKQLKRQLEEAEEEAQRANAsRRKLQRELEDAtEtADAMNR |
| P35611 | S613 | EPSD | ADD1 ADDA | AREQKEKsPPDQPAVPHPPPstPIKLEEDLVPEPTTGDDSD |
| P35611 | T614 | EPSD | ADD1 ADDA | REQKEKsPPDQPAVPHPPPstPIKLEEDLVPEPTTGDDSDA |
| P35998 | T193 | Sugiyama | PSMC2 MSS1 | TYSDVGGCKEQIEKLREVVEtPLLHPERFVNLGIEPPKGVL |
| P36578 | S295 | Sugiyama | RPL4 RPL1 | sNyNLPMHKMINtDLsRILKsPEIQRALRAPRKKIHRRVLK |
| P37802 | T180 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | RNFsDNQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL_ |
| P38398 | S114 | PSP | BRCA1 RNF53 | QLDTGLEYANSYNFAKKENNsPEHLKDEVSIIQSMGYRNRA |
| P38398 | S1497 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | BRCA1 RNF53 | FEVsADssTsKNKEPGVERssPSKCPsLDDRWYMHSCsGSL |
| P38398 | T967 | GPS6 | BRCA1 RNF53 | KGGSRFCLSsQFRGNETGLItPNKHGLLQNPYRIPPLFPIK |
| P38432 | S184 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | COIL CLN80 | RKNKATCGTVGDDNEEAKRKsPKKKEKCEYKKKAKNPKsPK |
| P38646 | S212 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | tVPAyFNDsQRQAtKDAGQIsGLNVLRVINEPTAAALAyGL |
| P38646 | T87 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VAVMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAKR |
| P38646 | T94 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | QAKVLENAEGARttPsVVAFtADGERLVGMPAKRQAVtNPN |
| P38919 | T163 | EPSD|PSP | EIF4A3 DDX48 KIAA0111 | GTNVGEDIRKLDyGQHVVAGtPGRVFDMIRRRSLRTRAIKM |
| P38936 | S130 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | CDKN1A CAP20 CDKN1 CIP1 MDA6 PIC1 SDI1 WAF1 | HVDLsLSCTLVPRsGEQAEGsPGGPGDSQGRKRRQtsMTDF |
| P39023 | S265 | Sugiyama | RPL3 OK/SW-cl.32 | HRGLRKVACIGAWHPARVAFsVARAGQKGYHHRTEINKKIY |
| P39748 | S187 | GPS6|EPSD | FEN1 RAD2 | VKAGKVYAAATEDMDCLTFGsPVLMRHLtASEAKKLPIQEF |
| P40763 | S727 | GPS6 | STAT3 APRF | KTKFICVtPttCsNtIDLPMsPRTLDSLMQFGNNGEGAEPS |
| P41252 | S1047 | Sugiyama | IARS1 IARS | ESHTEFIFTTIKAPLKPYPVsPsDKVLIQEKTQLKGSELEI |
| P42677 | S11 | Sugiyama | RPS27 MPS1 | __________MPLAKDLLHPsPEEEKRKHKKKRLVQsPNsy |
| P42677 | S27 | EPSD|PSP | RPS27 MPS1 | LLHPsPEEEKRKHKKKRLVQsPNsyFMDVKCPGCYKITTVF |
| P42858 | S1199 | Sugiyama | HTT HD IT15 | sPIRRKGKEKEPGEQAsVPLsPKKGSEASAASRQSDTSGPV |
| P43243 | S188 | Sugiyama | MATR3 KIAA0723 | EPPyRVPRDDWEEKRHFRRDsFDDRGPsLNPVLDyDHGsRs |
| P43487 | S60 | Sugiyama | RANBP1 | TLEEDEEELFKMRAKLFRFAsENDLPEWKERGTGDVKLLKH |
| P46013 | S357 | EPSD|PSP | MKI67 | FPLyEPAKMKtPVQysQQQNsPQKHKNKDLYTtGRREsVNL |
| P46060 | T409 | GPS6 | RANGAP1 KIAA1835 SD | EEEEEEEEEPQQRGQGEKSAtPSRKILDPNTGEPAPVLssP |
| P46087 | S732 | Sugiyama | NOP2 NOL1 NSUN1 | AFLRQNAPPKGTDtQtPAVLsPsKtQAtLKPKDHHQPLGRA |
| P46527 | S10 | EPSD | CDKN1B KIP1 p27 | ___________MSNVRVSNGsPsLERMDARQAEHPKPSACR |
| P46527 | T187 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | CDKN1B KIP1 p27 | ANRTEENVsDGsPNAGSVEQtPKKPGLRRRQt_________ |
| P46531 | S2513 | GPS6 | NOTCH1 TAN1 | PVDNTPSHQLQVPEHPFLtPsPEsPDQWssssPHSNVSDWS |
| P46531 | S2516 | GPS6 | NOTCH1 TAN1 | NTPSHQLQVPEHPFLtPsPEsPDQWssssPHSNVSDWSEGV |
| P46777 | S172 | Sugiyama | RPL5 MSTP030 | RTTTGNKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNA |
| P46777 | S176 | Sugiyama | RPL5 MSTP030 | GNKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNAEVHR |
| P46777 | S224 | Sugiyama | RPL5 MSTP030 | VADyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAH |
| P46782 | S142 | Sugiyama | RPS5 | REDSTRIGRAGTVRRQAVDVsPLRRVNQAIWLLCTGAREAA |
| P46783 | S146 | Sugiyama | RPS10 | TYRRSAVPPGADKKAEAGAGsAtEFQFRGGFGRGRGQPPQ_ |
| P46937 | S289 | Sugiyama | YAP1 YAP65 | MNQRIsQsAPVKQPPPLAPQsPQGGVMGGsNsNQQQQMRLQ |
| P47756 | S207 | Sugiyama | CAPZB | MNLGGsLtRQMEKDEtVsDCsPHIANIGRLVEDMENKIRst |
| P47914 | S142 | Sugiyama | RPL29 | KAKAKAKAKDQTKAQAAAPAsVPAQAPKRtQAPtKAsE___ |
| P48200 | S157 | EPSD|PSP | IREB2 | CAIQNAPNPGGGDLQKAGKLsPLKVQPKKLPCRGQTTCRGs |
| P48431 | S249 | PSP | SOX2 | QQGTPGMALGSMGSVVKSEAsssPPVVtSSSHSRAPCQAGD |
| P48431 | S250 | PSP | SOX2 | QGTPGMALGSMGSVVKSEAsssPPVVtSSSHSRAPCQAGDL |
| P48634 | T1353 | EPSD|PSP | PRRC2A BAT2 G2 | ERRGDKEAPPPVLLtPKAVGtPGGGGGGAVPGISAMSRGDL |
| P48681 | T1299 | ELM | NES Nbla00170 | GEEsREEsEEDELGETLPDStPLGFYLRsPtsPRWDPTGEQ |
| P48681 | T315 | ELM | NES Nbla00170 | LSLEVATYRTLLEAENsRLQtPGGGsKtsLsFQDPKLELQF |
| P48735 | T197 | SIGNOR | IDH2 | DQYKATDFVADRAGTFKMVFtPKDGSGVKEWEVYNFPAGGV |
| P49327 | Y289 | Sugiyama | FASN FAS | QEQLIRSLyQsAGVAPEsFEyIEAHGtGTKVGDPQELNGIt |
| P49418 | S272 | ELM | AMPH AMPH1 | SGPLRIAKtPsPPEEPsPLPsPtAsPNHTLAPAsPAPARPR |
| P49418 | S276 | ELM | AMPH AMPH1 | RIAKtPsPPEEPsPLPsPtAsPNHTLAPAsPAPARPRsPsQ |
| P49418 | S285 | ELM | AMPH AMPH1 | EEPsPLPsPtAsPNHTLAPAsPAPARPRsPsQTRKGPPVPP |
| P49450 | S19 | EPSD|PSP | CENPA | __MGPRRRsRKPEAPRRRsPsPtPtPGPsRRGPsLGAssHQ |
| P49454 | S156 | EPSD | CENPF | DVSLNPCNtPQKIFTTPLtPsQYYSGSKYEDLKEKYNKEVE |
| P49454 | T154 | EPSD | CENPF | SADVSLNPCNtPQKIFTTPLtPsQYYSGSKYEDLKEKYNKE |
| P49459 | S120 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | UBE2A RAD6A | YDVSSILTSIQSLLDEPNPNsPANSQAAQLYQENKREYEKR |
| P49643 | S476 | Sugiyama | PRIM2 PRIM2A | NGGKDIKKEPIQPEtPQPKPsVQKTKDASSALASLNSSLEM |
| P49643 | T470 | Sugiyama | PRIM2 PRIM2A | ESQRILNGGKDIKKEPIQPEtPQPKPsVQKTKDASSALASL |
| P49736 | S108 | EPSD|PSP | MCM2 BM28 CCNL1 CDCL1 KIAA0030 | DAYEAEGLALDDEDVEELtAsQREAAERAMRQRDREAGRGL |
| P49736 | S13 | GPS6|SIGNOR|EPSD|PSP | MCM2 BM28 CCNL1 CDCL1 KIAA0030 | ________MAEssEsFtMAssPAQRRRGNDPLtssPGRssR |
| P49736 | S139 | EPSD|PSP|Sugiyama | MCM2 BM28 CCNL1 CDCL1 KIAA0030 | QRDREAGRGLGRMRRGLLyDsDEEDEERPARKRRQVERAtE |
| P49736 | S27 | GPS6|EPSD|PSP|Sugiyama | MCM2 BM28 CCNL1 CDCL1 KIAA0030 | sFtMAssPAQRRRGNDPLtssPGRssRRtDALtssPGRDLP |
| P49736 | S40 | EPSD|PSP | MCM2 BM28 CCNL1 CDCL1 KIAA0030 | GNDPLtssPGRssRRtDALtssPGRDLPPFEDEsEGLLGtE |
| P49736 | S41 | GPS6|EPSD|PSP | MCM2 BM28 CCNL1 CDCL1 KIAA0030 | NDPLtssPGRssRRtDALtssPGRDLPPFEDEsEGLLGtEG |
| P49736 | S53 | EPSD|PSP | MCM2 BM28 CCNL1 CDCL1 KIAA0030 | RRtDALtssPGRDLPPFEDEsEGLLGtEGPLEEEEDGEELI |
| P49768 | T354 | ELM | PSEN1 AD3 PS1 PSNL1 | GGFsEEWEAQRDsHLGPHRstPEsRAAVQELsssILAGEDP |
| P49790 | S386 | EPSD | NUP153 | RLMtPKPVSIATNRSVYFKPsLtPsGEFRKTNQRIDNKCST |
| P49790 | T388 | EPSD | NUP153 | MtPKPVSIATNRSVYFKPsLtPsGEFRKTNQRIDNKCSTGY |
| P49915 | S313 | EPSD | GMPS | QVKVINAAHSFYNGtttLPIsDEDRtPRKRISKTLNMttsP |
| P49915 | T318 | EPSD | GMPS | NAAHSFYNGtttLPIsDEDRtPRKRISKTLNMttsPEEKRK |
| P49916 | S210 | SIGNOR|EPSD|PSP | LIG3 | GtPKKKAVVQAKLtttGQVtsPVKGAsFVTSTNPRKFsGFs |
| P49916 | S913 | EPSD|PSP | LIG3 | NMQTAKPSAMKVGEKLAtKssPVKVGEKRKAADETLCQTKV |
| P49916 | T191 | EPSD|PSP | LIG3 | DNEKEQITQHIADLSSKAAGtPKKKAVVQAKLtttGQVtsP |
| P50395 | S61 | Sugiyama | GDI2 RABGDIB | GEsAsItPLEDLyKRFKIPGsPPEsMGRGRDWNVDLIPKFL |
| P50502 | S181 | Sugiyama | ST13 AAG2 FAM10A1 HIP SNC6 | LQKPNAAIRDCDRAIEINPDsAQPyKWRGKAHRLLGHWEEA |
| P50570 | S764 | EPSD|PSP | DNM2 DYN2 | VstPVPPPVDDtWLQsAssHsPtPQRRPVSSIHPPGRPPAV |
| P50613 | S164 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | CDK7 CAK CAK1 CDKN7 MO15 STK1 | LLDENGVLKLADFGLAKsFGsPNRAytHQVVtRWYRAPELL |
| P50613 | T170 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | CDK7 CAK CAK1 CDKN7 MO15 STK1 | VLKLADFGLAKsFGsPNRAytHQVVtRWYRAPELLFGARMY |
| P50750 | S90 | EPSD|PSP | CDK9 CDC2L4 TAK | LQLLKHENVVNLIEICRTKAsPYNRCKGSIYLVFDFCEHDL |
| P51116 | S601 | Sugiyama | FXR2 FMR1L2 | RPQRRNRSRRRRNRGNRtDGsIsGDRQPVtVADyIsRAEsQ |
| P51587 | S3291 | GPS6|EPSD | BRCA2 FACD FANCD1 | LDFLSRLPLPPPVSPICTFVsPAAQKAFQPPRSCGTKYETP |
| P51587 | T77 | PSP | BRCA2 FACD FANCD1 | yEPNLFKTPQRKPsYNQLAstPIIFKEQGLTLPLYQsPVKE |
| P51649 | T181 | EPSD|PSP | ALDH5A1 SSADH | AFFLEWFSEEARRVYGDIIHtPAKDRRALVLKQPIGVAAVI |
| P51858 | S165 | Sugiyama | HDGF HMG1L2 | AKEKNEKGALKRRAGDLLEDsPKRPKEAENPEGEEKEAAtL |
| P51991 | S358 | Sugiyama | HNRNPA3 HNRPA3 | QQQSNYGPMKGGsFGGRssGsPyGGGyGsGGGsGGyGsRRF |
| P51991 | Y360 | Sugiyama | HNRNPA3 HNRPA3 | QSNYGPMKGGsFGGRssGsPyGGGyGsGGGsGGyGsRRF__ |
| P51991 | Y364 | Sugiyama | HNRNPA3 HNRPA3 | GPMKGGsFGGRssGsPyGGGyGsGGGsGGyGsRRF______ |
| P52732 | T926 | ELM | KIF11 EG5 KNSL1 TRIP5 | LTKLNCFLEQDLKLDIPtGttPQRKsyLyPSTLVRTEPREH |
| P52789 | S415 | Sugiyama | HK2 | QRIKENKGEERLRstIGVDGsVyKKHPHFAKRLHKTVRRLV |
| P52948 | S612 | EPSD|PSP | NUP98 ADAR2 | MPKKsIKKLVLKNLNNsNLFsPVNRDsENLAsPsEyPENGE |
| P52948 | S623 | Sugiyama | NUP98 ADAR2 | KNLNNsNLFsPVNRDsENLAsPsEyPENGERFsFLSKPVDE |
| P53396 | S455 | Sugiyama | ACLY | ANFLLNAsGststPAPsRtAsFsEsRADEVAPAKKAKPAMP |
| P54132 | S175 | SIGNOR|EPSD|PSP | BLM RECQ2 RECQL3 | DDMDDFDTSETSKsFVtPPQsHFVRVStAQKSKKGKRNFFK |
| P54132 | T171 | SIGNOR | BLM RECQ2 RECQL3 | INDWDDMDDFDTSETSKsFVtPPQsHFVRVStAQKSKKGKR |
| P54198 | S584 | EPSD | HIRA DGCR1 HIR TUPLE1 | AFDSRFTERSKAtPGAPALtsMtPtAVERLKEQNLVKELRP |
| P54198 | S687 | iPTMNet | HIRA DGCR1 HIR TUPLE1 | AEKEAMCLsAPALALKLPIPsPQRAFTLQVSSDPSMYIEVE |
| P54198 | T555 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | HIRA DGCR1 HIR TUPLE1 | NKDsMNAtstPAALsPsVLttPsKIEPMKAFDSRFTERSKA |
| P54198 | T583 | EPSD | HIRA DGCR1 HIR TUPLE1 | KAFDSRFTERSKAtPGAPALtsMtPtAVERLKEQNLVKELR |
| P54198 | T586 | EPSD | HIRA DGCR1 HIR TUPLE1 | DSRFTERSKAtPGAPALtsMtPtAVERLKEQNLVKELRPRD |
| P54198 | T588 | EPSD | HIRA DGCR1 HIR TUPLE1 | RFTERSKAtPGAPALtsMtPtAVERLKEQNLVKELRPRDLL |
| P54652 | S41 | Sugiyama | HSPA2 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P54652 | T229 | Sugiyama | HSPA2 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVSHLAEEFK |
| P54652 | T39 | Sugiyama | HSPA2 | VGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQ |
| P54652 | T46 | Sugiyama | HSPA2 | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPTN |
| P54652 | Y42 | Sugiyama | HSPA2 | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P55036 | S115 | Sugiyama | PSMD4 MCB1 | LALKHRQGKNHKMRIIAFVGsPVEDNEKDLVKLAKRLKKEK |
| P55060 | S931 | Sugiyama | CSE1L CAS XPO2 | KKEHDPVGQMVNNPKIHLAQsLHKLSTACPGRVPSMVSTSL |
| P55196 | T1352 | EPSD|PSP | AFDN AF6 MLLT4 | AstLtKSGPGRWKTPAAIPAtPVAVSQPIRTDLPPPPPPPP |
| P55273 | S76 | SIGNOR|EPSD|PSP | CDKN2D | IALELLKQGAsPNVQDTSGTsPVHDAARTGFLDTLKVLVEH |
| P55273 | T141 | SIGNOR | CDKN2D | AVVSFLAAESDLHRRDARGLtPLELALQRGAQDLVDILQGH |
| P55795 | S104 | EPSD|PSP|Sugiyama | HNRNPH2 FTP3 HNRPH2 | EVFKSNsVEMDWVLKHtGPNsPDtANDGFVRLRGLPFGCSK |
| P55809 | S170 | Sugiyama | OXCT1 OXCT SCOT | AGVPAFyTPtGyGTLVQEGGsPIKYNKDGSVAIASKPREVR |
| P57740 | S10 | EPSD | NUP107 | ___________MDRsGFGEIssPVIREAEVTRTARKQSAQK |
| P57740 | S11 | EPSD | NUP107 | __________MDRsGFGEIssPVIREAEVTRTARKQSAQKR |
| P60709 | S199 | Sugiyama | ACTB | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P60709 | S323 | Sugiyama | ACTB | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P60709 | S368 | Sugiyama | ACTB | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P60709 | T324 | Sugiyama | ACTB | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P60709 | Y240 | Sugiyama | ACTB | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P61247 | S192 | Sugiyama | RPS3A FTE1 MFTL | MTREVQTNDLKEVVNKLIPDsIGKDIEKACQsIyPLHDVFV |
| P61254 | S12 | Sugiyama | RPL26 | _________MKFNPFVtsDRsKNRKRHFNAPsHIRRKIMss |
| P61254 | S32 | Sugiyama | RPL26 | sKNRKRHFNAPsHIRRKIMssPLSKELRQKYNVRSMPIRKD |
| P61254 | T8 | Sugiyama | RPL26 | _____________MKFNPFVtsDRsKNRKRHFNAPsHIRRK |
| P61604 | S51 | Sugiyama | HSPE1 | IMLPEKSQGKVLQAtVVAVGsGsKGKGGEIQPVsVKVGDKV |
| P61916 | S40 | Sugiyama | NPC2 HE1 | EPVQFKDCGsVDGVIKEVNVsPCPtQPCQLSKGQSYSVNVT |
| P61978 | S216 | EPSD|PSP | HNRNPK HNRPK | GGKPDRVVECIKIILDLIsEsPIKGRAQPyDPNFyDETyDy |
| P61978 | S284 | PSP|Sugiyama | HNRNPK HNRPK | MPPGRGGRPMPPSRRDyDDMsPRRGPPPPPPGRGGRGGsRA |
| P61978 | S401 | Sugiyama | HNRNPK HNRPK | GDLGGPIIttQVtIPKDLAGsIIGKGGQRIKQIRHEsGAsI |
| P62136 | T320 | SIGNOR|ELM|EPSD|PSP | PPP1CA PPP1A | DKNKGKyGQFSGLNPGGRPItPPRNsAKAKK__________ |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62263 | T133 | Sugiyama | RPS14 PRO2640 | QsALRALARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL__ |
| P62266 | T34 | Sugiyama | RPS23 | RSHRRDQKWHDKQYKKAHLGtALKANPFGGAsHAKGIVLEK |
| P62273 | Y7 | Sugiyama | RPS29 | ______________MGHQQLyWsHPRKFGQGSRSCRVCSNR |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P62324 | S159 | EPSD|PSP | BTG1 | NVQMVDSRISCKEELLLGRtsPsKNYNMMTVSG________ |
| P62424 | T93 | Sugiyama | RPL7A SURF-3 SURF3 | RLKVPPAINQFtQALDRQTAtQLLKLAHKYRPEtKQEKKQR |
| P62714 | S212 | Sugiyama | PPP2CB | EGPMCDLLWSDPDDRGGWGIsPRGAGYTFGQDISETFNHAN |
| P62736 | S325 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P62736 | T326 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P62736 | Y242 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P62750 | S43 | Sugiyama | RPL23A | KAKKAVLKGVHSHKKKKIRtsPTFRRPKTLRLRRQPKYPRK |
| P62753 | T127 | Sugiyama | RPS6 OK/SW-cl.2 | SVLNLVIVKKGEKDIPGLtDttVPRRLGPKRASRIRKLFNL |
| P62826 | T66 | Sugiyama | RAN ARA24 OK/SW-cl.81 | EVHPLVFHTNRGPIKFNVWDtAGQEKFGGLRDGYYIQAQCA |
| P62913 | T47 | EPSD|PSP | RPL11 | GEsGDRLtRAAKVLEQLtGQtPVFsKARyTVRsFGIRRNEK |
| P62942 | S9 | Sugiyama | FKBP1A FKBP1 FKBP12 | ____________MGVQVEtIsPGDGRtFPKRGQtCVVHytG |
| P63173 | T14 | Sugiyama | RPL38 | _______MPRKIEEIKDFLLtARRKDAKSVKIKKNKDNVKF |
| P63261 | S199 | Sugiyama | ACTG1 ACTG | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P63261 | S323 | Sugiyama | ACTG1 ACTG | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P63261 | S368 | Sugiyama | ACTG1 ACTG | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P63261 | T324 | Sugiyama | ACTG1 ACTG | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P63261 | Y240 | Sugiyama | ACTG1 ACTG | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P63267 | S324 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P63267 | T325 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P63267 | Y241 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P67775 | S212 | Sugiyama | PPP2CA | EGPMCDLLWSDPDDRGGWGIsPRGAGYTFGQDISETFNHAN |
| P67809 | S167 | Sugiyama | YBX1 NSEP1 YB1 | RYPRRRGPPRNyQQNyQNsEsGEKNEGsEsAPEGQAQQRRP |
| P67809 | T89 | Sugiyama | YBX1 NSEP1 YB1 | RNGyGFINRNDtKEDVFVHQtAIKKNNPRKyLRsVGDGEtV |
| P67870 | S209 | ELM | CSNK2B CK2N G5A | GFKIHPMAYQLQLQAAsNFKsPVKtIR______________ |
| P68032 | S325 | Sugiyama | ACTC1 ACTC | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68032 | T326 | Sugiyama | ACTC1 ACTC | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68032 | Y242 | Sugiyama | ACTC1 ACTC | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68133 | S325 | Sugiyama | ACTA1 ACTA | TTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68133 | T326 | Sugiyama | ACTA1 ACTA | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68133 | Y242 | Sugiyama | ACTA1 ACTA | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68363 | T56 | Sugiyama | TUBA1B | MPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtVID |
| P68363 | Y432 | Sugiyama | TUBA1B | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| P68400 | S362 | ELM | CSNK2A1 CK2A1 | GStPVSSANMMSGISSVPtPsPLGPLAGsPVIAAANPLGMP |
| P68400 | S370 | ELM | CSNK2A1 CK2A1 | NMMSGISSVPtPsPLGPLAGsPVIAAANPLGMPVPAAAGAQ |
| P68400 | T344 | ELM | CSNK2A1 CK2A1 | FytVVKDQARMGSSSMPGGStPVSSANMMSGISSVPtPsPL |
| P68400 | T360 | ELM | CSNK2A1 CK2A1 | PGGStPVSSANMMSGISSVPtPsPLGPLAGsPVIAAANPLG |
| P78316 | S96 | Sugiyama | NOP14 C4orf9 NOL14 RES4-25 | ERDKSNVFRDKRFGEyNsNMsPEEKMMKRFALEQQRHHEKK |
| P78317 | T112 | SIGNOR|EPSD|PSP | RNF4 SNURF RES4-26 | VVssDDEELsRDRDVYVTtHtPRNARDEGATGLRPSGTVSC |
| P78317 | T26 | SIGNOR|EPSD|PSP | RNF4 SNURF RES4-26 | RRGGAINSRQAQKRTREATStPEISLEAEPIELVETAGDEI |
| P78347 | T556 | EPSD | GTF2I BAP135 WBSCR6 | FVIKRPELLTHsttEVTQPRtNtPVKEDWNVRITKLRKQVE |
| P78347 | T558 | EPSD | GTF2I BAP135 WBSCR6 | IKRPELLTHsttEVTQPRtNtPVKEDWNVRITKLRKQVEEI |
| P82970 | T31 | EPSD|PSP | HMGN5 NSBP1 | DMRQEPKRRsARLsAMLVPVtPEVKPKRTSSSRKMKTKSDM |
| P83731 | S38 | Sugiyama | RPL24 | GRRYARTDGKVFQFLNAKCEsAFLSKRNPRQINWtVLyRRK |
| P83731 | S9 | Sugiyama | RPL24 | ____________MKVELCsFsGyKIYPGHGRRYARTDGKVF |
| P83731 | T52 | Sugiyama | RPL24 | LNAKCEsAFLSKRNPRQINWtVLyRRKHKKGQsEEIQKKRT |
| P83731 | Y55 | Sugiyama | RPL24 | KCEsAFLSKRNPRQINWtVLyRRKHKKGQsEEIQKKRTRRA |
| P84022 | S204 | SIGNOR|iPTMNet|PSP | SMAD3 MADH3 | YLSEDGETSDHQMNHSMDAGsPNLsPNPMsPAHNNLDLQPV |
| P84022 | S208 | SIGNOR|iPTMNet|PSP | SMAD3 MADH3 | DGETSDHQMNHSMDAGsPNLsPNPMsPAHNNLDLQPVTYCE |
| P84022 | S213 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | SMAD3 MADH3 | DHQMNHSMDAGsPNLsPNPMsPAHNNLDLQPVTYCEPAFWC |
| P84022 | T179 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | SMAD3 MADH3 | SIPENTNFPAGIEPQSNIPEtPPPGYLSEDGETSDHQMNHS |
| P84022 | T8 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | SMAD3 MADH3 | _____________MSsILPFtPPIVKRLLGWKKGEQNGQEE |
| P84098 | S12 | Sugiyama | RPL19 | _________MSMLRLQKRLAssVLRCGKKKVWLDPNEtNEI |
| P85037 | S420 | Sugiyama | FOXK1 MNF | RGVSCFRtPFGPLssRsAPAsPtHPGLMsPRsGGLQtPECL |
| P85037 | S428 | Sugiyama | FOXK1 MNF | PFGPLssRsAPAsPtHPGLMsPRsGGLQtPECLsREGsPIP |
| Q00059 | S124 | EPSD | TFAM TCF6 TCF6L2 | RAEWQVYKEEISRFKEQLtPsQIMsLEKEIMDKHLKRKAMT |
| Q00059 | T122 | EPSD | TFAM TCF6 TCF6L2 | AYRAEWQVYKEEISRFKEQLtPsQIMsLEKEIMDKHLKRKA |
| Q00526 | T14 | Sugiyama | CDK3 CDKN3 | _______MDMFQKVEKIGEGtyGVVyKAKNRETGQLVALKK |
| Q00526 | T160 | Sugiyama | CDK3 CDKN3 | AIKLADFGLARAFGVPLRtYtHEVVTLWYRAPEILLGSKFY |
| Q00526 | Y15 | Sugiyama | CDK3 CDKN3 | ______MDMFQKVEKIGEGtyGVVyKAKNRETGQLVALKKI |
| Q00526 | Y19 | Sugiyama | CDK3 CDKN3 | __MDMFQKVEKIGEGtyGVVyKAKNRETGQLVALKKIRLDL |
| Q00536 | S138 | EPSD|PSP | CDK16 PCTAIRE1 PCTK1 | LsLPADIRLPEGYLEKLTLNsPIFDKPLsRRLRRVsLsEIG |
| Q00536 | S95 | ELM | CDK16 PCTAIRE1 PCTK1 | KMGsDGEsDQAsAtssDEVQsPVRVRMRNHPPRKIstEDIN |
| Q01105 | S168 | Sugiyama | SET | ENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQTQN |
| Q01105 | T169 | Sugiyama | SET | NKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQTQNK |
| Q01130 | S212 | Sugiyama | SRSF2 SFRS2 | PPPVsKRESKSRSRsKsPPKsPEEEGAVss___________ |
| Q01167 | S373 | SIGNOR|EPSD|PSP | FOXK2 ILF ILF1 | RGVPCFRtPLGPLssRsAPAsPNHAGVLsAHssGAQtPEsL |
| Q01167 | S428 | SIGNOR|EPSD|PSP | FOXK2 ILF ILF1 | AAQPKLAVIQEARFAQsAPGsPLssQPVLITVQRQLPQAIK |
| Q01196 | S249 | SIGNOR | RUNX1 AML1 CBFA2 | stAFNPQPQSQMQDTRQIQPsPPWsyDQsyQyLGSIAsPsV |
| Q01196 | S266 | SIGNOR | RUNX1 AML1 CBFA2 | IQPsPPWsyDQsyQyLGSIAsPsVHPAtPIsPGRASGMTTL |
| Q01196 | S276 | SIGNOR | RUNX1 AML1 CBFA2 | QsyQyLGSIAsPsVHPAtPIsPGRASGMTTLSAELSSRLsT |
| Q01196 | T273 | SIGNOR | RUNX1 AML1 CBFA2 | syDQsyQyLGSIAsPsVHPAtPIsPGRASGMTTLSAELSSR |
| Q01860 | S12 | SIGNOR | POU5F1 OCT3 OCT4 OTF3 | _________MAGHLASDFAFsPPPGGGGDGPGGPEPGWVDP |
| Q02363 | S5 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | ID2 BHLHB26 | ________________MKAFsPVRSVRKNsLSDHSLGISRs |
| Q02535 | S5 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | ID3 1R21 BHLHB25 HEIR1 | ________________MKALsPVRGCyEAVCCLsERSLAIA |
| Q02539 | T152 | EPSD|PSP | H1-1 H1F1 HIST1H1A | ATGASKKLKKATGASKKSVKtPKKAKKPAATRKSSKNPKKP |
| Q02543 | S123 | Sugiyama | RPL18A | AGAVtQCyRDMGARHRARAHsIQIMKVEEIAASKCRRPAVK |
| Q02543 | T24 | Sugiyama | RPL18A | SGTLREYKVVGRCLPTPKCHtPPLYRMRIFAPNHVVAKSRF |
| Q02750 | T286 | ELM | MAP2K1 MEK1 PRKMK1 | PDAKELELMFGCQVEGDAAEtPPRPRtPGRPLssyGMDsRP |
| Q03112 | S624 | SIGNOR | MECOM EVI1 MDS1 PRDM3 | DIESDKEKFKENGKMFKDKVsPLQNLASINNKKEYSNHSIF |
| Q03252 | S37 | EPSD|PSP | LMNB2 LMN2 | AAATMAtPLPGRAGGPAtPLsPtRLsRLQEKEELRELNDRL |
| Q03252 | T39 | EPSD | LMNB2 LMN2 | ATMAtPLPGRAGGPAtPLsPtRLsRLQEKEELRELNDRLAH |
| Q04323 | S199 | EPSD | UBXN1 SAKS1 | YGGsVGSQPPPVAPEPGPVPssPsQEPPtKREYDQCRIQVR |
| Q04323 | S200 | EPSD | UBXN1 SAKS1 | GGsVGSQPPPVAPEPGPVPssPsQEPPtKREYDQCRIQVRL |
| Q04323 | S202 | EPSD | UBXN1 SAKS1 | sVGSQPPPVAPEPGPVPssPsQEPPtKREYDQCRIQVRLPD |
| Q04637 | S1231 | Sugiyama | EIF4G1 EIF4F EIF4G EIF4GI | tEDRDRGRDAVKREAALPPVsPLKAALsEEELEKKsKAIIE |
| Q04637 | T647 | EPSD|PSP | EIF4G1 EIF4F EIF4G EIF4GI | MQKPEGLPHISDVVLDKANKtPLRPLDPTRLQGINCGPDFt |
| Q05193 | S774 | ELM | DNM1 DNM | MPPPVDDSWLQVQSVPAGRRsPTSsPtPQRRAPAVPPARPG |
| Q05193 | S778 | ELM | DNM1 DNM | VDDSWLQVQSVPAGRRsPTSsPtPQRRAPAVPPARPGsRGP |
| Q05209 | S19 | SIGNOR|EPSD|PSP | PTPN12 | __MEQVEILRKFIQRVQAMKsPDHNGEDNFARDFMRLRRLs |
| Q05516 | S197 | SIGNOR|EPSD|PSP | ZBTB16 PLZF ZNF145 | PGPMVDQSPSVSTSFGLSAMsPTKAAVDSLMTIGQSLLQGT |
| Q05516 | T282 | SIGNOR|EPSD|PSP | ZBTB16 PLZF ZNF145 | SSISGGMGDKVEERGKEGPGtPTRSSVITSARELHYGREES |
| Q05519 | S207 | EPSD | SRSF11 SFRS11 | LLKLMSTVDPKLNHVAAGLVsPsLKsDTsSKEIEEAMKRVR |
| Q05519 | S209 | EPSD | SRSF11 SFRS11 | KLMSTVDPKLNHVAAGLVsPsLKsDTsSKEIEEAMKRVREA |
| Q05682 | T730 | EPSD|PSP|Sugiyama | CALD1 CAD CDM | RNIKsMWEKGNVFssPtAAGtPNKEtAGLKVGVSsRINEWL |
| Q06210 | T263 | Sugiyama | GFPT1 GFAT GFPT | QGERGKDKKGSCNLsRVDsttCLFPVEEKAVEyyFASDASA |
| Q06830 | T90 | SIGNOR | PRDX1 PAGA PAGB TDPX2 | NCQVIGASVDSHFCHLAWVNtPKKQGGLGPMNIPLVSDPKR |
| Q07666 | S20 | Sugiyama | KHDRBS1 SAM68 | _MQRRDDPAARMsRssGRsGsMDPsGAHPsVRQtPsRQPPL |
| Q07820 | S121 | EPSD|PSP | MCL1 BCL2L3 | PTRRAAPLEEMEAPAADAIMsPEEELDGYEPEPLGKRPAVL |
| Q07820 | S64 | GPS6|EPSD|PSP | MCL1 BCL2L3 | ARREIGGGEAGAVIGGSAGAsPPstLtPDSRRVARPPPIGA |
| Q07820 | T163 | EPSD|PSP | MCL1 BCL2L3 | LLELVGEsGNNtstDGsLPstPPPAEEEEDELYRQSLEIIS |
| Q07820 | T70 | EPSD|PSP | MCL1 BCL2L3 | GGEAGAVIGGSAGAsPPstLtPDSRRVARPPPIGAEVPDVT |
| Q07820 | T92 | EPSD|PSP | MCL1 BCL2L3 | DSRRVARPPPIGAEVPDVTAtPARLLFFAPTRRAAPLEEME |
| Q07960 | S51 | Sugiyama | ARHGAP1 CDC42GAP RHOGAP1 | KNWPsDEMPDFPKsDDsKsssPELVtHLKWDDPyyDIARHQ |
| Q08050 | T611 | SIGNOR|iPTMNet|EPSD | FOXM1 FKHL16 HFH11 MPP2 WIN | SQEVGGPFKtPIKETLPISStPsKSVLPRtPEsWRLtPPAK |
| Q08999 | S1044 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | RBL2 RB2 | YSQANMDAPPLsPYPFVRtGsPRRIQLSQNHPVyIsPHKNE |
| Q08999 | S1068 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | RBL2 RB2 | IQLSQNHPVyIsPHKNEtMLsPREKIFYYFsNsPsKRLREI |
| Q08999 | S1080 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | RBL2 RB2 | PHKNEtMLsPREKIFYYFsNsPsKRLREINSMIRTGEtPTK |
| Q08999 | S1112 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | RBL2 RB2 | IRTGEtPTKKRGILLEDGsEsPAKRICPENHSALLRRLQDV |
| Q08999 | S413 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | RBL2 RB2 | KSKALRIStPLTGVRyIKENsPCVtPVSTATHSLSRLHTML |
| Q08999 | S639 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | RBL2 RB2 | CEEVMPPQNLERADEICIAGsPLtPRRVtEVRADTGGLGRs |
| Q08999 | S662 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | RBL2 RB2 | tPRRVtEVRADTGGLGRsItsPTtLyDRYssPPAStTRRRL |
| Q08999 | S688 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | RBL2 RB2 | DRYssPPAStTRRRLFVENDsPsDGGtPGRMPPQPLVNAVP |
| Q08999 | S952 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | RBL2 RB2 | IKGKRKRRNSGSSDSRsHQNsPtELNKDRtsRDssPVMRss |
| Q08999 | S973 | EPSD | RBL2 RB2 | PtELNKDRtsRDssPVMRssstLPVPQPssAPPtPtRLTGA |
| Q08999 | S982 | EPSD | RBL2 RB2 | sRDssPVMRssstLPVPQPssAPPtPtRLTGANsDMEEEER |
| Q08999 | T1097 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | RBL2 RB2 | FsNsPsKRLREINSMIRTGEtPTKKRGILLEDGsEsPAKRI |
| Q08999 | T417 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | RBL2 RB2 | LRIStPLTGVRyIKENsPCVtPVSTATHSLSRLHTMLTGLR |
| Q08999 | T642 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | RBL2 RB2 | VMPPQNLERADEICIAGsPLtPRRVtEVRADTGGLGRsIts |
| Q08999 | T694 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | RBL2 RB2 | PAStTRRRLFVENDsPsDGGtPGRMPPQPLVNAVPVQNVSG |
| Q08AD1 | S1319 | Sugiyama | CAMSAP2 CAMSAP1L1 KIAA1078 | NEsVHsGKRtPRsEsVEGFLsPsRCGsRNGEKDWENAstts |
| Q08J23 | S743 | Sugiyama | NSUN2 SAKI TRM4 | AstGQPDNDVtEGQRAGEPNsPDAEEANsPDVtAGCDPAGV |
| Q09161 | S22 | Sugiyama | NCBP1 CBP80 NCBP | SRRRHsDENDGGQPHKRRKtsDANEtEDHLEsLICKVGEKS |
| Q09666 | S177 | Sugiyama | AHNAK PM227 | VtAytVDVTGREGAKDIDIssPEFKIKIPRHELtEISNVDV |
| Q09666 | S41 | Sugiyama | AHNAK PM227 | HGLTIAQRDDGVFVQEVtQNsPAARTGVVKEGDQIVGATIy |
| Q0VD86 | S191 | SIGNOR|EPSD|PSP | INCA1 HSD45 | ATYPQEEDRFLtPGRAQLLWsPWSPLDQEEACASRQLHSLA |
| Q0VD86 | S23 | SIGNOR|EPSD|PSP | INCA1 HSD45 | VQDDGVNLIPFAKCSRVVSRsPPPRLPSQSLRPMPQRYGDV |
| Q0VD86 | T182 | EPSD|PSP | INCA1 HSD45 | EYPDLEEERATYPQEEDRFLtPGRAQLLWsPWSPLDQEEAC |
| Q12778 | S249 | GPS6|SIGNOR|EPSD|PSP | FOXO1 FKHR FOXO1A | EGTGKssWWMLNPEGGKSGKsPRRRAAsMDNNSKFAKSRSR |
| Q12778 | S298 | PSP | FOXO1 FKHR FOXO1A | QSGQEGAGDsPGSQFSKWPAsPGsHsNDDFDNWSTFRPRts |
| Q12792 | S143 | Sugiyama | TWF1 PTK9 | GTVKEDVSLHGYKKyLLsQssPAPLtAAEEELRQIKINEVQ |
| Q12800 | S289 | EPSD|PSP | TFCP2 LSF SEF | YETTILTECSPWPEITYVNNsPsPGFNSSHSSFSLGEGNGs |
| Q12800 | S291 | EPSD|PSP | TFCP2 LSF SEF | TTILTECSPWPEITYVNNsPsPGFNSSHSSFSLGEGNGsPN |
| Q12800 | S309 | SIGNOR|EPSD|PSP | TFCP2 LSF SEF | sPsPGFNSSHSSFSLGEGNGsPNHQPEPPPPVTDNLLPTTT |
| Q12800 | T258 | EPSD|PSP | TFCP2 LSF SEF | FKPKGADRKQKTDREKMEKRtPHEKEKYQPSYETTILTECS |
| Q12802 | S2728 | Sugiyama | AKAP13 BRX HT31 LBC | PsPsAPSIAKsGsLDsELsVsPKRNsISRTHKDKGPFHILS |
| Q12879 | S1232 | ELM | GRIN2A NMDAR2A | THCRSCLSNMPTYSGHFTMRsPFKCDACLRMGNLyDIDEDQ |
| Q12888 | T1609 | EPSD | TP53BP1 | SLEQGNRLREQYGLGPYEAVtPLtKAADIsLDNLVEGKRKR |
| Q12888 | T1612 | EPSD | TP53BP1 | QGNRLREQYGLGPYEAVtPLtKAADIsLDNLVEGKRKRRsN |
| Q12906 | S382 | EPSD|PSP | ILF3 DRBF MPHOSPH4 NF90 | sttyAItPMKRPMEEDGEEKsPsKKKKKIQKKEEKAEPPQA |
| Q12906 | S384 | EPSD | ILF3 DRBF MPHOSPH4 NF90 | tyAItPMKRPMEEDGEEKsPsKKKKKIQKKEEKAEPPQAMN |
| Q12906 | T363 | EPSD | ILF3 DRBF MPHOSPH4 NF90 | MPKKPKNENPVDYTVQIPPsttyAItPMKRPMEEDGEEKsP |
| Q12906 | T364 | EPSD | ILF3 DRBF MPHOSPH4 NF90 | PKKPKNENPVDYTVQIPPsttyAItPMKRPMEEDGEEKsPs |
| Q12906 | T368 | EPSD | ILF3 DRBF MPHOSPH4 NF90 | KNENPVDYTVQIPPsttyAItPMKRPMEEDGEEKsPsKKKK |
| Q12948 | T68 | EPSD|PSP | FOXC1 FKHL7 FREAC3 | SHPAHAEQYPGGMARAYGPYtPQPQPKDMVKPPYSYIALIT |
| Q12959 | S158 | SIGNOR|EPSD|PSP | DLG1 | sEKNLsEIENVHGFVSHSHIsPIKPTEAVLPSPPTVPVIPV |
| Q12959 | S443 | SIGNOR|EPSD|PSP | DLG1 | SSQPVDNHVsPSSFLGQtPAsPARYSPVSKAVLGDDEITRE |
| Q13033 | S229 | Sugiyama | STRN3 GS2NA SG2NA | SEPNGsVETKNLEQILNGGEsPKQKGQEIKRSSGDVLETFN |
| Q13045 | S856 | Sugiyama | FLII FLIL | KNWDDVLTVDYTRNAEAVLQsPGLsGKVKRDAEKKDQMKAD |
| Q13118 | S206 | PSP | KLF10 TIEG TIEG1 | RRRTHLNVEAARKNIPCAAVsPNRSKCERNTVADVDEKASA |
| Q13153 | T212 | ELM | PAK1 | PRPEHTKsVytRsVIEPLPVtPtRDVAtsPIsPtENNttPP |
| Q13200 | S16 | Sugiyama | PSMD2 TRAP2 | _____MEEGGRDKAPVQPQQsPAAAPGGtDEKPsGKERRDA |
| Q13242 | S216 | EPSD|PSP | SRSF9 SFRS9 SRP30C | RSGsRGRDsPyQsRGsPHyFsPFRPy_______________ |
| Q13283 | S231 | Sugiyama | G3BP1 G3BP | QEEKPEPVLEETAPEDAQKsssPAPADIAQtVQEDLRtFsW |
| Q13283 | S232 | Sugiyama | G3BP1 G3BP | EEKPEPVLEETAPEDAQKsssPAPADIAQtVQEDLRtFsWA |
| Q13303 | S31 | PSP | KCNAB2 KCNA2B KCNK2 | ARLsLRQtGsPGMIystRYGsPKRQLQFYRNLGKSGLRVSC |
| Q13309 | S64 | SIGNOR|EPSD|PSP | SKP2 FBXL1 | EEPDsENIPQELLsNLGHPEsPPRKRLKsKGsDKDFVIVRR |
| Q13330 | S522 | EPSD|PSP | MTA1 | PINSAAIKAECTARLPEAsQsPLVLKQAVRKPLEAVLRYLE |
| Q13352 | S33 | EPSD|PSP | ITGB3BP CENPR NRIF3 | LEENsFDPSKITRKKsVItYsPttGtCQMsLFAsPTSSEEQ |
| Q13352 | S46 | EPSD|PSP | ITGB3BP CENPR NRIF3 | KKsVItYsPttGtCQMsLFAsPTSSEEQKHRNGLSNEKRKK |
| Q13404 | S146 | Sugiyama | UBE2V1 CROC1 UBE2V UEV1 P/OKcl.19 | RLMMSKENMKLPQPPEGQCysN___________________ |
| Q13415 | S258 | iPTMNet|EPSD|PSP | ORC1 ORC1L PARC1 | ELGNLGNPQMSQQTSCAsLDsPGRIKRKVAFSEITsPsKRS |
| Q13415 | S273 | iPTMNet|EPSD|PSP | ORC1 ORC1L PARC1 | CAsLDsPGRIKRKVAFSEITsPsKRSQPDKLQtLsPALKAP |
| Q13415 | T375 | iPTMNet|EPSD|PSP | ORC1 ORC1L PARC1 | PENIKKRDAKEAKAQNEATstPHRIRRKSsVLTMNRIRQQL |
| Q13416 | T116 | SIGNOR|EPSD|PSP | ORC2 ORC2L | SFQNRKHSEKMAKLASELAKtPQKSVSFSLKNDPEITINVP |
| Q13416 | T226 | SIGNOR|EPSD|PSP | ORC2 ORC2L | IFSQKIQAQNRVVsAPVGKEtPsKRMKRDKTsDLVEEYFEA |
| Q13428 | S1378 | Sugiyama | TCOF1 | tPRSKKKKKLGAGEGGEAsVsPEKtsttSKGKAKRDKASGD |
| Q13428 | S582 | EPSD | TCOF1 | TAVAPAQEKsLGNILQAKPtssPAKGPPQKAGPVAVQVKAE |
| Q13428 | S583 | EPSD | TCOF1 | AVAPAQEKsLGNILQAKPtssPAKGPPQKAGPVAVQVKAEK |
| Q13428 | S982 | EPSD | TCOF1 | VDPNRsPAGPAAtPAQAQAAstPRKARASESTARssssEsE |
| Q13428 | T983 | EPSD | TCOF1 | DPNRsPAGPAAtPAQAQAAstPRKARASESTARssssEsED |
| Q13435 | S317 | Sugiyama | SF3B2 SAP145 | ETDARssLGQsAsEtEEDtVsVsKKEKNRKRRNRKKKKKPQ |
| Q13509 | S168 | Sugiyama | TUBB3 TUBB4 | GTLLISKVREEYPDRIMNtFsVVPsPKVSDTVVEPYNATLS |
| Q13509 | S172 | Sugiyama | TUBB3 TUBB4 | ISKVREEYPDRIMNtFsVVPsPKVSDTVVEPYNATLSIHQL |
| Q13561 | T198 | Sugiyama | DCTN2 DCTN50 | LLQLEATKNSKGGSGGKttGtPPDssLVtyELHsRPEQDKF |
| Q13573 | S224 | EPSD|Sugiyama | SNW1 SKIIP SKIP | KDPMEPPRFKINKKIPRGPPsPPAPVMHsPsRKMTVKEQQE |
| Q13573 | S232 | EPSD|Sugiyama | SNW1 SKIIP SKIP | FKINKKIPRGPPsPPAPVMHsPsRKMTVKEQQEWKIPPCIS |
| Q13573 | S234 | EPSD | SNW1 SKIIP SKIP | INKKIPRGPPsPPAPVMHsPsRKMTVKEQQEWKIPPCISNW |
| Q13884 | S87 | Sugiyama | SNTB1 SNT2B1 | SFCRGAGAGHPGAGGAQPPDsPAGVRTAFTDLPEQVPESIS |
| Q14004 | S383 | Sugiyama | CDK13 CDC2L CDC2L5 CHED KIAA1791 | sRRRSPSYSRHSSYERGGDVsPsPyssSsWRRsRsPysPVL |
| Q14004 | S385 | Sugiyama | CDK13 CDC2L CDC2L5 CHED KIAA1791 | RRSPSYSRHSSYERGGDVsPsPyssSsWRRsRsPysPVLRR |
| Q14103 | S190 | Sugiyama | HNRNPD AUF1 HNRPD | KRAKAMKTKEPVKKIFVGGLsPDtPEEKIREYFGGFGEVES |
| Q14103 | T193 | EPSD|PSP|Sugiyama | HNRNPD AUF1 HNRPD | KAMKTKEPVKKIFVGGLsPDtPEEKIREYFGGFGEVESIEL |
| Q14106 | S254 | SIGNOR|PSP | TOB2 KIAA1663 TOB4 TROB2 | SLSMHSLNFITANPAPQSQLsPNAKEFVYNGGGSPSLFFDA |
| Q14152 | S584 | Sugiyama | EIF3A EIF3S10 KIAA0139 | EHQRILARRQtIEERKERLEsLNIQREKEELEQREAELQKV |
| Q14157 | S416 | Sugiyama | UBAP2L KIAA0144 NICE4 | tQsPsLVQYDLKNPsDsAVHsPFtKRQAFtPsstMMEVFLQ |
| Q14157 | S467 | Sugiyama | UBAP2L KIAA0144 NICE4 | AAPPPPssPLPsKstsAPQMsPGssDNQsssPQPAQQKLKQ |
| Q14160 | S1437 | Sugiyama | SCRIB CRIB1 KIAA0147 LAP4 SCRB1 VARTUL | ALDGETLGEEEQEDEQPPWAsPsPtsRQsPAsPPPLGGGAP |
| Q14160 | S1448 | Sugiyama | SCRIB CRIB1 KIAA0147 LAP4 SCRB1 VARTUL | QEDEQPPWAsPsPtsRQsPAsPPPLGGGAPVRTAKAERRHQ |
| Q14191 | S1133 | EPSD|PSP | WRN RECQ3 RECQL2 | KPCDKISSGSNISKKsIMVQsPEKAySSsQPVISAQEQETQ |
| Q14191 | S426 | PSP | WRN RECQ3 RECQL2 | EQQSQEEYLSDIAYKSTEHLsPNDNENDTSYVIEsDEDLEM |
| Q14194 | T509 | EPSD|PSP | CRMP1 DPYSL1 ULIP3 | FGLQGVSRGMYDGPVyEVPAtPKYAtPAPsAKssPsKHQPP |
| Q14195 | T507 | EPSD | DPYSL3 CRMP4 DRP3 ULIP ULIP1 | KMADLHAVPRGMYDGPVFDLtttPKGGtPAGsARGsPTRPN |
| Q14195 | T508 | EPSD | DPYSL3 CRMP4 DRP3 ULIP ULIP1 | MADLHAVPRGMYDGPVFDLtttPKGGtPAGsARGsPTRPNP |
| Q14195 | T509 | EPSD | DPYSL3 CRMP4 DRP3 ULIP ULIP1 | ADLHAVPRGMYDGPVFDLtttPKGGtPAGsARGsPTRPNPP |
| Q14202 | T826 | EPSD|PSP | ZMYM3 DXS6673E KIAA0385 ZNF261 | PVKTRsAPtAPtPPPPPPPAtPRKNKAAMCKPLMQNRGVSC |
| Q14207 | S1100 | GPS6|EPSD|PSP | NPAT CAND3 E14 | NHKMVSQNKERNAVSFPNLDsPNVSSTLKPPSNNAIKREKE |
| Q14207 | S775 | GPS6|EPSD|PSP | NPAT CAND3 E14 | ELTSAVSsINGENLPtIILssPtKsPtKNAELVKCLSSEET |
| Q14207 | S779 | GPS6|EPSD|PSP | NPAT CAND3 E14 | AVSsINGENLPtIILssPtKsPtKNAELVKCLSSEETVGAV |
| Q14207 | T1270 | GPS6|SIGNOR|EPSD|PSP | NPAT CAND3 E14 | IQRHSSVSRLADSSDLPVPRtPGsGAGEKHKEEPIDIIKAP |
| Q14207 | T1350 | GPS6|SIGNOR|EPSD|PSP | NPAT CAND3 E14 | MAAHTLMILSRAAISRttsAtPLKDNTQQFRASSRSTTKKR |
| Q14247 | S405 | EPSD|PSP|Sugiyama | CTTN EMS1 | EEARRKLEEQARAKtQtPPVsPAPQPtEERLPssPVyEDAA |
| Q14257 | T137 | Sugiyama | RCN2 ERC55 | VTWDEyNIQMyDRVIDFDENtALDDAEEEsFRKLHLKDKKR |
| Q14493 | T62 | SIGNOR | SLBP HBP | PEDAEEAEHRGAERRPEsFttPEGPKPRSRCSDWASAVEED |
| Q14568 | T109 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | LTIVDTGIGMTKADLINNLGtIAKSGtKAFMEALQAGADIS |
| Q14669 | S991 | Sugiyama | TRIP12 KIAA0045 ULF | AAADLGsPSLQHSRDDsLDLsPQGRLsDVLKRKRLPKRGPR |
| Q14676 | S1068 | EPSD|PSP | MDC1 KIAA0170 NFBD1 | PPQKPLNSQSQKHLAPPPLLsPLLPSIKPTVRKtRQDGsQE |
| Q14676 | T1630 | EPSD|PSP | MDC1 KIAA0170 NFBD1 | EPVVPTAPEPHPttstDQPVtPKLTSRATRRKTNRSSVKtP |
| Q14676 | T341 | EPSD|PSP | MDC1 KIAA0170 NFBD1 | AQPFGFIDsDtDAEEERIPAtPVVIPMKKRKIFHGVGTRGP |
| Q14807 | S462 | EPSD | KIF22 KID KNSL4 | RLLsLDRLLASQGsQGAPLLstPKRERMVLMKTVEEKDLEI |
| Q14807 | T463 | EPSD | KIF22 KID KNSL4 | LLsLDRLLASQGsQGAPLLstPKRERMVLMKTVEEKDLEIE |
| Q14814 | S180 | Sugiyama | MEF2D | SGSLVTPSLVTSSLTDPRLLsPQQPALQRNsVsPGLPQRPA |
| Q14839 | S531 | EPSD | CHD4 | GQPPsPtPVPRPPDADPNtPsPKPLEGRPERQFFVKWQGMS |
| Q14839 | T529 | EPSD | CHD4 | KWGQPPsPtPVPRPPDADPNtPsPKPLEGRPERQFFVKWQG |
| Q14847 | T104 | Sugiyama | LASP1 MLN50 | VRYKEEFEKNKGKGFsVVADtPELQRIKKTQDQIsNIKyHE |
| Q14974 | S12 | Sugiyama | KPNB1 NTF97 | _________MELITILEKtVsPDRLELEAAQKFLERAAVEN |
| Q14980 | S1757 | Sugiyama | NUMA1 NMP22 NUMA | ITSKLPRtQPDGtsVPGEPAsPIsQRLPPKVEsLEsLyFtP |
| Q14980 | T1776 | EPSD|PSP | NUMA1 NMP22 NUMA | AsPIsQRLPPKVEsLEsLyFtPIPARsQAPLEssLDsLGDV |
| Q14980 | T2000 | Sugiyama | NUMA1 NMP22 NUMA | GITTRQQRKRVsLEPHQGPGtPEsKKATSCFPRPMtPRDRH |
| Q14CB8 | T476 | EPSD | ARHGAP19 | KGTSKENRNLLFsGsPAVtMtPtRLKWSEGKKEGKKGFL__ |
| Q14CB8 | T478 | EPSD | ARHGAP19 | TSKENRNLLFsGsPAVtMtPtRLKWSEGKKEGKKGFL____ |
| Q15003 | T49 | EPSD|PSP | NCAPH BRRN BRRN1 CAPH KIAA0074 | PsERVFPMPLPRKAPLNIPGtPVLEDFPQNDDEKERLQRRR |
| Q15047 | S1066 | EPSD|PSP | SETDB1 ESET KIAA0067 KMT1E | DDRNKMSVVTESSRNYGyNPsPVKPEGLRRPPSKTSMHQSR |
| Q15067 | S26 | Sugiyama | ACOX1 ACOX | RRERDSASFNPELLtHILDGsPEKtRRRREIENMILNDPDF |
| Q15084 | S205 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | FYAPWCGHCKNLEPEWAAAAsEVKEQTKGKVKLAAVDAtVN |
| Q15181 | S250 | Sugiyama | PPA1 IOPPP PP | LVTKKTNGKGIsCMNttLsEsPFKCDPDAARAIVDALPPPC |
| Q15293 | T76 | Sugiyama | RCN1 RCN | FQYDHEAFLGKEDsKtFDQLtPDEsKERLGKIVDRIDNDGD |
| Q15329 | T261 | SIGNOR | E2F5 | FPVPPPDDLTQPSSQSLTPVtPQKSSMATQNLPEQHVSERS |
| Q15398 | T342 | EPSD | DLGAP5 DLG7 KIAA0008 | TyQVTPMtPRsANAFLtPsytWtPLKTEVDESQATKEILAQ |
| Q15398 | T344 | EPSD | DLGAP5 DLG7 KIAA0008 | QVTPMtPRsANAFLtPsytWtPLKTEVDESQATKEILAQKC |
| Q15554 | S365 | EPSD|PSP | TERF2 TRBF2 TRF2 | AAFAKLDQKDLVLPTQALPAsPALKNKRPRKDENESSAPAD |
| Q15642 | S304 | Sugiyama | TRIP10 CIP4 STOT STP | FEDFsQPMNRAPsDssLGtPsDGRPELRGPGRSRTKRWPFG |
| Q15648 | S1207 | EPSD|PSP | MED1 ARC205 CRSP1 CRSP200 DRIP205 DRIP230 PBP PPARBP PPARGBP RB18A TRAP220 TRIP2 | sKPNIsPsHsRPPGGsDKLAsPMKPVPGtPPssKAKsPIss |
| Q15648 | T1215 | EPSD|PSP | MED1 ARC205 CRSP1 CRSP200 DRIP205 DRIP230 PBP PPARBP PPARGBP RB18A TRAP220 TRIP2 | HsRPPGGsDKLAsPMKPVPGtPPssKAKsPIssGsGGsHMS |
| Q15717 | S202 | EPSD|PSP | ELAVL1 HUR | KFAANPNQNKNVALLsQLyHsPARRFGGPVHHQAQRFRFsP |
| Q15773 | S238 | Sugiyama | MLF2 | GAGGRRAEGPPRLAIQGPEDsPsRQsRRYDW__________ |
| Q15788 | S1006 | PSP | NCOA1 BHLHE74 SRC1 | ERPNLYSQPYssPSPTANLPsPFQGMVRQKPSLGTMPVQVt |
| Q15788 | S1033 | GPS6|PSP | NCOA1 BHLHE74 SRC1 | RQKPSLGTMPVQVtPPRGAFsPGMGMQPRQTLNRPPAAPNQ |
| Q15788 | S1185 | PSP | NCOA1 BHLHE74 SRC1 | QQFPYPPNYGTNPGtPPASTsPFSQLAANPEASLANRNSMV |
| Q15788 | S1250 | PSP | NCOA1 BHLHE74 SRC1 | FQYPGAGMVPQGEANFAPSLsPGSSMVPMPIPPPQSSLLQQ |
| Q15788 | S1279 | PSP | NCOA1 BHLHE74 SRC1 | PIPPPQSSLLQQtPPASGYQsPDMKAWQQGAIGNNNVFSQA |
| Q15788 | S22 | GPS6|PSP | NCOA1 BHLHE74 SRC1 | SGLGDsSSDPANPDSHKRKGsPCDTLAssTEKRRREQENKY |
| Q15788 | S325 | PSP | NCOA1 BHLHE74 SRC1 | REPSYARQLFQEVMTRGTASsPSYRFILNDGTMLSAHTKCK |
| Q15788 | S395 | GPS6|PSP | NCOA1 BHLHE74 SRC1 | DDTNSGMSIPRVNPSVNPsIsPAHGVARSSTLPPSNSNMVS |
| Q15788 | S488 | PSP | NCOA1 BHLHE74 SRC1 | SLNLNNSPMEGTGISLAQFMsPRRQVTSGLATRPRMPNNSF |
| Q15788 | S569 | GPS6|PSP | NCOA1 BHLHE74 SRC1 | NNSVGFSASSPVLRQMSSQNsPSRLNIQPAKAESKDNKEIA |
| Q15788 | S997 | PSP | NCOA1 BHLHE74 SRC1 | QAtPPLIMEERPNLYSQPYssPSPTANLPsPFQGMVRQKPS |
| Q15788 | T1026 | PSP | NCOA1 BHLHE74 SRC1 | sPFQGMVRQKPSLGTMPVQVtPPRGAFsPGMGMQPRQTLNR |
| Q15788 | T1179 | PSP | NCOA1 BHLHE74 SRC1 | LPQGAPQQFPYPPNYGTNPGtPPASTsPFSQLAANPEASLA |
| Q15788 | T1271 | PSP | NCOA1 BHLHE74 SRC1 | PGSSMVPMPIPPPQSSLLQQtPPASGYQsPDMKAWQQGAIG |
| Q15788 | T1426 | PSP | NCOA1 BHLHE74 SRC1 | DPYLNQPGPLGTQKPTSGPQtPQAQQKSLLQQLLTE_____ |
| Q15788 | T789 | PSP | NCOA1 BHLHE74 SRC1 | DDVKVKVEKKEQMDPCNTNPtPMTKPTPEEIKLEAQSQFTA |
| Q15788 | T979 | PSP | NCOA1 BHLHE74 SRC1 | KLVQGGGLDVLSERFPPQQAtPPLIMEERPNLYSQPYssPS |
| Q15796 | S245 | PSP | SMAD2 MADH2 MADR2 | YISEDGETSDQQLNQsMDtGsPAELsPTTLsPVNHsLDLQP |
| Q15796 | S250 | PSP | SMAD2 MADH2 MADR2 | GETSDQQLNQsMDtGsPAELsPTTLsPVNHsLDLQPVTYSE |
| Q15796 | S255 | PSP | SMAD2 MADH2 MADR2 | QQLNQsMDtGsPAELsPTTLsPVNHsLDLQPVTYSEPAFWC |
| Q15813 | S495 | EPSD|PSP | TBCE | KGLLSRLLKVPVSDLLLSYEsPKKPGREIELENDLKSLQFY |
| Q15910 | T345 | GPS6|EPSD|PSP | EZH2 KMT6 | YQHLEGAKEFAAALTAERIKtPPKRPGGRRRGRLPNNssRP |
| Q15910 | T416 | SIGNOR|EPSD|PSP | EZH2 KMT6 | EEEEKKDETSsSsEANsRCQtPIKMKPNIEPPENVEWSGAE |
| Q15942 | S303 | EPSD | ZYX | GAPGGsGsQPNQKLGHPEALsAGtGsPQPPsFtyAQQREKP |
| Q15942 | S308 | EPSD | ZYX | sGsQPNQKLGHPEALsAGtGsPQPPsFtyAQQREKPRVQEK |
| Q15942 | T306 | EPSD | ZYX | GGsGsQPNQKLGHPEALsAGtGsPQPPsFtyAQQREKPRVQ |
| Q16204 | S244 | SIGNOR|EPSD|PSP|Sugiyama | CCDC6 D10S170 TST1 | LEAEKRILQEKLDQPVsAPPsPRDIsMEIDsPENMMRHIRF |
| Q16549 | S722 | Sugiyama | PCSK7 LPC PC7 PC8 SPC7 | GPCHWPHRSRKAKEEGtELEsVPLCSSKDPDEVETESRGPP |
| Q16549 | T718 | Sugiyama | PCSK7 LPC PC7 PC8 SPC7 | VCRSGPCHWPHRSRKAKEEGtELEsVPLCSSKDPDEVETES |
| Q16584 | S770 | SIGNOR|PSP | MAP3K11 MLK3 PTK1 SPRK | PGtPGTPRsPPLGLIsRPRPsPLRSRIDPWsFVSAGPRPsP |
| Q16595 | S158 | Sugiyama | FXN FRDA X25 | GDLGTYVINKQTPNKQIWLSsPSSGPKRYDWTGKNWVYSHD |
| Q16630 | T157 | Sugiyama | CPSF6 CFIM68 | SKKLMDLLPKRELHGQNPVVtPCNKQFLsQFEMQSRKTTQS |
| Q16656 | S102 | PSP | NRF1 | AAAVATGKKRKRPHVFESNPsIRKRQQTRLLRKLRATLDEY |
| Q16656 | S136 | PSP | NRF1 | RATLDEYTTRVGQQAIVLCIsPsKPNPVFKVFGAAPLENVV |
| Q16658 | S127 | Sugiyama | FSCN1 FAN1 HSN SNL | AHRRYFGGtEDRLsCFAQtVsPAEKWSVHIAMHPQVNIYSV |
| Q16658 | S234 | Sugiyama | FSCN1 FAN1 HSN SNL | LEFRsGKVAFRDCEGRyLAPsGPsGtLKAGKATKVGKDELF |
| Q16762 | S38 | Sugiyama | TST | ESIRTGKLGPGLRVLDAsWysPGTREARKEYLERHVPGASF |
| Q2NL82 | T490 | EPSD|PSP | TSR1 KIAA1401 | KMLEKYKQERLEEMFPDEVDtPRDVAARIRFQKYRGLKSFR |
| Q32MZ4 | S16 | Sugiyama | LRRFIP1 GCF2 TRIP | _____MtsPAAAQSREIDCLsPEAQKLAEARLAAKRAARAE |
| Q32P44 | S883 | EPSD | EML3 | SIFQWRVLGAGGAGPAPAtPsRtPsLsPAssLDV_______ |
| Q32P44 | T881 | EPSD | EML3 | DASIFQWRVLGAGGAGPAPAtPsRtPsLsPAssLDV_____ |
| Q32P51 | S95 | Sugiyama | HNRNPA1L2 HNRNPA1L | TPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| Q4VCS5 | S847 | EPSD | AMOT KIAA1071 | LLGGDYRAEYVPSTPsPVPPstPLLsAHsKTGsRDCSTQTE |
| Q4VCS5 | S852 | EPSD | AMOT KIAA1071 | YRAEYVPSTPsPVPPstPLLsAHsKTGsRDCSTQTERGTES |
| Q4VCS5 | S855 | EPSD | AMOT KIAA1071 | EYVPSTPsPVPPstPLLsAHsKTGsRDCSTQTERGTESNKT |
| Q4VCS5 | T848 | EPSD | AMOT KIAA1071 | LGGDYRAEYVPSTPsPVPPstPLLsAHsKTGsRDCSTQTER |
| Q53EL6 | S94 | Sugiyama | PDCD4 H731 | GDsVsDsGsDALRSGLtVPtsPKGRLLDRRSRSGKGRGLPK |
| Q53ET0 | S433 | EPSD|PSP | CRTC2 TORC2 | APSYPASTPGASPHHRRVPLsPLsLLAGPADARRSQQQLPK |
| Q53GL7 | T101 | SIGNOR|EPSD|PSP | PARP10 | RPAPPRAPARLLLQGLPPGTtPQRLEQHVQALLRASGLPVQ |
| Q53H80 | S18 | EPSD|PSP | AKIRIN2 C6orf166 | ___MACGATLKRTLDFDPLLsPAsPKRRRCAPLSAPTsAAA |
| Q53H80 | S21 | EPSD|PSP | AKIRIN2 C6orf166 | MACGATLKRTLDFDPLLsPAsPKRRRCAPLSAPTsAAAsPL |
| Q562R1 | Y241 | Sugiyama | ACTBL2 | ALDFEQEMVRAAAssSPERsyELPDGQVItIGNERFRCPEA |
| Q58FF7 | S408 | Sugiyama | HSP90AB3P HSP90BC | EPIDEYCVQQLKEFDGKsLVsVtKEGLELPEDEEEKKKMEE |
| Q58FF8 | S308 | Sugiyama | HSP90AB2P HSP90BB | YMTEPIDGYQLKEFDGKsLVsVtKEGLELPEDGEEKKRMEE |
| Q58FF8 | T104 | Sugiyama | HSP90AB2P HSP90BB | LTLVDTGIGMTKADLINNLGtIAKFQDQTEYLEEMQVKEVV |
| Q5JTV8 | S143 | EPSD|PSP | TOR1AIP1 LAP1 | KTRRTTRLQQQHsEQPPLQPsPVMtRRGLRDsHssEEDEAs |
| Q5JTZ9 | T673 | EPSD|PSP | AARS2 AARSL KIAA1270 | QGSHLNPEQLRLDVTTQtPLtPEQLRAVENTVQEAVGQDEA |
| Q5R3I4 | S362 | Sugiyama | TTC38 | GAHDPQTTQELLTTLRDASEsPGENCQHLLARDVGLPLCQA |
| Q5T4S7 | S178 | Sugiyama | UBR4 KIAA0462 KIAA1307 RBAF600 | AKLPQTVKTLSDVEDQKELAsPVsPELRQKEVQMNFLNQLT |
| Q5T4S7 | S181 | Sugiyama | UBR4 KIAA0462 KIAA1307 RBAF600 | PQTVKTLSDVEDQKELAsPVsPELRQKEVQMNFLNQLTSVF |
| Q5T5Y3 | S1080 | EPSD | CAMSAP1 | sKNNSQDHKVKAPVHFVEPLsPtGVAGHRKAPRLGQGRNSR |
| Q5TZA2 | S1460 | SIGNOR | CROCC KIAA0445 | LRRGLGLGRAPsPAPRPVPGsPARDAPAEGSGEGLNSPSTL |
| Q68CZ2 | S660 | Sugiyama | TNS3 TEM6 TENS1 TPP | RVAVQRGVGsGPHPPDTQQPsPsKAFKPRFPGDQVVNGAGP |
| Q68CZ2 | S662 | Sugiyama | TNS3 TEM6 TENS1 TPP | AVQRGVGsGPHPPDTQQPsPsKAFKPRFPGDQVVNGAGPEL |
| Q69YN4 | S1579 | Sugiyama | VIRMA KIAA1429 MSTP054 | CCSDFDLHSELERsFLsEPssPGRtKTTKGFKLGKHKHETF |
| Q6NW29 | S23 | Sugiyama | RWDD4 FAM28A RWDD4A | ANEDQEMELEALRSIyEGDEsFRELsPVSFQyRIGENGDPK |
| Q6P1L8 | S49 | Sugiyama | MRPL14 MRPL32 RPML32 | LSAIQKMTRVRVVDNSALGNsPyHRAPRCIHVYKKNGVGKV |
| Q6P1N0 | S208 | EPSD|PSP | CC2D1A AKI1 LGD2 | EADIPPPVAIGKGPAstPtysPAPTQPAPRIASAPEPRVTL |
| Q6P1X5 | S1185 | Sugiyama | TAF2 CIF150 TAF2B | HKHKHKHDSKEKDKEPFtFssPAsGRsIRsPSLsD______ |
| Q6P6C2 | S305 | Sugiyama | ALKBH5 ABH5 OFOXD1 | TRLDAPRLETKSLSSSVLPPsYAsDRLsGNNRDPALKPKRS |
| Q6PD62 | T925 | Sugiyama | CTR9 KIAA0155 SH2BP1 | GGGGRRSKKGGEFDEFVNDDtDDDLPIsKKKKRRKGsGsEQ |
| Q6PEY2 | T56 | Sugiyama | TUBA3E | MPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtVVD |
| Q6PKG0 | S774 | EPSD|PSP | LARP1 KIAA0731 LARP | LFGAPEPstIARsLPttVPEsPNyRNtRtPRtPRtPQLKDS |
| Q6PKG0 | T303 | EPSD|PSP | LARP1 KIAA0731 LARP | ANRGEIKGsEsAtYVPVAPPtPAWQPEIKPEPAWHDQDEts |
| Q6PKG0 | T649 | EPSD|PSP | LARP1 KIAA0731 LARP | EEsDyEIDDRDVNKILIVtQtPHyMRRHPGGDRTGNHTSRA |
| Q6S8J3 | S1068 | Sugiyama | POTEE A26C1A POTE2 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q6S8J3 | Y940 | Sugiyama | POTEE A26C1A POTE2 | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| Q6UB35 | S357 | EPSD|PSP | MTHFD1L FTHFSDC1 | WLREQQHRRWRLHCLKLQPLsPVPsDIEIsRGQTPKAVDVL |
| Q6Y7W6 | S30 | EPSD|PSP | GIGYF2 KIAA0642 PERQ2 TNRC15 | FGPEWLRALssGGsItsPPLsPALPKYKLADYRYGREEMLA |
| Q6Y7W6 | S593 | EPSD|PSP | GIGYF2 KIAA0642 PERQ2 TNRC15 | CDESFQPLGDIMKMWGRVPFsPGPAPPPHMGELDQERLTRQ |
| Q6ZMR3 | S161 | Sugiyama | LDHAL6A LDHL2 | DILTYVAWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIH |
| Q6ZN18 | S24 | Sugiyama | AEBP2 | AItDMADLEELsRLsPLPPGsPGsAARGRAEPPEEEEEEEE |
| Q71RC2 | S583 | Sugiyama | LARP4 PP13296 | DLIEDssVQKDGLNQttIPVsPPsttKPsRAstAsPCNNNI |
| Q71RC2 | S586 | Sugiyama | LARP4 PP13296 | EDssVQKDGLNQttIPVsPPsttKPsRAstAsPCNNNINAA |
| Q71RC2 | S594 | Sugiyama | LARP4 PP13296 | GLNQttIPVsPPsttKPsRAstAsPCNNNINAAtAVALQEP |
| Q71U36 | T56 | Sugiyama | TUBA1A TUBA3 | MPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtVID |
| Q71U36 | Y432 | Sugiyama | TUBA1A TUBA3 | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| Q71UM5 | S27 | EPSD|PSP | RPS27L | LLHPsLEEEKKKHKKKRLVQsPNsyFMDVKCPGCYKITTVF |
| Q7KZ85 | T1523 | EPSD|PSP | SUPT6H KIAA0162 SPT6H | TVNGLFRWFKDHYQDPVPGItPssssRtRtPAsINAtPANI |
| Q7Z2Z1 | S1001 | GPS6|SIGNOR|EPSD|PSP | TICRR C15orf42 | HRQIKGRSsDPGPDIGVVEEsPEKGDEIsLRRsPRIKQLSF |
| Q7Z2Z1 | T969 | EPSD|PSP | TICRR C15orf42 | LDNFKKNKGYHKLLTKSVAEtPVHKQISKRLLHRQIKGRSs |
| Q7Z417 | S692 | Sugiyama | NUFIP2 KIAA1321 PIG1 | IWNLQKQDPKRIItyNEAMDsPDQ_________________ |
| Q7Z417 | T219 | EPSD | NUFIP2 KIAA1321 PIG1 | TNGYMGKGADNDGsGsEsGyttPKKRKARRNsAKGCENLNI |
| Q7Z417 | T220 | EPSD | NUFIP2 KIAA1321 PIG1 | NGYMGKGADNDGsGsEsGyttPKKRKARRNsAKGCENLNIV |
| Q7Z4V5 | S370 | Sugiyama | HDGFL2 HDGF2 HDGFRP2 HRP2 UNQ785/PRO1604 | KERRRERADRGEAERGsGGssGDELREDDEPVKKRGRKGRG |
| Q7Z4V5 | S399 | Sugiyama | HDGFL2 HDGF2 HDGFRP2 HRP2 UNQ785/PRO1604 | EPVKKRGRKGRGRGPPsssDsEPEAELEREAKKSAKKPQSS |
| Q7Z5K2 | S221 | Sugiyama | WAPL FOE KIAA0261 WAPAL | AsEIKETNDTWNSQFGKRPEsPsEIsPIKGsVRTGLFEWDN |
| Q7Z5K2 | S226 | Sugiyama | WAPL FOE KIAA0261 WAPAL | ETNDTWNSQFGKRPEsPsEIsPIKGsVRTGLFEWDNDFEDI |
| Q86T82 | S628 | GPS6|SIGNOR|EPSD|PSP | USP37 KIAA1594 | AHMAISRPLKASQMVNSCITsPstPsKKFTFKSKSSLALCL |
| Q86U86 | S25 | EPSD | PBRM1 BAF180 PB1 | RRRAtsPsssVsGDFDDGHHsVstPGPsRKRRRLsNLPtVD |
| Q86U86 | S27 | EPSD | PBRM1 BAF180 PB1 | RAtsPsssVsGDFDDGHHsVstPGPsRKRRRLsNLPtVDPI |
| Q86U86 | S32 | EPSD | PBRM1 BAF180 PB1 | sssVsGDFDDGHHsVstPGPsRKRRRLsNLPtVDPIAVCHE |
| Q86U86 | T28 | EPSD | PBRM1 BAF180 PB1 | AtsPsssVsGDFDDGHHsVstPGPsRKRRRLsNLPtVDPIA |
| Q86VM9 | S613 | EPSD | ZC3H18 NHN1 | SGSRSRsRsFsssPsPsPtPsPHRPsIRTKGEPAPPPGKAG |
| Q86VM9 | S618 | EPSD | ZC3H18 NHN1 | RsRsFsssPsPsPtPsPHRPsIRTKGEPAPPPGKAGEKSVK |
| Q86VM9 | S795 | EPSD | ZC3H18 NHN1 | STQPPKSAKPPAGGKssQQPstPQQAPPGQPQQGTFVAHKE |
| Q86VM9 | T796 | EPSD | ZC3H18 NHN1 | TQPPKSAKPPAGGKssQQPstPQQAPPGQPQQGTFVAHKEI |
| Q86VV8 | S310 | Sugiyama | RTTN | SYCHEARGTHHSQNPsPGsssPRPSVVGRTGQRPRGDGQDW |
| Q86WB0 | S394 | EPSD | ZC3HC1 NIPA HSPC216 | RTRPVTRsMGtGDtPGLEVPssPLRKAKRARLCsssssDTS |
| Q86WB0 | S395 | SIGNOR|EPSD | ZC3HC1 NIPA HSPC216 | TRPVTRsMGtGDtPGLEVPssPLRKAKRARLCsssssDTSS |
| Q86XL3 | S528 | EPSD|PSP | ANKLE2 KIAA0692 LEM4 | RYGGsPRDPVLTLRAFAGPLsPAKAEDFRKLWKTPPREKAG |
| Q86YP4 | S598 | EPSD | GATAD2A | SATSNWKKtPLsTGGtLAFVsPsLAVHKSSSAVDRQREYLL |
| Q86YP4 | S600 | EPSD | GATAD2A | TSNWKKtPLsTGGtLAFVsPsLAVHKSSSAVDRQREYLLDM |
| Q8IWC1 | S461 | Sugiyama | MAP7D3 MDP3 | sPEAMVKASPKTsLEAsMEAsPKAKARDAPKKSEMDKQALI |
| Q8IWS0 | S154 | EPSD | PHF6 CENP-31 KIAA1823 | tAHNsEADLEEsFNEHELEPssPKsKKKSRKGRPRKTNFKG |
| Q8IWS0 | S155 | EPSD | PHF6 CENP-31 KIAA1823 | AHNsEADLEEsFNEHELEPssPKsKKKSRKGRPRKTNFKGL |
| Q8IXJ6 | S368 | SIGNOR|EPSD|PSP | SIRT2 SIR2L SIR2L2 | EHASIDAQSGAGVPNPstsAsPKKsPPPAKDEARTTEREKP |
| Q8IXK0 | S751 | Sugiyama | PHC2 EDR2 PH2 | tHsQEDssRCSDNSSYEEPLsPIsASSSTSRRRQGQRDLEL |
| Q8IXM2 | S106 | EPSD | BACC1 BAP18 C17orf49 | EDSGIPLPAEsPKKGPKKVAsGVLsPPPAAPPPsSssVPEA |
| Q8IXM2 | S110 | EPSD | BACC1 BAP18 C17orf49 | IPLPAEsPKKGPKKVAsGVLsPPPAAPPPsSssVPEAGGPP |
| Q8IXM2 | S96 | EPSD|PSP | BACC1 BAP18 C17orf49 | IKATVKRKVYEDSGIPLPAEsPKKGPKKVAsGVLsPPPAAP |
| Q8IXQ3 | S67 | EPSD | C9orf40 | LGVPEQHRKRKIDAGTMAEPsAsPsKRRDsGDNsAPsGQER |
| Q8IXQ3 | S69 | EPSD | C9orf40 | VPEQHRKRKIDAGTMAEPsAsPsKRRDsGDNsAPsGQERED |
| Q8IXQ3 | S71 | EPSD | C9orf40 | EQHRKRKIDAGTMAEPsAsPsKRRDsGDNsAPsGQEREDHG |
| Q8IYB3 | S769 | EPSD | SRRM1 SRM160 | ssRsVsGsPEPAAKKPPAPPsPVQsQsPstNWsPAVPVKKA |
| Q8IYB3 | S773 | EPSD | SRRM1 SRM160 | VsGsPEPAAKKPPAPPsPVQsQsPstNWsPAVPVKKAKsPt |
| Q8IYB3 | S874 | Sugiyama | SRRM1 SRM160 | tttLAQEEPVAAPEPKKEtEsEAEDNLDDLEKHLREKALRS |
| Q8IZ21 | S118 | Sugiyama | PHACTR4 PRO2963 | PSDAMLKNGHTTPIGNARsssPVQVEEEPVRLAsLRKAIPE |
| Q8IZL8 | S477 | EPSD|PSP | PELP1 HMX3 MNAR | ALLTHLLSDISPPADALKLRsPRGsPDGsLQtGKPSAPKKL |
| Q8IZL8 | S991 | SIGNOR|EPSD|PSP | PELP1 HMX3 MNAR | EVEEGAPPPPTLPPALPPPEsPPKVQPEPEPEPGLLLEVEE |
| Q8N3F8 | S470 | EPSD | MICALL1 KIAA1668 MIRAB13 | LGHPEstPKSLHPWyGItPtssPKtKKRPAPRAPsAsPLAL |
| Q8N3F8 | S471 | EPSD | MICALL1 KIAA1668 MIRAB13 | GHPEstPKSLHPWyGItPtssPKtKKRPAPRAPsAsPLALH |
| Q8N3F8 | S619 | EPSD | MICALL1 KIAA1668 MIRAB13 | GAtPtPLLLVGDRsPVPsPGsssPQLQVKSSCKENPFNRKP |
| Q8N3F8 | S620 | EPSD | MICALL1 KIAA1668 MIRAB13 | AtPtPLLLVGDRsPVPsPGsssPQLQVKSSCKENPFNRKPs |
| Q8N3F8 | S621 | EPSD | MICALL1 KIAA1668 MIRAB13 | tPtPLLLVGDRsPVPsPGsssPQLQVKSSCKENPFNRKPsP |
| Q8N3F8 | T469 | EPSD | MICALL1 KIAA1668 MIRAB13 | ALGHPEstPKSLHPWyGItPtssPKtKKRPAPRAPsAsPLA |
| Q8N556 | S264 | Sugiyama | AFAP1 AFAP | IKEAYSGCSGPVDSECPPPPssPVHKAELEKKLssERPssD |
| Q8N556 | S265 | Sugiyama | AFAP1 AFAP | KEAYSGCSGPVDSECPPPPssPVHKAELEKKLssERPssDG |
| Q8N684 | S197 | Sugiyama | CPSF7 | CVRVPRGGIPPRAHsRDssDsADGRAtPsENLVPSSARVDK |
| Q8NBJ5 | S612 | Sugiyama | COLGALT1 GLT25D1 PSEC0241 | QKMREQQALSREAKNsDVLQsPLDsAARDEL__________ |
| Q8NBJ7 | S44 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | NGQATSMVQLQGGRFLMGtNsPDSRDGDGPVREATVKPFAI |
| Q8NBZ0 | S154 | EPSD|PSP | INO80E CCDC95 | ASSRYPPFPSDYLALQLPEPsPLRPKREKRPRLPRKLKMAV |
| Q8NE71 | S22 | Sugiyama | ABCF1 ABC50 | PKAPKQQPPEPEWIGDGEstsPsDKVVKKGKKDKKIKKTFF |
| Q8NEN9 | S989 | Sugiyama | PDZD8 PDZK8 | KHtPNtsDNEGsDtEVCGPNsPsKRGNSTGIKLVRKEGGLD |
| Q8NEY1 | S312 | Sugiyama | NAV1 KIAA1151 KIAA1213 POMFIL3 STEERIN1 | TCYDsDDANPRsVssLsNRssPLSWRYGQSSPRLQAGDAPS |
| Q8NFC6 | S2905 | EPSD | BOD1L1 BOD1L FAM44A KIAA1327 | TTLKMKDDSKTDTGIVTVEQsPsssKLKVMQTDESNKETAN |
| Q8NFC6 | S2907 | EPSD | BOD1L1 BOD1L FAM44A KIAA1327 | LKMKDDSKTDTGIVTVEQsPsssKLKVMQTDESNKETANLQ |
| Q8NFC6 | S2908 | EPSD | BOD1L1 BOD1L FAM44A KIAA1327 | KMKDDSKTDTGIVTVEQsPsssKLKVMQTDESNKETANLQE |
| Q8NFC6 | S2909 | EPSD | BOD1L1 BOD1L FAM44A KIAA1327 | MKDDSKTDTGIVTVEQsPsssKLKVMQTDESNKETANLQER |
| Q8NFD5 | S1744 | Sugiyama | ARID1B BAF250B DAN15 KIAA1235 OSA2 | ALDTINILLYDDSTVATFNLsQLSGFLELLVEYFRKCLIDI |
| Q8NFI4 | S181 | Sugiyama | ST13P5 FAM10A5 | LQKPNAAIQDCDRAIEINPDsAQPyKWRGKAHRLLGHWEEA |
| Q8TAM6 | S280 | Sugiyama | ERMN KIAA1189 | TISYRKIRKGNTKQRIDEFEsMMHL________________ |
| Q8TAP6 | S83 | SIGNOR|EPSD|PSP | CEP76 C18orf9 | DDVMKELNFVtDsVEQELPssPKQPICFDRQSTLKKTNIDP |
| Q8TAP8 | S45 | EPSD | PPP1R35 C7orf47 | PPEPQVPQLRAPVPEPGLDLsLsPRPDsPQPRHGSPGRRKG |
| Q8TAP8 | S47 | EPSD | PPP1R35 C7orf47 | EPQVPQLRAPVPEPGLDLsLsPRPDsPQPRHGSPGRRKGRA |
| Q8TAP8 | S52 | EPSD | PPP1R35 C7orf47 | QLRAPVPEPGLDLsLsPRPDsPQPRHGSPGRRKGRAERRGA |
| Q8TBN0 | S179 | Sugiyama | RAB3IL1 | TLVItstPAsPNRELHPQLLsPtKAGPRKGHSRHKstsstL |
| Q8WUM0 | S27 | EPSD | NUP133 | sPRtPGtGSRRGPLAGLGPGstPRtAsRKGLPLGsAVssPV |
| Q8WUM0 | S50 | EPSD|PSP | NUP133 | RtAsRKGLPLGsAVssPVLFsPVGRRssLssRGtPtRMFPH |
| Q8WUM0 | T28 | EPSD | NUP133 | PRtPGtGSRRGPLAGLGPGstPRtAsRKGLPLGsAVssPVL |
| Q8WVD3 | T27 | SIGNOR | RNF138 NARF HSD-4 HSD4 | AATSYTEDDFYCPVCQEVLKtPVRTTACQHVFCRKCFLTAM |
| Q8WVM8 | S303 | Sugiyama | SCFD1 C14orf163 KIAA0917 STXBP1L2 FKSG23 | DVLDFHLNRVNLEEssGVENsPAGARPKRKNKKsYDLtPVD |
| Q8WVV9 | S75 | Sugiyama | HNRNPLL HNRPLL SRRF BLOCK24 | GGGRsFsQPEAGGsHHKVsVsPVVHVRGLCEsVVEADLVEA |
| Q8WWY3 | S445 | EPSD | PRPF31 PRP31 | QRTLQKQsVVyGGKstIRDRssGtAssVAFtPLQGLEIVNP |
| Q8WWY3 | S446 | EPSD | PRPF31 PRP31 | RTLQKQsVVyGGKstIRDRssGtAssVAFtPLQGLEIVNPQ |
| Q8WWY3 | S450 | EPSD | PRPF31 PRP31 | KQsVVyGGKstIRDRssGtAssVAFtPLQGLEIVNPQAAEK |
| Q8WWY3 | S451 | EPSD | PRPF31 PRP31 | QsVVyGGKstIRDRssGtAssVAFtPLQGLEIVNPQAAEKK |
| Q8WWY3 | T455 | EPSD | PRPF31 PRP31 | yGGKstIRDRssGtAssVAFtPLQGLEIVNPQAAEKKVAEA |
| Q8WX93 | S484 | Sugiyama | PALLD KIAA0992 CGI-151 | VRGAPPLQVQWFRQGsEIQDsPDFRILQKKPRSTAEPEEIC |
| Q8WXE1 | S224 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | ATRIP AGS1 | TKLQTSERANKLAAPsVsHVsPRKNPSVVIKPEACsPQFGK |
| Q8WXE1 | S239 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | ATRIP AGS1 | sVsHVsPRKNPSVVIKPEACsPQFGKTSFPTKESFSANMSL |
| Q8WXG6 | S1270 | Sugiyama | MADD DENN IG20 KIAA0358 | STIFGKAHSLKPSIKEKLAGsPIRTSEDVSQRVYLYEGLLG |
| Q8WXI9 | S135 | Sugiyama | GATAD2B KIAA1150 | ERGRLtPsPDIIVLsDNEAssPRsSsRMEERLKAANLEMFK |
| Q8WXI9 | T120 | Sugiyama | GATAD2B KIAA1150 | INDEPVDMSARRsEPERGRLtPsPDIIVLsDNEAssPRsSs |
| Q8WYH8 | T152 | EPSD|PSP | ING5 | RGQKEKRGSRGRGRRtsEEDtPKKKKHKGGSEFTDTILSVH |
| Q8WYP5 | S1214 | Sugiyama | AHCTF1 ELYS TMBS62 MSTP108 | FSEFTPQSILRstLRstPLAsPsPsPGRsPQRLKEtRIsFV |
| Q8WYP5 | S1222 | Sugiyama | AHCTF1 ELYS TMBS62 MSTP108 | ILRstLRstPLAsPsPsPGRsPQRLKEtRIsFVEEDVHPKW |
| Q8WYP5 | S1283 | Sugiyama | AHCTF1 ELYS TMBS62 MSTP108 | VPVETEWLKSKDRttsFFLNsPEKEHQEMDEGsQsLEKLDV |
| Q8WYQ5 | S95 | Sugiyama | DGCR8 C22orf12 DGCRK6 LP4941 | LSKGSFSKGRLLIDPNCsGHsPRTARHAPAVRKFSPDLKLL |
| Q92530 | S153 | Sugiyama | PSMF1 | RIVSGIITPIHEQWEKANVssPHREFPPAtAREVDPLRIPP |
| Q92547 | T848 | EPSD|PSP | TOPBP1 KIAA0259 | SKDKLFKPSFDVKDALAALEtPGRPsQQKRKPstPLsEVIV |
| Q92574 | T1047 | Sugiyama | TSC1 KIAA0243 TSC | RGSSGSRGGGGssssssELstPEKPPHQRAGPFSSRWETTM |
| Q92615 | S664 | Sugiyama | LARP4B KIAA0217 LARP5 | ELRKPSYAEICQRTSKEPPssPLQPQKEQKPNTVGCGKEEK |
| Q92620 | S232 | EPSD | DHX38 DDX38 KIAA0224 PRP16 | RSTWEEEDsGyGSSRRSQWEsPsPTPSYRDSERSHRLSTRD |
| Q92620 | S234 | EPSD | DHX38 DDX38 KIAA0224 PRP16 | TWEEEDsGyGSSRRSQWEsPsPTPSYRDSERSHRLSTRDRD |
| Q92698 | S49 | SIGNOR|EPSD|PSP | RAD54L RAD54A | LVtPRKRKsssEtQIQECFLsPFRKPLSQLTNQPPCLDSSQ |
| Q92698 | T31 | EPSD|PSP | RAD54L RAD54A | AKRKPEGRSCDDEDWQPGLVtPRKRKsssEtQIQECFLsPF |
| Q92785 | S251 | EPSD | DPF2 BAF45D REQ UBID4 | sHLAEEEGEDKEDsQPPtPVsQRSEEQKSKKGPDGLALPNN |
| Q92785 | T176 | EPSD|PSP | DPF2 BAF45D REQ UBID4 | RILEPDDFLDDLDDEDyEEDtPKRRGKGKSKGKGVGSARKK |
| Q92785 | T248 | EPSD | DPF2 BAF45D REQ UBID4 | YAHsHLAEEEGEDKEDsQPPtPVsQRSEEQKSKKGPDGLAL |
| Q92879 | S179 | Sugiyama | CELF1 BRUNOL2 CUGBP CUGBP1 NAB50 | AMAQTAIKAMHQAQtMEGCssPMVVKFADTQKDKEQKRMAQ |
| Q92890 | S299 | Sugiyama | UFD1 UFD1L | KKVEEDEAGGRFVAFsGEGQsLRKKGRKP____________ |
| Q969V6 | T573 | EPSD|PSP | MRTFA KIAA1438 MAL MKL1 | LQLEQEKRAQQPAPAPAPLGtPVKQENSFSSCQLSQQPLGP |
| Q96B36 | S212 | Sugiyama | AKT1S1 PRAS40 | GFKEKRtEARssDEENGPPssPDLDRIAAsMRALVLREAED |
| Q96C19 | S74 | EPSD|Sugiyama | EFHD2 SWS1 | ELSAKLLRRADLNQGIGEPQsPsRRVFNPytEFKEFSRKQI |
| Q96C19 | S76 | EPSD|Sugiyama | EFHD2 SWS1 | SAKLLRRADLNQGIGEPQsPsRRVFNPytEFKEFSRKQIKD |
| Q96C36 | S303 | EPSD | PYCR2 | KKTLLDRVKLEsPTVSTLtPssPGKLLTRSLALGGKKD___ |
| Q96C36 | S304 | EPSD | PYCR2 | KTLLDRVKLEsPTVSTLtPssPGKLLTRSLALGGKKD____ |
| Q96C36 | T301 | EPSD | PYCR2 | ALKKTLLDRVKLEsPTVSTLtPssPGKLLTRSLALGGKKD_ |
| Q96E09 | S143 | EPSD|PSP | PABIR1 C9orf42 FAM122A | LSDNDVEKSASPKRIDFIPVsPAPsPtRGIGKQCFSPSLQS |
| Q96EA4 | S513 | EPSD | SPDL1 CCDC99 | sLEDNNLQLEKSVSIYTPVVsLsPHKNLPVDMQLKKEKKCV |
| Q96EA4 | S515 | EPSD | SPDL1 CCDC99 | EDNNLQLEKSVSIYTPVVsLsPHKNLPVDMQLKKEKKCVKL |
| Q96GN5 | T129 | Sugiyama | CDCA7L HR1 JPO2 R1 | DDGKAsLVsEEEEDEEEDKAtPRRSRSRRSSIGLRVAFQFP |
| Q96GX5 | T194 | SIGNOR|PSP | MASTL GW GWL THC2 | DFGLSKVTLNRDINMMDILTtPSMAKPRQDYSRtPGQVLSL |
| Q96II8 | S419 | EPSD|PSP | LRCH3 | DSLSSQFMAYIEQRRIsHEGsPVKPVAIREFQKTEDMRRYL |
| Q96KS0 | S130 | EPSD|PSP | EGLN2 EIT6 | QGARPEAPKRKWAEDGGDAPsPsKRPWARQENQEAEREGGM |
| Q96MH2 | S76 | Sugiyama | HEXIM2 L3 | EDLAGAVGGLGWNsRsPRtQsPGGCsAEAVLARKKHRRRPS |
| Q96NB3 | S351 | Sugiyama | ZNF830 CCDC16 | KLKEILTIKELQKKEEENADsDDEGELQDLLSQDWRVKGAL |
| Q96RR4 | S105 | Sugiyama | CAMKK2 CAMKKB KIAA0787 | tsGSQARPHLSGRKLsLQERsQGGLAAGGsLDMNGRCICPs |
| Q96RR4 | S114 | Sugiyama | CAMKK2 CAMKKB KIAA0787 | LSGRKLsLQERsQGGLAAGGsLDMNGRCICPsLPysPVssP |
| Q96T88 | S661 | EPSD|PSP | UHRF1 ICBP90 NP95 RNF106 | RTGKGKWKRKSAGGGPSRAGsPRRTSKKTKVEPYsLTAQQS |
| Q96T88 | S675 | SIGNOR | UHRF1 ICBP90 NP95 RNF106 | GPSRAGsPRRTSKKTKVEPYsLTAQQSSLIREDKSNAKLWN |
| Q99459 | S410 | EPSD | CDC5L KIAA0432 PCDC5RP | sDFsGVtPQRQVVQtPNtVLstPFRtPsNGAEGLtPRsGtt |
| Q99459 | T411 | EPSD | CDC5L KIAA0432 PCDC5RP | DFsGVtPQRQVVQtPNtVLstPFRtPsNGAEGLtPRsGttP |
| Q99504 | S266 | EPSD | EYA3 | APAPAAQRLssGDPstsPsLsQttPsKDtDDQSRKNMTSKN |
| Q99504 | S271 | EPSD | EYA3 | AQRLssGDPstsPsLsQttPsKDtDDQSRKNMTSKNRGKRK |
| Q99504 | T268 | EPSD | EYA3 | APAAQRLssGDPstsPsLsQttPsKDtDDQSRKNMTSKNRG |
| Q99504 | T269 | EPSD | EYA3 | PAAQRLssGDPstsPsLsQttPsKDtDDQSRKNMTSKNRGK |
| Q99607 | S648 | EPSD|PSP | ELF4 ELFR MEF | EPSVTTSGSLLTRsPtPAPFsPFNPTSLIKMEPHDI_____ |
| Q99607 | T643 | EPSD|PSP | ELF4 ELFR MEF | SLLMAEPSVTTSGSLLTRsPtPAPFsPFNPTSLIKMEPHDI |
| Q99626 | S283 | SIGNOR|EPSD|PSP | CDX2 CDX3 | PPPQPPQPQPGPLRSVPEPLsPVSsLQAsVPGsVPGVLGPT |
| Q99626 | S287 | SIGNOR | CDX2 CDX3 | PPQPQPGPLRSVPEPLsPVSsLQAsVPGsVPGVLGPTGGVL |
| Q99626 | S291 | SIGNOR | CDX2 CDX3 | QPGPLRSVPEPLsPVSsLQAsVPGsVPGVLGPTGGVLNPTV |
| Q99626 | S295 | SIGNOR | CDX2 CDX3 | LRSVPEPLsPVSsLQAsVPGsVPGVLGPTGGVLNPTVTQ__ |
| Q99638 | S328 | SIGNOR|EPSD|PSP | RAD9A | IAMETTIGNEGSRVLPsIsLsPGPQPPKsPGPHsEEEDEAE |
| Q99708 | S327 | SIGNOR | RBBP8 CTIP | RFSDstsKtPPQEELPtRVssPVFGATSSIKSGLDLNTsLs |
| Q99708 | T315 | EPSD|PSP | RBBP8 CTIP | FEESTRNTEDSLRFSDstsKtPPQEELPtRVssPVFGATSS |
| Q99708 | T847 | SIGNOR|EPSD|PSP | RBBP8 CTIP | EREKKLASCSRHRFRYIPPNtPENFWEVGFPStQTCMERGY |
| Q99728 | S148 | EPSD|PSP | BARD1 | PRKSLFNDAGNKKNSIKMWFsPRSKKVRYVVSKASVQTQPA |
| Q99728 | S251 | EPSD|PSP | BARD1 | SKEESKQKLVSFCSQPSVISsPQINGEIDLLASGSLTESEC |
| Q99728 | S288 | EPSD|PSP | BARD1 | ESECFGSLTEVSLPLAEQIEsPDTKSRNEVVtPEKVCKNYL |
| Q99728 | T299 | EPSD|PSP | BARD1 | SLPLAEQIEsPDTKSRNEVVtPEKVCKNYLTSKKSLPLENN |
| Q99741 | S106 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | CDC6 CDC18L | PHsHTLKGRRLVFDNQLTIKsPsKRELAKVHQNKILSSVRK |
| Q99741 | S54 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | CDC6 CDC18L | LEPtNVQTVtCsPRVKALPLsPRKRLGDDNLCNtPHLPPCs |
| Q99741 | S74 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | CDC6 CDC18L | sPRKRLGDDNLCNtPHLPPCsPPKQGKKENGPPHsHTLKGR |
| Q9BQA1 | S176 | Sugiyama | WDR77 MEP50 WD45 HKMT1069 Nbla10071 | QQVVLSSYRAHAAQVTCVAAsPHKDSVFLsCSEDNRILLWD |
| Q9BQE3 | T56 | Sugiyama | TUBA1C TUBA6 | MPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtVID |
| Q9BQG0 | S11 | Sugiyama | MYBBP1A P160 | __________MEsRDPAQPMsPGEAtQsGARPADRYGLLKH |
| Q9BQG0 | S1163 | Sugiyama | MYBBP1A P160 | GVQRPKLEKKDAKEIPsAtQsPIsKKRKKKGFLPETKKRKK |
| Q9BTU6 | S51 | Sugiyama | PI4K2A | VPGGAVRVAAAAGsGPsPPGsPGHDRERQPLLDRARGAAAQ |
| Q9BUJ2 | S194 | Sugiyama | HNRNPUL1 E1BAP5 HNRPUL1 | PYEENRGRGYFEHREDRRGRsPQPPAEEDEDDFDDtLVAID |
| Q9BUJ2 | S512 | Sugiyama | HNRNPUL1 E1BAP5 HNRPUL1 | IQIAARKKRNyILDQtNVyGsAQRRKMRPFEGFQRKAIVIC |
| Q9BUJ2 | S716 | EPSD | HNRNPUL1 E1BAP5 HNRPUL1 | PPPQQPPPPQPPPQQPPPPPsysPARNPPGAstYNKNSNIP |
| Q9BUJ2 | S718 | EPSD | HNRNPUL1 E1BAP5 HNRPUL1 | PQQPPPPQPPPQQPPPPPsysPARNPPGAstYNKNSNIPGS |
| Q9BVC5 | S193 | EPSD | C2orf49 | QNHDLTHRKsPsGPVKsPPLsPVGttPVKLKRAAPKEEAEA |
| Q9BVC5 | T197 | EPSD | C2orf49 | LTHRKsPsGPVKsPPLsPVGttPVKLKRAAPKEEAEAMNNL |
| Q9BVC5 | T198 | EPSD | C2orf49 | THRKsPsGPVKsPPLsPVGttPVKLKRAAPKEEAEAMNNLK |
| Q9BWD1 | S208 | Sugiyama | ACAT2 ACTL | RTENAQKAGHFDKEIVPVLVstRKGLIEVKtDEFPRHGsNI |
| Q9BX68 | T47 | Sugiyama | HINT2 | QVRGAAGVTDGNEVAKAQQAtPGGAAPtIFsRILDKsLPAD |
| Q9BXP5 | S493 | Sugiyama | SRRT ARS2 ASR2 | VNIKEICWNLQNIRLRECELsPGVNRDLTRRVRNINGITQH |
| Q9BXR0 | S139 | EPSD|PSP | QTRT1 TGT TGUT | EVTEEGVRFRSPYDGNETLLsPEKSVQIQNALGSDIIMQLD |
| Q9BY44 | S517 | EPSD | EIF2A CDA02 MSTP004 MSTP089 | AKQEARsDKsPDLAPtPAPQstPRNtVsQsIsGDPEIDKKI |
| Q9BY44 | T518 | EPSD | EIF2A CDA02 MSTP004 MSTP089 | KQEARsDKsPDLAPtPAPQstPRNtVsQsIsGDPEIDKKIK |
| Q9BYX7 | S368 | Sugiyama | POTEKP ACTBL3 FKSG30 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q9BYX7 | Y240 | Sugiyama | POTEKP ACTBL3 FKSG30 | ALDSEQEMAMAASSSSVEKsyELPDGQVItIGNERFRCPEA |
| Q9BZL4 | S509 | EPSD|PSP | PPP1R12C LENG3 MBS85 | TKPPPCLENssPPsRIPEPEsPAKPNVPTASTAPPADSRDR |
| Q9C086 | S63 | Sugiyama | INO80B HMGA1L4 PAPA1 ZNHIT4 | HKKKHKKKHHQEEDAGPtQPsPAKPQLKLKIKLGGQVLGTK |
| Q9C0C2 | S1103 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | KRGWVGEFSLSVGPQREAAFsPGQQDWsRDFCIEASERsyQ |
| Q9C0C2 | S435 | EPSD|Sugiyama | TNKS1BP1 KIAA1741 TAB182 | DAHLRPtsLVQRRFsEGVLQsPsQDQEKLGGsLAALPQGQG |
| Q9C0C2 | S437 | EPSD | TNKS1BP1 KIAA1741 TAB182 | HLRPtsLVQRRFsEGVLQsPsQDQEKLGGsLAALPQGQGsQ |
| Q9C0C2 | S672 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | TLARAETtQARtEAQDLCRAsPEPPGPEsSSRWLDDLLAsP |
| Q9C0C2 | S691 | EPSD|PSP | TNKS1BP1 KIAA1741 TAB182 | AsPEPPGPEsSSRWLDDLLAsPPPsGGGARRGAGAELKDtQ |
| Q9C0C9 | S836 | EPSD|PSP | UBE2O KIAA1734 | EAIKILESLKNMtVEQLLtGsPtsPtVEPEKPTREKKFLDD |
| Q9C0D5 | S1564 | EPSD|PSP | TANC1 KIAA1728 | QSAVRNGSMKVQISSQNPPPsPMPGRIAATPAGSRTQHLEG |
| Q9H1E3 | S181 | EPSD|PSP | NUCKS1 NUCKS JC7 | KPERKEKKMPKPRLKAtVtPsPVKGKGKVGRPTAsKAsKEK |
| Q9H1E3 | S214 | Sugiyama | NUCKS1 NUCKS JC7 | AsKAsKEKtPsPKEEDEEPEsPPEKKtstsPPPEKsGDEGs |
| Q9H211 | S31 | EPSD|PSP | CDT1 | ARRRPGPPRIAPPKLACRtPsPARPALRAPASATSGSRKRA |
| Q9H211 | T29 | EPSD|PSP | CDT1 | FFARRRPGPPRIAPPKLACRtPsPARPALRAPASATSGSRK |
| Q9H2C0 | S174 | Sugiyama | GAN GAN1 KLHL16 | TEYLETHFRDVSSTEEFLELsPQKLKEVISLEKLNVGNERY |
| Q9H2D6 | S1955 | Sugiyama | TRIOBP KIAA1662 TARA HRIHFB2122 | KADGQRQALDyVELsPLtQAsPQRARTPARTPDRLAKQEEL |
| Q9H2G4 | S20 | SIGNOR|iPTMNet|EPSD|PSP | TSPYL2 CDA1 DENTT TSPX HRIHFB2216 | _MDRPDEGPPAKTRRLsssEsPQRDPPPPPPPPPLLRLPLP |
| Q9H2G4 | T340 | SIGNOR|iPTMNet|EPSD|PSP | TSPYL2 CDA1 DENTT TSPX HRIHFB2216 | NMVIVKEFQRNRSGRLVSHStPIRWHRGQEPQARRHGNQDA |
| Q9H2U2 | S317 | Sugiyama | PPA2 HSPC124 | DSPFRCtQEEARsLVEsVsssPNKEsNEEEQVWHFLGK___ |
| Q9H3D4 | S477 | SIGNOR | TP63 KET P63 P73H P73L TP73L | ssYGNssPPLNKMNSMNKLPsVsQLINPQQRNALtPTTIPD |
| Q9H3D4 | S560 | SIGNOR | TP63 KET P63 P73H P73L TP73L | PPPYPTDCSIVSFLARLGCSsCLDYFTTQGLTTIYQIEHYS |
| Q9H3D4 | T491 | SIGNOR|EPSD|PSP | TP63 KET P63 P73H P73L TP73L | SMNKLPsVsQLINPQQRNALtPTTIPDGMGANIPMMGTHMP |
| Q9H3P2 | T157 | EPSD|PSP | NELFA WHSC2 P/OKcl.15 | LPLECQYLNKNALttLAGPLtPPVKHFQLKRKPKSATLRAE |
| Q9H425 | S37 | EPSD|PSP | C1orf198 | sGNRPLDDRERKRFTYFSsLsPMARKIMQDKEKIREKYGPE |
| Q9H4A3 | S1261 | Sugiyama | WNK1 HSN2 KDP KIAA0344 PRKWNK1 | GIPTSSLTQVVHSAGRRFIVsPVPEsRLRESKVFPSEITDT |
| Q9H6F5 | S102 | Sugiyama | CCDC86 CYCLON | QGQPEPGAAsPQRQQDLHLEsPQRQPEysPEsPRCQPKPSE |
| Q9H6F5 | S113 | Sugiyama | CCDC86 CYCLON | QRQQDLHLEsPQRQPEysPEsPRCQPKPSEEAPKCsQDQGV |
| Q9H6F5 | S91 | Sugiyama | CCDC86 CYCLON | RLQQGAGLEsPQGQPEPGAAsPQRQQDLHLEsPQRQPEysP |
| Q9H6K1 | S215 | EPSD|PSP | ILRUN C6orf106 | ETEFNTQPHRKVEGNFNPFAsPQKNRQsDENNLKDPGGSEF |
| Q9H773 | S85 | Sugiyama | DCTPP1 XTP3TPA CDA03 | GELAELFQWKTDGEPGPQGWsPRERAALQEELSDVLIYLVA |
| Q9H7L9 | S234 | EPSD | SUDS3 SAP45 SDS3 | EQIMEDLRTLNKLKsPKRPAsPssPEHLPAtPAEsPAQRFE |
| Q9H7L9 | S236 | EPSD | SUDS3 SAP45 SDS3 | IMEDLRTLNKLKsPKRPAsPssPEHLPAtPAEsPAQRFEAR |
| Q9H7L9 | S237 | EPSD | SUDS3 SAP45 SDS3 | MEDLRTLNKLKsPKRPAsPssPEHLPAtPAEsPAQRFEARI |
| Q9H7L9 | T244 | EPSD | SUDS3 SAP45 SDS3 | NKLKsPKRPAsPssPEHLPAtPAEsPAQRFEARIEDGKLYY |
| Q9H8Y8 | S451 | Sugiyama | GORASP2 GOLPH6 | DstPVsEKPVsAAVDANAsEsP___________________ |
| Q9H8Y8 | T225 | EPSD|PSP | GORASP2 GOLPH6 | RPFEEGKKIsLPGQMAGtPItPLKDGFTEVQLSSVNPPSLS |
| Q9H910 | S97 | EPSD|PSP | JPT2 C16orf34 HN1L L11 | PVQTRQHLNPPGGKtsDIFGsPVtATSRLAHPNKPKDHVFL |
| Q9H9C1 | S130 | EPSD | VIPAS39 C14orf133 SPE39 VIPAR | SSFFRGRtRPGsFQsLsDALsDtPAKSYAPELGRPKGEYRD |
| Q9H9C1 | T132 | EPSD | VIPAS39 C14orf133 SPE39 VIPAR | FFRGRtRPGsFQsLsDALsDtPAKSYAPELGRPKGEYRDYS |
| Q9HAV4 | S1137 | Sugiyama | XPO5 KIAA1291 RANBP21 | QIPEIQKDSLDQFDCKLLNPsLQKVADKRRKDQFKRLIAGC |
| Q9NP87 | S12 | SIGNOR | POLM polmu | _________MLPKRRRARVGsPsGDAASStPPSTRFPGVAI |
| Q9NP87 | S372 | SIGNOR|EPSD|PSP | POLM polmu | CRLQDQGLILYHQHQHsCCEsPtRLAQQSHMDAFERSFCIF |
| Q9NP87 | T21 | SIGNOR | POLM polmu | MLPKRRRARVGsPsGDAASStPPSTRFPGVAIYLVEPRMGR |
| Q9NPF5 | S448 | EPSD | DMAP1 KIAA1425 | LGPDPKDtIIDVVGAPLtPNsRKRREsAsSSSSVKKAKKP_ |
| Q9NPF5 | T445 | EPSD | DMAP1 KIAA1425 | EPGLGPDPKDtIIDVVGAPLtPNsRKRREsAsSSSSVKKAK |
| Q9NQ39 | S157 | Sugiyama | RPS10P5 RPS10L | TYRRCSVPPGADKKAEAGAGsAtEFQFRGRCGRGRGQPPQ_ |
| Q9NQR4 | S133 | Sugiyama | NIT2 CUA002 | IHLFDIDVPGKITFQESKTLsPGDsFSTFDTPyCRVGLGIC |
| Q9NR30 | S71 | Sugiyama | DDX21 | VFPKAKQVKKKAEPSEVDMNsPKSKKAKKKEEPSQNDIsPK |
| Q9NRH3 | S80 | EPSD|PSP | TUBG2 | yIPRAVLLDLEPRVIHSILNsPYAKLYNPENIYLSEHGGGA |
| Q9NS91 | S99 | EPSD|PSP | RAD18 RNF73 | DELVKSLNFARNHLLQFALEsPAKsPAsssSKNLAVKVYtP |
| Q9NSV4 | T19 | EPSD|PSP | DIAPH3 DIAP3 | __MERHQPRLHHPAQGSAAGtPYPssAsLRGCRESKMPRRK |
| Q9NTI5 | S1283 | Sugiyama | PDS5B APRIN AS3 KIAA0979 | QWPEEKRLKEDILENEDEQNsPPKKGKRGRPPKPLGGGtPK |
| Q9NTI5 | S1369 | EPSD | PDS5B APRIN AS3 KIAA0979 | SRRAQQRAEsPEssAIEstQstPQKGRGRPsKtPsPsQPKK |
| Q9NTI5 | T1370 | EPSD | PDS5B APRIN AS3 KIAA0979 | RRAQQRAEsPEssAIEstQstPQKGRGRPsKtPsPsQPKKN |
| Q9NXR1 | T228 | EPSD|PSP | NDE1 NUDE | AtGsVPstPIAHRGPsssLNtPGsFRRGLDDstGGtPLtPA |
| Q9NY27 | S226 | Sugiyama | PPP4R2 SBBI57 | QNEEKNHSDsstsEsEVssVsPLKNKHPDEDAVEAEGHEVK |
| Q9NY74 | S111 | PSP | ETAA1 ETAA16 | sSFssPNDPDGQNDIFWDQNsPLTKQLGKGRKKQIYTTDsD |
| Q9NY74 | S95 | PSP | ETAA1 ETAA16 | ERYETPKRALKMDSLssSFssPNDPDGQNDIFWDQNsPLTK |
| Q9NYB0 | S203 | EPSD|PSP|Sugiyama | TERF2IP DRIP5 RAP1 PP8000 | RYLKHLRGQEHKyLLGDAPVsPssQKLKRKAEEDPEAADsG |
| Q9NYF8 | T840 | EPSD|PSP | BCLAF1 BTF KIAA0164 | NNSNTTFQKRPKEEEWDPEYtPKSKKYFLHDDRDDGVDYWA |
| Q9NYV4 | S249 | Sugiyama | CDK12 CRK7 CRKRS KIAA0904 | DSSKQDDsPsGAsYGQDyDLsPsRsHtssNYDsYKKsPGsT |
| Q9NYV6 | S44 | SIGNOR|EPSD|PSP | RRN3 TIFIA | LGASRTGISNMRALENDFFNsPPRKTVRFGGTVTEVLLKYK |
| Q9NZB2 | S990 | Sugiyama | FAM120A C9orf10 KIAA0183 OSSA | FPLQVVSVGGPARGRPRGVIstPVIRTFGRGGRYYGRGYKN |
| Q9NZJ0 | S428 | EPSD | DTL CDT2 CDW1 DCAF2 L2DTL RAMP | WAsQKKKESRPGLVTVtssQstPAKAPRAKCNPsNssPssA |
| Q9NZJ0 | T429 | EPSD|Sugiyama | DTL CDT2 CDW1 DCAF2 L2DTL RAMP | AsQKKKESRPGLVTVtssQstPAKAPRAKCNPsNssPssAA |
| Q9NZJ0 | T464 | PSP | DTL CDT2 CDW1 DCAF2 L2DTL RAMP | sPssAACAPsCAGDLPLPsNtPtFsIKtsPAKARSPINRRG |
| Q9NZT2 | S378 | Sugiyama | OGFR | LERsQGDEAGGHGEDRPEPLsPKEsKKRKLELSRREQPPTE |
| Q9P270 | S48 | EPSD|PSP | SLAIN2 KIAA1458 | NEQLRSRsGAVQGAGsLGPGsPVRAGAsIPssGAAsPRGFP |
| Q9P2B4 | S563 | EPSD|PSP | CTTNBP2NL KIAA1433 | RGDTSHsPtPGKVssPLsPLsPGIKsPtIPRAERGNPPPIP |
| Q9P2D1 | S2471 | EPSD | CHD7 KIAA1416 | ATSsTSNFSSLSSKFILPNVstPVSDAFKTQMELLQAGLsR |
| Q9P2D1 | T2472 | EPSD | CHD7 KIAA1416 | TSsTSNFSSLSSKFILPNVstPVSDAFKTQMELLQAGLsRt |
| Q9P2J5 | S391 | Sugiyama | LARS1 KIAA1352 LARS | VIYVLPMLTIKEDKGtGVVTsVPsDsPDDIAALRDLKKKQA |
| Q9P2N5 | S798 | EPSD | RBM27 KIAA1311 | IFstPGHPKMIySSSNLKtPsKLCSGSKSHDVQEVLKKKQE |
| Q9P2N5 | T796 | EPSD | RBM27 KIAA1311 | CQIFstPGHPKMIySSSNLKtPsKLCSGSKSHDVQEVLKKK |
| Q9UD71 | T75 | ELM | PPP1R1B DARPP32 | QRASGEGHHLKsKRPNPCAYtPPSLKAVQRIAESHLQSIsN |
| Q9UEY8 | S423 | EPSD|PSP | ADD3 ADDL | DVEIPAtVtAFsFEDDtVPLsPLKYMAQRQQREKTRWLNsP |
| Q9UEY8 | S677 | Sugiyama | ADD3 ADDL | NIEITIKsPEKIEEVLsPEGsPsKsPsKKKKKFRTPsFLKK |
| Q9UEY8 | S681 | Sugiyama | ADD3 ADDL | TIKsPEKIEEVLsPEGsPsKsPsKKKKKFRTPsFLKKNKKK |
| Q9UEY8 | S683 | Sugiyama | ADD3 ADDL | KsPEKIEEVLsPEGsPsKsPsKKKKKFRTPsFLKKNKKKEK |
| Q9UFC0 | S243 | EPSD | LRWD1 CENP-33 ORCA | HKPRARLAALKRPDDVPLsLsPsKRACAsPsAQVEGsPVAG |
| Q9UFC0 | S245 | EPSD | LRWD1 CENP-33 ORCA | PRARLAALKRPDDVPLsLsPsKRACAsPsAQVEGsPVAGsD |
| Q9UGP5 | S167 | EPSD|PSP | POLL | AEQDASIPPGTHEALLQtALsPPPPPtRPVsPPQKAKEAPN |
| Q9UGP5 | S177 | EPSD|PSP | POLL | THEALLQtALsPPPPPtRPVsPPQKAKEAPNTQAQPISDDE |
| Q9UGP5 | S230 | EPSD|PSP | POLL | DLEALISGHYPTSLEGDCEPsPAPAVLDKWVCAQPSSQKAT |
| Q9UGP5 | T553 | SIGNOR|EPSD|PSP | POLL | STAVVRNTHGCKVGPGRVLPtPTEKDVFRLLGLPYREPAER |
| Q9UGV2 | S333 | Sugiyama | NDRG3 | MGYIPSASMTRLARsRtHstsssLGsGEsPFsRsVtsNQsD |
| Q9UGV2 | T332 | Sugiyama | NDRG3 | GMGYIPSASMTRLARsRtHstsssLGsGEsPFsRsVtsNQs |
| Q9UHB6 | S490 | Sugiyama | LIMA1 EPLIN SREBP3 PP624 | ENEEILERPAQLANAREtPHsPGVEDAPIAKVGVLAAsMEA |
| Q9UHR4 | S261 | Sugiyama | BAIAP2L1 IRTKS | NMIEEIKtPAstPVsGtPQAsPMIERSNVVRKDyDtLsKCs |
| Q9UI10 | T86 | Sugiyama | EIF2B4 EIF2BD | AAQCQVGPTRELPESGIQLGtPREKVPAGRSKAELRAERRA |
| Q9UIF9 | S1183 | EPSD | BAZ2A KIAA0314 TIP5 | sLNPALFSMKMELAGSNttAssPARARGRPRKTKPGSMQPR |
| Q9UIF9 | S1184 | EPSD | BAZ2A KIAA0314 TIP5 | LNPALFSMKMELAGSNttAssPARARGRPRKTKPGSMQPRH |
| Q9UIF9 | S509 | EPSD|PSP | BAZ2A KIAA0314 TIP5 | SVTSPKAsPVtsPAAAFPtAsPANKDVSSFLETTADVEEIT |
| Q9UJU6 | S232 | Sugiyama | DBNL CMAP SH3P7 PP5423 | RELREAARREQRyQEQGGEAsPQRtWEQQQEVVSRNRNEQE |
| Q9UJU6 | S274 | EPSD | DBNL CMAP SH3P7 PP5423 | AVHPREIFKQKERAMsttsIssPQPGKLRsPFLQKQLtQPE |
| Q9UJU6 | S275 | EPSD | DBNL CMAP SH3P7 PP5423 | VHPREIFKQKERAMsttsIssPQPGKLRsPFLQKQLtQPEt |
| Q9UK61 | T819 | PSP | TASOR C3orf63 FAM208A KIAA1105 | LsTDDAyEELRQKHEYELNstPDKKDYEQPTCAKVENAQFK |
| Q9UKM9 | S135 | EPSD|PSP | RALY HNRPCL2 P542 | DYDYYRDDFYDRLFDYRGRLsPVPVPRAVPVKRPRVTVPLV |
| Q9UKV3 | T254 | Sugiyama | ACIN1 ACINUS KIAA0670 | ARAAKLsEGsQPAEEEEDQEtPsRNLRVRADRNLKTEEEEE |
| Q9UKY1 | T568 | EPSD|PSP | ZHX1 | ESPTVGTAQPKQSWNPFPDFtPQKFKEKTAEQLRVLQASFL |
| Q9ULW0 | T72 | SIGNOR|EPSD|PSP | TPX2 C20orf1 C20orf2 DIL2 HCA519 | GGLFQGKtPLRKANLQQAIVtPLKPVDNtYYKEAEKENLVE |
| Q9ULX3 | T121 | EPSD|PSP | NOB1 ART4 NOB1P PSMD8BP1 MSTP158 | SHLKQEPQKVKVSSSIQHPEtPLHISGFHLPYKPKPPQETE |
| Q9UM11 | S151 | SIGNOR|ELM|iPTMNet|EPSD|PSP | FZR1 CDH1 FYR FZR KIAA1242 | SLsTKRssPDDGNDVsPYsLsPVSNKSQKLLRsPRKPTRKI |
| Q9UM11 | S163 | SIGNOR|ELM|iPTMNet|EPSD|PSP | FZR1 CDH1 FYR FZR KIAA1242 | NDVsPYsLsPVSNKSQKLLRsPRKPTRKISKIPFKVLDAPE |
| Q9UM11 | S40 | EPSD|PSP | FZR1 CDH1 FYR FZR KIAA1242 | TMPRVTEMRRTLtPAssPVssPsKHGDRFIPSRAGANWSVN |
| Q9UM11 | T121 | EPSD|PSP | FZR1 CDH1 FYR FZR KIAA1242 | GAGIEKVQDPQTEDRRLQPstPEKKGLFTYSLsTKRssPDD |
| Q9UNX3 | S12 | Sugiyama | RPL26L1 RPL26P1 | _________MKFNPFVtsDRsKNRKRHFNAPSHVRRKIMss |
| Q9UNX3 | S32 | Sugiyama | RPL26L1 RPL26P1 | sKNRKRHFNAPSHVRRKIMssPLSKELRQKYNVRSMPIRKD |
| Q9UNX3 | T8 | Sugiyama | RPL26L1 RPL26P1 | _____________MKFNPFVtsDRsKNRKRHFNAPSHVRRK |
| Q9UPN3 | T7213 | EPSD|PSP | MACF1 ABP620 ACF7 KIAA0465 KIAA0754 KIAA1251 | RTNIELREKFILPEGASQGMtPFRSRGRRsKPSsRAAsPtR |
| Q9UPP1 | S880 | PSP | PHF8 KIAA1111 ZNF422 | DDPALKSRPKKKKNSDDAPWsPKARVTPTLPKQDRPVREGT |
| Q9UPQ0 | S521 | Sugiyama | LIMCH1 KIAA1102 | ATVETTIARASVLDtsMsAGsGsPsKTVtPKAVPMLtPKPY |
| Q9UPQ0 | S523 | Sugiyama | LIMCH1 KIAA1102 | VETTIARASVLDtsMsAGsGsPsKTVtPKAVPMLtPKPYsQ |
| Q9UPT8 | S143 | Sugiyama | ZC3H4 C19orf7 KIAA1064 | KSKHKRHAsSSDDFsDFsDDsDFsPSEKGHRKyREysPPyA |
| Q9UPT8 | S146 | Sugiyama | ZC3H4 C19orf7 KIAA1064 | HKRHAsSSDDFsDFsDDsDFsPSEKGHRKyREysPPyAPsH |
| Q9UQ35 | S1320 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sMASSWGGPHFsPEHKELsNsPLRENsFGsPLEFRNsGPLG |
| Q9UQ35 | S1329 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | HFsPEHKELsNsPLRENsFGsPLEFRNsGPLGTEMNtGFss |
| Q9UQ35 | S1648 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | APRALPRRSRSGSSSKGRGPsPEGssstEssPEHPPKSRTA |
| Q9UQ35 | S2132 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | SRMsCFsRPsMsPtPLDRCRsPGMLEPLGssRtPMsVLQQA |
| Q9UQ35 | S2694 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | RSRSPRKPIDsLRDsRsLsysPVERRRPsPQPsPRDQQSSs |
| Q9UQ80 | S34 | PSP | PA2G4 EBP1 | EDLVVTKYKMGGDIANRVLRsLVEASssGVsVLsLCEKGDA |
| Q9UQR0 | S267 | PSP | SCML2 | VKNIAKtEssPsEAsQHsMQsPQKTTLILPTQQVRRSSRIK |
| Q9UQR0 | S511 | EPSD|PSP | SCML2 | TERQstKRsPQQtVPYVVPLsPKLPKTKEYAsEGEPLFAGG |
| Q9UQR0 | S590 | EPSD|PSP | SCML2 | sQDFSRSVPGTTssPLVGDIsPKssPHEVKFQMQRKsEAPS |
| Q9UQR0 | T305 | EPSD|PSP | SCML2 | RIKPPGPTAVPKRSSSVKNItPRKKGPNSGKKEKPLPVICS |
| Q9Y253 | S687 | EPSD|PSP | POLH RAD30 RAD30A XPV | HSSNPQVVSAVSHQGKRNPKsPLACTNKRPRPEGMQTLESF |
| Q9Y266 | S136 | EPSD | NUDC | QLEIDQKKDAENHEAQLKNGsLDsPGKQDtEEDEEEDEKDK |
| Q9Y266 | S139 | EPSD|Sugiyama | NUDC | IDQKKDAENHEAQLKNGsLDsPGKQDtEEDEEEDEKDKGKL |
| Q9Y2J2 | S960 | EPSD | EPB41L3 DAL1 KIAA0987 | LEQKPHFESSTVKTETIsFGsVsPGGVKLEISTKEVPVVHT |
| Q9Y2J2 | S962 | EPSD | EPB41L3 DAL1 KIAA0987 | QKPHFESSTVKTETIsFGsVsPGGVKLEISTKEVPVVHTET |
| Q9Y2J2 | T466 | EPSD | EPB41L3 DAL1 KIAA0987 | GEVGTGQYATTKGIsQtNLIttVtPEKKAEEERDEEEDKRR |
| Q9Y2J2 | T467 | EPSD | EPB41L3 DAL1 KIAA0987 | EVGTGQYATTKGIsQtNLIttVtPEKKAEEERDEEEDKRRK |
| Q9Y2K7 | T550 | EPSD|PSP | KDM2A CXXC8 FBL11 FBL7 FBXL11 JHDM1A KIAA1004 | VRVPTIPITKPHTMKPAPRLtPVRPAAAsPIVsGARRRRVR |
| Q9Y2T7 | T124 | Sugiyama | YBX2 CSDA3 MSY2 | RNGyGFINRNDtKEDVFVHQtAIKRNNPRKFLRsVGDGEtV |
| Q9Y2V2 | S30 | Sugiyama | CARHSP1 | QPPtHQAsVGLLDtPRsRERsPsPLRGNVVPsPLPtRRtRt |
| Q9Y2V2 | S32 | Sugiyama | CARHSP1 | PtHQAsVGLLDtPRsRERsPsPLRGNVVPsPLPtRRtRtFs |
| Q9Y2V2 | S41 | Sugiyama | CARHSP1 | LDtPRsRERsPsPLRGNVVPsPLPtRRtRtFsAtVRASQGP |
| Q9Y2W1 | T874 | EPSD|PSP | THRAP3 BCLAF2 TRAP150 | NNSNNDFQKRNREEEWDPEytPKsKKYYLHDDREGEGsDKW |
| Q9Y2X3 | S440 | Sugiyama | NOP58 NOL5 NOP5 HSPC120 | EHKSEVKtyDPSGDstLPtCsKKRKIEQVDKEDEITEKKAK |
| Q9Y2X3 | S509 | Sugiyama | NOP58 NOL5 NOP5 HSPC120 | KRGKKKHIKEEPLsEEEPCtstAIAsPEKKKKKKKKRENED |
| Q9Y2X3 | S514 | Sugiyama | NOP58 NOL5 NOP5 HSPC120 | KHIKEEPLsEEEPCtstAIAsPEKKKKKKKKRENED_____ |
| Q9Y314 | S166 | EPSD | NOSIP CGI-25 | PSVGPPsKDKDKVLPSFWIPsLtPEAKATKLEKPSRTVTCP |
| Q9Y314 | T168 | EPSD | NOSIP CGI-25 | VGPPsKDKDKVLPSFWIPsLtPEAKATKLEKPSRTVTCPMS |
| Q9Y3Z3 | T592 | EPSD|PSP | SAMHD1 MOP5 | WCADRNFTKPQDGDVIAPLItPQKKEWNDstsVQNPtRLRE |
| Q9Y4J8 | S501 | Sugiyama | DTNA DRP3 | NKNREILQEIQRLRLEHEQAsQPtPEKAQQNPTLLAELRLL |
| Q9Y4J8 | T504 | Sugiyama | DTNA DRP3 | REILQEIQRLRLEHEQAsQPtPEKAQQNPTLLAELRLLRQR |
| Q9Y676 | S49 | EPSD|PSP | MRPS18B C6orf14 HSPC183 PTD017 | LQTLCTKAPsEEDsLSsVPIsPYKDEPWKYLESEEYQERYG |
| Q9Y6G9 | S207 | Sugiyama | DYNC1LI1 DNCLI1 | EQKLIRDFQEyVEPGEDFPAsPQRRNtAsQEDKDDsVVLPL |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell Cycle | R-HSA-1640170 | 5.551115e-16 | 15.256 | 1 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 3.508305e-14 | 13.455 | 1 | 0 |
| Chromatin organization | R-HSA-4839726 | 1.721201e-10 | 9.764 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 6.928917e-10 | 9.159 | 1 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 9.029687e-10 | 9.044 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 5.253450e-09 | 8.280 | 1 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 5.102878e-08 | 7.292 | 1 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 2.573583e-07 | 6.589 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 2.911062e-07 | 6.536 | 1 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 2.747040e-06 | 5.561 | 1 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 6.082974e-06 | 5.216 | 0 | 0 |
| M Phase | R-HSA-68886 | 6.718600e-06 | 5.173 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 8.411767e-06 | 5.075 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 1.232439e-05 | 4.909 | 1 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.580389e-05 | 4.801 | 1 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.733355e-05 | 4.761 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 2.174507e-05 | 4.663 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 2.102129e-05 | 4.677 | 1 | 1 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 2.102129e-05 | 4.677 | 1 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 2.160443e-05 | 4.665 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.906192e-05 | 4.720 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 2.410404e-05 | 4.618 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 3.396290e-05 | 4.469 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 4.322224e-05 | 4.364 | 0 | 0 |
| S Phase | R-HSA-69242 | 4.317366e-05 | 4.365 | 1 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 7.265268e-05 | 4.139 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 9.027753e-05 | 4.044 | 1 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 1.008635e-04 | 3.996 | 1 | 1 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 1.149615e-04 | 3.939 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 1.160184e-04 | 3.935 | 1 | 1 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 1.349056e-04 | 3.870 | 1 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.320664e-04 | 3.879 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 1.332458e-04 | 3.875 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 1.372330e-04 | 3.863 | 1 | 0 |
| G1/S Transition | R-HSA-69206 | 1.977412e-04 | 3.704 | 1 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 3.120283e-04 | 3.506 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 3.120283e-04 | 3.506 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 3.095938e-04 | 3.509 | 1 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 3.324093e-04 | 3.478 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 3.316357e-04 | 3.479 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 3.450848e-04 | 3.462 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 3.450848e-04 | 3.462 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 3.884036e-04 | 3.411 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 4.043754e-04 | 3.393 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 4.267337e-04 | 3.370 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 4.669009e-04 | 3.331 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 5.192123e-04 | 3.285 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 5.192123e-04 | 3.285 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 5.077665e-04 | 3.294 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 5.077665e-04 | 3.294 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 5.192123e-04 | 3.285 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 5.497781e-04 | 3.260 | 1 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 5.497781e-04 | 3.260 | 1 | 1 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 5.347282e-04 | 3.272 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 6.501600e-04 | 3.187 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 6.501600e-04 | 3.187 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 6.501600e-04 | 3.187 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 6.501600e-04 | 3.187 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 7.336249e-04 | 3.135 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 7.353021e-04 | 3.134 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 7.927799e-04 | 3.101 | 1 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 7.927799e-04 | 3.101 | 1 | 1 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 8.619163e-04 | 3.065 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 9.363342e-04 | 3.029 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 9.363342e-04 | 3.029 | 1 | 1 |
| G2/M Checkpoints | R-HSA-69481 | 9.783857e-04 | 3.009 | 1 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 1.044108e-03 | 2.981 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 1.096768e-03 | 2.960 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 1.182374e-03 | 2.927 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 1.184235e-03 | 2.927 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.186591e-03 | 2.926 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 1.297244e-03 | 2.887 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 1.297244e-03 | 2.887 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 1.328354e-03 | 2.877 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.468103e-03 | 2.833 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 1.437292e-03 | 2.842 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 1.600023e-03 | 2.796 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 1.684208e-03 | 2.774 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 1.684208e-03 | 2.774 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.712393e-03 | 2.766 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.712393e-03 | 2.766 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 1.846633e-03 | 2.734 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.777247e-03 | 2.750 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 1.846633e-03 | 2.734 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.959737e-03 | 2.708 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 1.959737e-03 | 2.708 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 2.027463e-03 | 2.693 | 1 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 2.269309e-03 | 2.644 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 2.235539e-03 | 2.651 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 2.318474e-03 | 2.635 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 2.633694e-03 | 2.579 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 2.633694e-03 | 2.579 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 2.635350e-03 | 2.579 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 2.790783e-03 | 2.554 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 2.844665e-03 | 2.546 | 1 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 2.876137e-03 | 2.541 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 3.199042e-03 | 2.495 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 3.031474e-03 | 2.518 | 1 | 1 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 3.251377e-03 | 2.488 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 3.273917e-03 | 2.485 | 1 | 1 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 3.425495e-03 | 2.465 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 3.872692e-03 | 2.412 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 4.176774e-03 | 2.379 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 4.176774e-03 | 2.379 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 4.099285e-03 | 2.387 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 4.083957e-03 | 2.389 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 4.340303e-03 | 2.362 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 4.367240e-03 | 2.360 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 4.561401e-03 | 2.341 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 4.654950e-03 | 2.332 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 5.294661e-03 | 2.276 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 5.866849e-03 | 2.232 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 6.135450e-03 | 2.212 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 6.916821e-03 | 2.160 | 1 | 1 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 7.537293e-03 | 2.123 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 7.755036e-03 | 2.110 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 7.871709e-03 | 2.104 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 8.389028e-03 | 2.076 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 8.389028e-03 | 2.076 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 8.414629e-03 | 2.075 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 8.473046e-03 | 2.072 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 8.473046e-03 | 2.072 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 8.778650e-03 | 2.057 | 1 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 9.549444e-03 | 2.020 | 1 | 1 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 9.279446e-03 | 2.032 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 9.746769e-03 | 2.011 | 1 | 1 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 9.697195e-03 | 2.013 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 9.857738e-03 | 2.006 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 1.147417e-02 | 1.940 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 1.174388e-02 | 1.930 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 1.330268e-02 | 1.876 | 1 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.346432e-02 | 1.871 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 1.355549e-02 | 1.868 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.392448e-02 | 1.856 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 1.484541e-02 | 1.828 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 1.661836e-02 | 1.779 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 1.607864e-02 | 1.794 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 1.621763e-02 | 1.790 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.626434e-02 | 1.789 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 1.675697e-02 | 1.776 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.835199e-02 | 1.736 | 1 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.836236e-02 | 1.736 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 1.876024e-02 | 1.727 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 1.876615e-02 | 1.727 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.906071e-02 | 1.720 | 1 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 1.954954e-02 | 1.709 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 1.988027e-02 | 1.702 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 2.124787e-02 | 1.673 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 2.310058e-02 | 1.636 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 2.364010e-02 | 1.626 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 2.364010e-02 | 1.626 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 2.364010e-02 | 1.626 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 2.217206e-02 | 1.654 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 2.310058e-02 | 1.636 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 2.411516e-02 | 1.618 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 2.411516e-02 | 1.618 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 2.470296e-02 | 1.607 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 2.948409e-02 | 1.530 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 2.948409e-02 | 1.530 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 2.948409e-02 | 1.530 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 2.948409e-02 | 1.530 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 2.948409e-02 | 1.530 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 2.948409e-02 | 1.530 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 2.948409e-02 | 1.530 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 2.948409e-02 | 1.530 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 2.948409e-02 | 1.530 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 2.932892e-02 | 1.533 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 2.743737e-02 | 1.562 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 2.700888e-02 | 1.568 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 2.875150e-02 | 1.541 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 2.740906e-02 | 1.562 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 2.763313e-02 | 1.559 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 2.972759e-02 | 1.527 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 2.972759e-02 | 1.527 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 2.972759e-02 | 1.527 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 2.972759e-02 | 1.527 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 2.974871e-02 | 1.527 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 3.102545e-02 | 1.508 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 3.111048e-02 | 1.507 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 3.119236e-02 | 1.506 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 3.119236e-02 | 1.506 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 3.309561e-02 | 1.480 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 3.402102e-02 | 1.468 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 3.471363e-02 | 1.459 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 3.816081e-02 | 1.418 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 3.735487e-02 | 1.428 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 3.735487e-02 | 1.428 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 3.816081e-02 | 1.418 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 3.471363e-02 | 1.459 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 3.871911e-02 | 1.412 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 3.871911e-02 | 1.412 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 4.046904e-02 | 1.393 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 4.218821e-02 | 1.375 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 4.223080e-02 | 1.374 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 4.223080e-02 | 1.374 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 4.312896e-02 | 1.365 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 4.331972e-02 | 1.363 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 4.331972e-02 | 1.363 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 4.388726e-02 | 1.358 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 4.436617e-02 | 1.353 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 4.559995e-02 | 1.341 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 4.559995e-02 | 1.341 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 4.669307e-02 | 1.331 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 4.669307e-02 | 1.331 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 4.669307e-02 | 1.331 | 1 | 1 |
| Phosphorylation of the APC/C | R-HSA-176412 | 5.272045e-02 | 1.278 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 5.085441e-02 | 1.294 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 4.626238e-02 | 1.335 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 4.632837e-02 | 1.334 | 1 | 0 |
| Synthesis of DNA | R-HSA-69239 | 5.076714e-02 | 1.294 | 1 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 4.669307e-02 | 1.331 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 5.272045e-02 | 1.278 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 5.272045e-02 | 1.278 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 4.669307e-02 | 1.331 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 5.032836e-02 | 1.298 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 5.394929e-02 | 1.268 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 5.394929e-02 | 1.268 | 1 | 1 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 5.682868e-02 | 1.245 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 5.752577e-02 | 1.240 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 5.909672e-02 | 1.228 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 6.038772e-02 | 1.219 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 6.038772e-02 | 1.219 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 6.040433e-02 | 1.219 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 6.040433e-02 | 1.219 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 6.040433e-02 | 1.219 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 6.040433e-02 | 1.219 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 6.102016e-02 | 1.215 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 6.102016e-02 | 1.215 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 6.350964e-02 | 1.197 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 6.406965e-02 | 1.193 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 6.406965e-02 | 1.193 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 6.446803e-02 | 1.191 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 6.744704e-02 | 1.171 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 6.744704e-02 | 1.171 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 6.744704e-02 | 1.171 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 7.740532e-02 | 1.111 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 7.250590e-02 | 1.140 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 6.754422e-02 | 1.170 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 7.022436e-02 | 1.154 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 7.740532e-02 | 1.111 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 6.901715e-02 | 1.161 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 7.131136e-02 | 1.147 | 1 | 1 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 7.823363e-02 | 1.107 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 7.823363e-02 | 1.107 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 7.879588e-02 | 1.103 | 1 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 7.939322e-02 | 1.100 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 7.939322e-02 | 1.100 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 7.969080e-02 | 1.099 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 8.257062e-02 | 1.083 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 8.339585e-02 | 1.079 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 8.684252e-02 | 1.061 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 8.705011e-02 | 1.060 | 1 | 0 |
| Heme signaling | R-HSA-9707616 | 8.818363e-02 | 1.055 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 8.868967e-02 | 1.052 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 8.868967e-02 | 1.052 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 9.165078e-02 | 1.038 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 9.165078e-02 | 1.038 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 9.165078e-02 | 1.038 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 9.654877e-02 | 1.015 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 9.944350e-02 | 1.002 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 9.944350e-02 | 1.002 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 9.944350e-02 | 1.002 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 9.980719e-02 | 1.001 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 1.030476e-01 | 0.987 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 1.188843e-01 | 0.925 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 1.176732e-01 | 0.929 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 1.111102e-01 | 0.954 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 1.111102e-01 | 0.954 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 1.079587e-01 | 0.967 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.217380e-01 | 0.915 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.061179e-01 | 0.974 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.124547e-01 | 0.949 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 1.238959e-01 | 0.907 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 1.192223e-01 | 0.924 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 1.217380e-01 | 0.915 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.079587e-01 | 0.967 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.079587e-01 | 0.967 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.217380e-01 | 0.915 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 1.114192e-01 | 0.953 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 1.220475e-01 | 0.913 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 1.180359e-01 | 0.928 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 1.185391e-01 | 0.926 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 1.213439e-01 | 0.916 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 1.110437e-01 | 0.955 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 1.106937e-01 | 0.956 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 1.035928e-01 | 0.985 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 1.147183e-01 | 0.940 | 0 | 0 |
| Drug resistance of PDGFR mutants | R-HSA-9674415 | 1.241198e-01 | 0.906 | 0 | 0 |
| PDGFR mutants bind TKIs | R-HSA-9674428 | 1.241198e-01 | 0.906 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.241198e-01 | 0.906 | 0 | 0 |
| Sorafenib-resistant PDGFR mutants | R-HSA-9674404 | 1.241198e-01 | 0.906 | 0 | 0 |
| Sunitinib-resistant PDGFR mutants | R-HSA-9674401 | 1.241198e-01 | 0.906 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 1.241198e-01 | 0.906 | 0 | 0 |
| Imatinib-resistant PDGFR mutants | R-HSA-9674396 | 1.241198e-01 | 0.906 | 0 | 0 |
| Regorafenib-resistant PDGFR mutants | R-HSA-9674403 | 1.241198e-01 | 0.906 | 0 | 0 |
| Deletions in the AXIN1 gene destabilize the destruction complex | R-HSA-5467345 | 1.241198e-01 | 0.906 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 1.277531e-01 | 0.894 | 1 | 1 |
| Translesion synthesis by POLI | R-HSA-5656121 | 1.296836e-01 | 0.887 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.296836e-01 | 0.887 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 1.315576e-01 | 0.881 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 1.329621e-01 | 0.876 | 1 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 1.333646e-01 | 0.875 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 1.344879e-01 | 0.871 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 1.344879e-01 | 0.871 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 1.349925e-01 | 0.870 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 1.350194e-01 | 0.870 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 1.351150e-01 | 0.869 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 1.351150e-01 | 0.869 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 1.370257e-01 | 0.863 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 1.370257e-01 | 0.863 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 1.486851e-01 | 0.828 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 1.486851e-01 | 0.828 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 1.486851e-01 | 0.828 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 1.486851e-01 | 0.828 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 1.406023e-01 | 0.852 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 1.651368e-01 | 0.782 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 1.651368e-01 | 0.782 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 1.651368e-01 | 0.782 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 1.651368e-01 | 0.782 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 1.651368e-01 | 0.782 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 1.495570e-01 | 0.825 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 1.706197e-01 | 0.768 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 1.527150e-01 | 0.816 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 1.527150e-01 | 0.816 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 1.527150e-01 | 0.816 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 1.493301e-01 | 0.826 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 1.715790e-01 | 0.766 | 1 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 1.715790e-01 | 0.766 | 1 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 1.480815e-01 | 0.829 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 1.512253e-01 | 0.820 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 1.715786e-01 | 0.766 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 1.715790e-01 | 0.766 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 1.406023e-01 | 0.852 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 1.712698e-01 | 0.766 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 1.528532e-01 | 0.816 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 1.420373e-01 | 0.848 | 1 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 1.420373e-01 | 0.848 | 1 | 1 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 1.727253e-01 | 0.763 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 1.428996e-01 | 0.845 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.706197e-01 | 0.768 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 1.694832e-01 | 0.771 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.607848e-01 | 0.794 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 1.583037e-01 | 0.801 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.698077e-01 | 0.770 | 1 | 1 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 1.712698e-01 | 0.766 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 1.663559e-01 | 0.779 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 1.605892e-01 | 0.794 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.583037e-01 | 0.801 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 1.715786e-01 | 0.766 | 0 | 0 |
| CASP5 inflammasome assembly | R-HSA-9948011 | 2.328403e-01 | 0.633 | 0 | 0 |
| Defective Mismatch Repair Associated With PMS2 | R-HSA-5632987 | 2.328403e-01 | 0.633 | 0 | 0 |
| Defective Mismatch Repair Associated With MLH1 | R-HSA-5545483 | 2.328403e-01 | 0.633 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 2.328403e-01 | 0.633 | 0 | 0 |
| Impaired BRCA2 binding to SEM1 (DSS1) | R-HSA-9763198 | 2.328403e-01 | 0.633 | 0 | 0 |
| Impaired BRCA2 translocation to the nucleus | R-HSA-9709275 | 2.328403e-01 | 0.633 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 1.894451e-01 | 0.723 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 1.894451e-01 | 0.723 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 1.894451e-01 | 0.723 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 1.894451e-01 | 0.723 | 0 | 0 |
| Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling | R-HSA-2644607 | 1.894451e-01 | 0.723 | 0 | 0 |
| FBXW7 Mutants and NOTCH1 in Cancer | R-HSA-2644605 | 1.894451e-01 | 0.723 | 0 | 0 |
| Nef mediated downregulation of CD28 cell surface expression | R-HSA-164939 | 3.280711e-01 | 0.484 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 3.280711e-01 | 0.484 | 0 | 0 |
| Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | R-HSA-5660686 | 3.280711e-01 | 0.484 | 0 | 0 |
| TALDO1 deficiency: failed conversion of SH7P, GA3P to Fru(6)P, E4P | R-HSA-6791055 | 3.280711e-01 | 0.484 | 0 | 0 |
| 3-hydroxyisobutyryl-CoA hydrolase deficiency | R-HSA-9916722 | 3.280711e-01 | 0.484 | 0 | 0 |
| TALDO1 deficiency: failed conversion of Fru(6)P, E4P to SH7P, GA3P | R-HSA-6791462 | 3.280711e-01 | 0.484 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 3.280711e-01 | 0.484 | 0 | 0 |
| Defective SLC9A9 causes autism 16 (AUTS16) | R-HSA-5619052 | 3.280711e-01 | 0.484 | 0 | 0 |
| Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | R-HSA-5619101 | 3.280711e-01 | 0.484 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 2.376445e-01 | 0.624 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 2.376445e-01 | 0.624 | 0 | 0 |
| IRS activation | R-HSA-74713 | 2.376445e-01 | 0.624 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 2.376445e-01 | 0.624 | 1 | 1 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 2.376445e-01 | 0.624 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 1.805765e-01 | 0.743 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 1.805765e-01 | 0.743 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 1.805765e-01 | 0.743 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 2.863708e-01 | 0.543 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 2.863708e-01 | 0.543 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 2.863708e-01 | 0.543 | 1 | 1 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 4.114853e-01 | 0.386 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 4.114853e-01 | 0.386 | 0 | 0 |
| Defective OPLAH causes OPLAHD | R-HSA-5578998 | 4.114853e-01 | 0.386 | 0 | 0 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 4.114853e-01 | 0.386 | 0 | 0 |
| Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2 | R-HSA-5083629 | 4.114853e-01 | 0.386 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 4.114853e-01 | 0.386 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 4.114853e-01 | 0.386 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 4.114853e-01 | 0.386 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 4.114853e-01 | 0.386 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 4.114853e-01 | 0.386 | 0 | 0 |
| Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1 | R-HSA-5083633 | 4.114853e-01 | 0.386 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 4.114853e-01 | 0.386 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 4.114853e-01 | 0.386 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 4.114853e-01 | 0.386 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 4.114853e-01 | 0.386 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 2.487735e-01 | 0.604 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 2.181582e-01 | 0.661 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 3.347511e-01 | 0.475 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 3.347511e-01 | 0.475 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 3.347511e-01 | 0.475 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 1.927502e-01 | 0.715 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 2.461993e-01 | 0.609 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 2.461993e-01 | 0.609 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 3.200276e-01 | 0.495 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 3.200276e-01 | 0.495 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 3.200276e-01 | 0.495 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 3.821208e-01 | 0.418 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 3.821208e-01 | 0.418 | 0 | 0 |
| CASP4-mediated substrate cleavage | R-HSA-9960519 | 4.845486e-01 | 0.315 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 4.845486e-01 | 0.315 | 0 | 0 |
| CASP5-mediated substrate cleavage | R-HSA-9960525 | 4.845486e-01 | 0.315 | 0 | 0 |
| Defective DPM2 causes DPM2-CDG | R-HSA-4719377 | 4.845486e-01 | 0.315 | 0 | 0 |
| Classical Kir channels | R-HSA-1296053 | 4.845486e-01 | 0.315 | 0 | 0 |
| Defective DPM1 causes DPM1-CDG | R-HSA-4717374 | 4.845486e-01 | 0.315 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 4.845486e-01 | 0.315 | 0 | 0 |
| Defective DPM3 causes DPM3-CDG | R-HSA-4719360 | 4.845486e-01 | 0.315 | 0 | 0 |
| Signalling to STAT3 | R-HSA-198745 | 4.845486e-01 | 0.315 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 1.821262e-01 | 0.740 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 3.042422e-01 | 0.517 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 2.534051e-01 | 0.596 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 2.893097e-01 | 0.539 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 1.996233e-01 | 0.700 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 2.754705e-01 | 0.560 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 4.279855e-01 | 0.369 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 3.147818e-01 | 0.502 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 1.976980e-01 | 0.704 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 2.979617e-01 | 0.526 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 3.914625e-01 | 0.407 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 3.914625e-01 | 0.407 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.900182e-01 | 0.721 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 2.828670e-01 | 0.548 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 2.198375e-01 | 0.658 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 3.635292e-01 | 0.439 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 3.635292e-01 | 0.439 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 2.242286e-01 | 0.649 | 1 | 1 |
| Dual Incision in GG-NER | R-HSA-5696400 | 3.034199e-01 | 0.518 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 2.737878e-01 | 0.563 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 2.737878e-01 | 0.563 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 2.771118e-01 | 0.557 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 2.912978e-01 | 0.536 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 2.912978e-01 | 0.536 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 2.912978e-01 | 0.536 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 3.438472e-01 | 0.464 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 4.719892e-01 | 0.326 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 4.719892e-01 | 0.326 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 5.485450e-01 | 0.261 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 5.485450e-01 | 0.261 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 5.485450e-01 | 0.261 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 5.485450e-01 | 0.261 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 5.485450e-01 | 0.261 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 2.544789e-01 | 0.594 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 2.936125e-01 | 0.532 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 3.670591e-01 | 0.435 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 3.670591e-01 | 0.435 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 2.822667e-01 | 0.549 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 4.608524e-01 | 0.336 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 4.608524e-01 | 0.336 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 3.109451e-01 | 0.507 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 3.444780e-01 | 0.463 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 4.181244e-01 | 0.379 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 3.433073e-01 | 0.464 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 3.433073e-01 | 0.464 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 5.138870e-01 | 0.289 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 5.138870e-01 | 0.289 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 5.138870e-01 | 0.289 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 5.138870e-01 | 0.289 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 4.437494e-01 | 0.353 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 4.437494e-01 | 0.353 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 4.006441e-01 | 0.397 | 1 | 1 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 4.304054e-01 | 0.366 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 4.561256e-01 | 0.341 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 5.265968e-01 | 0.279 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 5.535237e-01 | 0.257 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 5.535237e-01 | 0.257 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 5.535237e-01 | 0.257 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 5.535237e-01 | 0.257 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 5.535237e-01 | 0.257 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 5.535237e-01 | 0.257 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 5.535237e-01 | 0.257 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 6.045990e-01 | 0.219 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 6.045990e-01 | 0.219 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 4.591092e-01 | 0.338 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 4.486805e-01 | 0.348 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 4.486805e-01 | 0.348 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 4.933824e-01 | 0.307 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 4.933824e-01 | 0.307 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 4.387068e-01 | 0.358 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 5.026378e-01 | 0.299 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 5.354536e-01 | 0.271 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 5.354536e-01 | 0.271 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 5.139243e-01 | 0.289 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 4.913440e-01 | 0.309 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 5.269891e-01 | 0.278 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 5.577543e-01 | 0.254 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 5.214221e-01 | 0.283 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 5.404722e-01 | 0.267 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 5.908150e-01 | 0.229 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 5.403381e-01 | 0.267 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 5.589630e-01 | 0.253 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 5.589630e-01 | 0.253 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 5.589630e-01 | 0.253 | 0 | 0 |
| PKA activation | R-HSA-163615 | 5.876433e-01 | 0.231 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 5.887739e-01 | 0.230 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 5.905715e-01 | 0.229 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 5.905715e-01 | 0.229 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 6.162021e-01 | 0.210 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 6.257321e-01 | 0.204 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 6.257321e-01 | 0.204 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 6.257321e-01 | 0.204 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 6.257321e-01 | 0.204 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 6.257321e-01 | 0.204 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 6.536961e-01 | 0.185 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 6.536961e-01 | 0.185 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 6.536961e-01 | 0.185 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 6.325004e-01 | 0.199 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 6.303557e-01 | 0.200 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 6.303557e-01 | 0.200 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 6.303557e-01 | 0.200 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 6.323002e-01 | 0.199 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 6.460274e-01 | 0.190 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 6.529736e-01 | 0.185 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 6.677884e-01 | 0.175 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 6.728901e-01 | 0.172 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 6.691889e-01 | 0.174 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 6.807789e-01 | 0.167 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 6.885354e-01 | 0.162 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 6.885354e-01 | 0.162 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 6.966993e-01 | 0.157 | 0 | 0 |
| Metabolism of ingested MeSeO2H into MeSeH | R-HSA-5263617 | 6.966993e-01 | 0.157 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 6.966993e-01 | 0.157 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 6.966993e-01 | 0.157 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 1.919083e-01 | 0.717 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 5.859884e-01 | 0.232 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 6.757355e-01 | 0.170 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 3.803206e-01 | 0.420 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 2.049356e-01 | 0.688 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 1.925719e-01 | 0.715 | 1 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 6.731723e-01 | 0.172 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 6.731723e-01 | 0.172 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 3.453174e-01 | 0.462 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 5.687149e-01 | 0.245 | 1 | 0 |
| Extension of Telomeres | R-HSA-180786 | 2.794863e-01 | 0.554 | 1 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 6.731723e-01 | 0.172 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 2.947793e-01 | 0.531 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 2.893097e-01 | 0.539 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 3.034199e-01 | 0.518 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 3.386386e-01 | 0.470 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 3.673208e-01 | 0.435 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 5.577543e-01 | 0.254 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 3.558768e-01 | 0.449 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 2.465534e-01 | 0.608 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 4.516558e-01 | 0.345 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 4.940533e-01 | 0.306 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 3.383442e-01 | 0.471 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 6.257321e-01 | 0.204 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 3.923077e-01 | 0.406 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 6.029848e-01 | 0.220 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 5.605620e-01 | 0.251 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 3.111511e-01 | 0.507 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 4.940533e-01 | 0.306 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 5.185688e-01 | 0.285 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 5.869759e-01 | 0.231 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 6.855754e-01 | 0.164 | 1 | 1 |
| p75NTR signals via NF-kB | R-HSA-193639 | 4.608524e-01 | 0.336 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 3.175625e-01 | 0.498 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 6.855754e-01 | 0.164 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 6.185905e-01 | 0.209 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 3.635292e-01 | 0.439 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 3.453207e-01 | 0.462 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 5.265968e-01 | 0.279 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 2.576377e-01 | 0.589 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 5.876433e-01 | 0.231 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 3.097646e-01 | 0.509 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 6.807789e-01 | 0.167 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 4.612046e-01 | 0.336 | 1 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 2.376445e-01 | 0.624 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 3.821208e-01 | 0.418 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 2.828670e-01 | 0.548 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 4.265270e-01 | 0.370 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 4.719892e-01 | 0.326 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 5.138870e-01 | 0.289 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 4.304054e-01 | 0.366 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 5.619384e-01 | 0.250 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 5.561013e-01 | 0.255 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 6.433909e-01 | 0.192 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 6.323002e-01 | 0.199 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 2.140888e-01 | 0.669 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 5.908150e-01 | 0.229 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 5.545983e-01 | 0.256 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 2.785683e-01 | 0.555 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 4.047949e-01 | 0.393 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 5.876433e-01 | 0.231 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 4.141084e-01 | 0.383 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 4.141084e-01 | 0.383 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 4.141084e-01 | 0.383 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 4.141084e-01 | 0.383 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 2.461993e-01 | 0.609 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 3.147818e-01 | 0.502 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 1.977389e-01 | 0.704 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 4.265270e-01 | 0.370 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 4.516558e-01 | 0.345 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 4.437494e-01 | 0.353 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 4.047949e-01 | 0.393 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 6.045990e-01 | 0.219 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 5.908150e-01 | 0.229 | 0 | 0 |
| Protein folding | R-HSA-391251 | 5.929774e-01 | 0.227 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 6.257321e-01 | 0.204 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 6.536961e-01 | 0.185 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 6.582898e-01 | 0.182 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 4.701509e-01 | 0.328 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 4.701509e-01 | 0.328 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 6.439634e-01 | 0.191 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 1.789359e-01 | 0.747 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 4.486805e-01 | 0.348 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 2.109281e-01 | 0.676 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 4.091362e-01 | 0.388 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 3.696873e-01 | 0.432 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 2.893097e-01 | 0.539 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 4.690878e-01 | 0.329 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 4.940533e-01 | 0.306 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 5.908150e-01 | 0.229 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 6.257321e-01 | 0.204 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 6.323002e-01 | 0.199 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 3.805337e-01 | 0.420 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 6.295265e-01 | 0.201 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 2.626725e-01 | 0.581 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 4.145727e-01 | 0.382 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 6.644222e-01 | 0.178 | 1 | 1 |
| MTOR signalling | R-HSA-165159 | 2.233602e-01 | 0.651 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 6.123750e-01 | 0.213 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 4.725824e-01 | 0.326 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 5.789405e-01 | 0.237 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 4.561256e-01 | 0.341 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 2.376445e-01 | 0.624 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 2.863708e-01 | 0.543 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 2.842131e-01 | 0.546 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 4.719892e-01 | 0.326 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 5.485450e-01 | 0.261 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 3.923077e-01 | 0.406 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 4.608524e-01 | 0.336 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 3.878240e-01 | 0.411 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 4.367440e-01 | 0.360 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 4.304054e-01 | 0.366 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 5.535237e-01 | 0.257 | 0 | 0 |
| PTK6 Activates STAT3 | R-HSA-8849474 | 6.045990e-01 | 0.219 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 6.045990e-01 | 0.219 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 6.045990e-01 | 0.219 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 6.045990e-01 | 0.219 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 6.045990e-01 | 0.219 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 5.425657e-01 | 0.266 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 5.908150e-01 | 0.229 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 5.887739e-01 | 0.230 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 6.629634e-01 | 0.179 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 6.582898e-01 | 0.182 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 6.885354e-01 | 0.162 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 3.778745e-01 | 0.423 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 4.824707e-01 | 0.317 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 5.926759e-01 | 0.227 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 4.141084e-01 | 0.383 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 2.461993e-01 | 0.609 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 3.255613e-01 | 0.487 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 6.323002e-01 | 0.199 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 2.380110e-01 | 0.623 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 4.608524e-01 | 0.336 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 6.257321e-01 | 0.204 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 5.565067e-01 | 0.255 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 3.097646e-01 | 0.509 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 5.082533e-01 | 0.294 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 6.563068e-01 | 0.183 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 2.960431e-01 | 0.529 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 5.735742e-01 | 0.241 | 0 | 0 |
| Release of Hh-Np from the secreting cell | R-HSA-5362798 | 2.863708e-01 | 0.543 | 0 | 0 |
| Inhibition of nitric oxide production | R-HSA-9636249 | 4.845486e-01 | 0.315 | 0 | 0 |
| FasL/ CD95L signaling | R-HSA-75157 | 4.845486e-01 | 0.315 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 4.279855e-01 | 0.369 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 4.719892e-01 | 0.326 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 5.485450e-01 | 0.261 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 5.485450e-01 | 0.261 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 4.608524e-01 | 0.336 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 4.639014e-01 | 0.334 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 6.433909e-01 | 0.192 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 6.966993e-01 | 0.157 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 3.966158e-01 | 0.402 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 4.919907e-01 | 0.308 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 4.045767e-01 | 0.393 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 3.273324e-01 | 0.485 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 5.577543e-01 | 0.254 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 6.123148e-01 | 0.213 | 0 | 0 |
| IL-6-type cytokine receptor ligand interactions | R-HSA-6788467 | 6.582898e-01 | 0.182 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 6.691889e-01 | 0.174 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 6.677884e-01 | 0.175 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 2.342552e-01 | 0.630 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 4.135882e-01 | 0.383 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 4.719892e-01 | 0.326 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 2.381844e-01 | 0.623 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 5.926759e-01 | 0.227 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 2.380110e-01 | 0.623 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 4.181244e-01 | 0.379 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 3.433073e-01 | 0.464 | 1 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 6.162021e-01 | 0.210 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 1.866111e-01 | 0.729 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 4.802239e-01 | 0.319 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 5.561013e-01 | 0.255 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 6.952548e-01 | 0.158 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 2.107953e-01 | 0.676 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 5.347095e-01 | 0.272 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.925719e-01 | 0.715 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 4.639014e-01 | 0.334 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 2.328403e-01 | 0.633 | 0 | 0 |
| ARL13B-mediated ciliary trafficking of INPP5E | R-HSA-5624958 | 3.280711e-01 | 0.484 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 3.280711e-01 | 0.484 | 0 | 0 |
| Mitochondrial transcription initiation | R-HSA-163282 | 3.280711e-01 | 0.484 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 3.280711e-01 | 0.484 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 2.140888e-01 | 0.669 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 2.140888e-01 | 0.669 | 0 | 0 |
| tRNA-derived small RNA (tsRNA or tRNA-related fragment, tRF) biogenesis | R-HSA-9708296 | 4.114853e-01 | 0.386 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 2.461993e-01 | 0.609 | 0 | 0 |
| The IPAF inflammasome | R-HSA-844623 | 4.845486e-01 | 0.315 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 4.845486e-01 | 0.315 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 3.558768e-01 | 0.449 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 3.558768e-01 | 0.449 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 2.691596e-01 | 0.570 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 4.265270e-01 | 0.370 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 4.719892e-01 | 0.326 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 5.485450e-01 | 0.261 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 3.453207e-01 | 0.462 | 1 | 1 |
| MHC class II antigen presentation | R-HSA-2132295 | 2.107953e-01 | 0.676 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 2.484208e-01 | 0.605 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 4.608524e-01 | 0.336 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 5.138870e-01 | 0.289 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 4.942579e-01 | 0.306 | 0 | 0 |
| Kinesins | R-HSA-983189 | 4.141084e-01 | 0.383 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 4.690878e-01 | 0.329 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 5.535237e-01 | 0.257 | 0 | 0 |
| Trafficking of myristoylated proteins to the cilium | R-HSA-5624138 | 6.045990e-01 | 0.219 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 3.681115e-01 | 0.434 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 5.908150e-01 | 0.229 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 6.108909e-01 | 0.214 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 6.257321e-01 | 0.204 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 6.257321e-01 | 0.204 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 6.257321e-01 | 0.204 | 0 | 0 |
| TRAIL signaling | R-HSA-75158 | 6.536961e-01 | 0.185 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 6.536961e-01 | 0.185 | 0 | 0 |
| Synthesis of dolichyl-phosphate mannose | R-HSA-162699 | 6.536961e-01 | 0.185 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 6.536961e-01 | 0.185 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 6.536961e-01 | 0.185 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 6.456413e-01 | 0.190 | 1 | 1 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 6.582898e-01 | 0.182 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 6.932189e-01 | 0.159 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 6.807789e-01 | 0.167 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 6.966993e-01 | 0.157 | 0 | 0 |
| Intracellular metabolism of fatty acids regulates insulin secretion | R-HSA-434313 | 6.966993e-01 | 0.157 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 4.665000e-01 | 0.331 | 1 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 4.612046e-01 | 0.336 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 3.791561e-01 | 0.421 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 3.310992e-01 | 0.480 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 3.310992e-01 | 0.480 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 6.162021e-01 | 0.210 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 5.952610e-01 | 0.225 | 1 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 6.152200e-01 | 0.211 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 4.131219e-01 | 0.384 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 4.891428e-01 | 0.311 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 2.140888e-01 | 0.669 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 2.842131e-01 | 0.546 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 2.318597e-01 | 0.635 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 2.626725e-01 | 0.581 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 3.405212e-01 | 0.468 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 5.138870e-01 | 0.289 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 4.091362e-01 | 0.388 | 1 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 6.045990e-01 | 0.219 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 5.185688e-01 | 0.285 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 5.269891e-01 | 0.278 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 5.513183e-01 | 0.259 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 6.433909e-01 | 0.192 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 6.691889e-01 | 0.174 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 3.742183e-01 | 0.427 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 5.629028e-01 | 0.250 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 4.523422e-01 | 0.345 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 3.433073e-01 | 0.464 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 4.490546e-01 | 0.348 | 1 | 1 |
| Ca-dependent events | R-HSA-111996 | 6.493766e-01 | 0.188 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 2.863708e-01 | 0.543 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 2.863708e-01 | 0.543 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 2.487735e-01 | 0.604 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 2.181582e-01 | 0.661 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 3.821208e-01 | 0.418 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 4.719892e-01 | 0.326 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 5.535237e-01 | 0.257 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 5.354536e-01 | 0.271 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 5.619384e-01 | 0.250 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 6.257321e-01 | 0.204 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 6.536961e-01 | 0.185 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 6.536961e-01 | 0.185 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 5.805380e-01 | 0.236 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 5.081885e-01 | 0.294 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 5.540590e-01 | 0.256 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 5.461418e-01 | 0.263 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 2.328802e-01 | 0.633 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 4.141084e-01 | 0.383 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 2.487735e-01 | 0.604 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 4.293374e-01 | 0.367 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 4.135882e-01 | 0.383 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 5.577543e-01 | 0.254 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 6.757355e-01 | 0.170 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 4.940533e-01 | 0.306 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 5.905715e-01 | 0.229 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 2.711825e-01 | 0.567 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 6.728901e-01 | 0.172 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 5.843309e-01 | 0.233 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 4.933824e-01 | 0.307 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 6.677884e-01 | 0.175 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 4.293374e-01 | 0.367 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 3.280711e-01 | 0.484 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 3.280711e-01 | 0.484 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in invasion | R-HSA-9854909 | 2.376445e-01 | 0.624 | 0 | 0 |
| Transcription from mitochondrial promoters | R-HSA-75944 | 4.114853e-01 | 0.386 | 0 | 0 |
| SLC-mediated bile acid transport | R-HSA-9958517 | 4.279855e-01 | 0.369 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 4.719892e-01 | 0.326 | 0 | 0 |
| Sensory perception of sour taste | R-HSA-9729555 | 5.485450e-01 | 0.261 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 5.485450e-01 | 0.261 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 4.181244e-01 | 0.379 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 4.135882e-01 | 0.383 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 3.963423e-01 | 0.402 | 0 | 0 |
| Utilization of Ketone Bodies | R-HSA-77108 | 5.535237e-01 | 0.257 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 6.045990e-01 | 0.219 | 0 | 0 |
| Pyrophosphate hydrolysis | R-HSA-71737 | 6.045990e-01 | 0.219 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 5.908150e-01 | 0.229 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 5.545155e-01 | 0.256 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 6.728901e-01 | 0.172 | 0 | 0 |
| Synthesis of dolichyl-phosphate-glucose | R-HSA-480985 | 6.966993e-01 | 0.157 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 6.966993e-01 | 0.157 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 1.907020e-01 | 0.720 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 5.503650e-01 | 0.259 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 6.361125e-01 | 0.196 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 4.004747e-01 | 0.397 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 2.143396e-01 | 0.669 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 5.875765e-01 | 0.231 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 5.905715e-01 | 0.229 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 4.725824e-01 | 0.326 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 6.536961e-01 | 0.185 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 6.691889e-01 | 0.174 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 6.185905e-01 | 0.209 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 2.749652e-01 | 0.561 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 5.403381e-01 | 0.267 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 2.863708e-01 | 0.543 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 4.265270e-01 | 0.370 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 4.719892e-01 | 0.326 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 5.139243e-01 | 0.289 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 6.691889e-01 | 0.174 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 4.600418e-01 | 0.337 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 3.444780e-01 | 0.463 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 6.433909e-01 | 0.192 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 6.958443e-01 | 0.157 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 4.597276e-01 | 0.337 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 2.376445e-01 | 0.624 | 0 | 0 |
| The AIM2 inflammasome | R-HSA-844615 | 4.114853e-01 | 0.386 | 0 | 0 |
| Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells | R-HSA-210746 | 3.347511e-01 | 0.475 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 3.042422e-01 | 0.517 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 2.893097e-01 | 0.539 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 4.719892e-01 | 0.326 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 5.485450e-01 | 0.261 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 5.485450e-01 | 0.261 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 6.045990e-01 | 0.219 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 6.045990e-01 | 0.219 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 5.908150e-01 | 0.229 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 5.908150e-01 | 0.229 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 5.876433e-01 | 0.231 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 5.876433e-01 | 0.231 | 0 | 0 |
| Acetylcholine inhibits contraction of outer hair cells | R-HSA-9667769 | 6.536961e-01 | 0.185 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 6.536961e-01 | 0.185 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 6.536961e-01 | 0.185 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 6.582898e-01 | 0.182 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 6.966993e-01 | 0.157 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 6.107457e-01 | 0.214 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 3.923077e-01 | 0.406 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 6.433909e-01 | 0.192 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 6.920347e-01 | 0.160 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 2.184370e-01 | 0.661 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 4.597276e-01 | 0.337 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 6.257321e-01 | 0.204 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 6.582898e-01 | 0.182 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 5.535237e-01 | 0.257 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 2.754705e-01 | 0.560 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 4.802239e-01 | 0.319 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 6.045990e-01 | 0.219 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 6.257321e-01 | 0.204 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 6.536961e-01 | 0.185 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 6.966993e-01 | 0.157 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 6.810934e-01 | 0.167 | 0 | 0 |
| CREB3 factors activate genes | R-HSA-8874211 | 6.966993e-01 | 0.157 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 4.265270e-01 | 0.370 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 6.885354e-01 | 0.162 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 3.817996e-01 | 0.418 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 5.008895e-01 | 0.300 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 4.693037e-01 | 0.329 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 6.091162e-01 | 0.215 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 6.045990e-01 | 0.219 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 6.582898e-01 | 0.182 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 6.742146e-01 | 0.171 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 6.885354e-01 | 0.162 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 3.635292e-01 | 0.439 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 5.081885e-01 | 0.294 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 6.978912e-01 | 0.156 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 7.027265e-01 | 0.153 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 7.027265e-01 | 0.153 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 7.027265e-01 | 0.153 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 7.043860e-01 | 0.152 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 7.052768e-01 | 0.152 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 7.103984e-01 | 0.148 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 7.147525e-01 | 0.146 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 7.165412e-01 | 0.145 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 7.165412e-01 | 0.145 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 7.165412e-01 | 0.145 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 7.165412e-01 | 0.145 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 7.165412e-01 | 0.145 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 7.165412e-01 | 0.145 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 7.165412e-01 | 0.145 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 7.165412e-01 | 0.145 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 7.165412e-01 | 0.145 | 0 | 0 |
| FASTK family proteins regulate processing and stability of mitochondrial RNAs | R-HSA-9837092 | 7.165412e-01 | 0.145 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 7.165412e-01 | 0.145 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 7.165412e-01 | 0.145 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 7.165412e-01 | 0.145 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 7.165412e-01 | 0.145 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 7.166092e-01 | 0.145 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 7.166092e-01 | 0.145 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 7.166092e-01 | 0.145 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 7.166092e-01 | 0.145 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 7.192342e-01 | 0.143 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 7.196662e-01 | 0.143 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 7.214573e-01 | 0.142 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 7.214573e-01 | 0.142 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 7.214573e-01 | 0.142 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 7.223570e-01 | 0.141 | 1 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 7.223570e-01 | 0.141 | 1 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 7.246235e-01 | 0.140 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 7.275171e-01 | 0.138 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 7.278701e-01 | 0.138 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 7.279772e-01 | 0.138 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 7.315222e-01 | 0.136 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 7.321745e-01 | 0.135 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 7.343646e-01 | 0.134 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 7.343646e-01 | 0.134 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 7.343646e-01 | 0.134 | 0 | 0 |
| Synthesis of PIPs in the nucleus | R-HSA-8847453 | 7.343646e-01 | 0.134 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 7.343646e-01 | 0.134 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 7.343646e-01 | 0.134 | 0 | 0 |
| DAG1 core M1 glycosylations | R-HSA-8932506 | 7.343646e-01 | 0.134 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 7.343646e-01 | 0.134 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 7.343646e-01 | 0.134 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 7.343646e-01 | 0.134 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 7.343646e-01 | 0.134 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 7.343646e-01 | 0.134 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 7.343646e-01 | 0.134 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 7.343646e-01 | 0.134 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 7.343646e-01 | 0.134 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 7.343646e-01 | 0.134 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 7.382622e-01 | 0.132 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 7.382622e-01 | 0.132 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 7.382622e-01 | 0.132 | 0 | 0 |
| Ketone body metabolism | R-HSA-74182 | 7.382622e-01 | 0.132 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 7.393932e-01 | 0.131 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 7.403007e-01 | 0.131 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 7.403007e-01 | 0.131 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 7.423970e-01 | 0.129 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 7.423970e-01 | 0.129 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 7.423970e-01 | 0.129 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 7.423970e-01 | 0.129 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 7.423970e-01 | 0.129 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 7.442203e-01 | 0.128 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 7.447720e-01 | 0.128 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 7.447720e-01 | 0.128 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 7.480833e-01 | 0.126 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 7.527128e-01 | 0.123 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 7.537091e-01 | 0.123 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 7.552057e-01 | 0.122 | 1 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 7.563053e-01 | 0.121 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 7.578895e-01 | 0.120 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 7.585812e-01 | 0.120 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 7.585812e-01 | 0.120 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 7.589690e-01 | 0.120 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 7.612626e-01 | 0.118 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 7.642146e-01 | 0.117 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 7.648759e-01 | 0.116 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 7.662046e-01 | 0.116 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 7.662046e-01 | 0.116 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 7.662046e-01 | 0.116 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 7.662046e-01 | 0.116 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 7.662046e-01 | 0.116 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 7.673544e-01 | 0.115 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 7.673544e-01 | 0.115 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 7.673544e-01 | 0.115 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 7.673544e-01 | 0.115 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 7.673544e-01 | 0.115 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 7.673544e-01 | 0.115 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 7.673544e-01 | 0.115 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 7.673544e-01 | 0.115 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 7.673544e-01 | 0.115 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 7.673544e-01 | 0.115 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 7.673544e-01 | 0.115 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 7.673544e-01 | 0.115 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 7.673544e-01 | 0.115 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 7.673544e-01 | 0.115 | 0 | 0 |
| DAG1 core M2 glycosylations | R-HSA-8932504 | 7.673544e-01 | 0.115 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 7.673544e-01 | 0.115 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 7.673544e-01 | 0.115 | 0 | 0 |
| RSK activation | R-HSA-444257 | 7.673544e-01 | 0.115 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 7.673544e-01 | 0.115 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 7.673544e-01 | 0.115 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 7.673544e-01 | 0.115 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 7.675168e-01 | 0.115 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 7.696960e-01 | 0.114 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 7.703104e-01 | 0.113 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 7.750530e-01 | 0.111 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 7.760344e-01 | 0.110 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 7.760344e-01 | 0.110 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 7.776046e-01 | 0.109 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 7.776046e-01 | 0.109 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 7.776046e-01 | 0.109 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 7.776046e-01 | 0.109 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 7.776046e-01 | 0.109 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 7.788046e-01 | 0.109 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 7.880741e-01 | 0.103 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 7.880741e-01 | 0.103 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 7.880741e-01 | 0.103 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 7.880741e-01 | 0.103 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 7.880741e-01 | 0.103 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 7.910005e-01 | 0.102 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 7.910005e-01 | 0.102 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 7.910005e-01 | 0.102 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 7.910005e-01 | 0.102 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 7.921016e-01 | 0.101 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 7.921016e-01 | 0.101 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 7.948417e-01 | 0.100 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 7.948417e-01 | 0.100 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 7.948417e-01 | 0.100 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 7.962488e-01 | 0.099 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 7.962488e-01 | 0.099 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 7.962488e-01 | 0.099 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 7.962488e-01 | 0.099 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 7.962488e-01 | 0.099 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 7.962488e-01 | 0.099 | 0 | 0 |
| Degradation of GABA | R-HSA-916853 | 7.962488e-01 | 0.099 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 7.962488e-01 | 0.099 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 7.962488e-01 | 0.099 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 7.962488e-01 | 0.099 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 7.962488e-01 | 0.099 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 7.962488e-01 | 0.099 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 7.962488e-01 | 0.099 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 7.962488e-01 | 0.099 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 7.977166e-01 | 0.098 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 8.042692e-01 | 0.095 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 8.047769e-01 | 0.094 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 8.047769e-01 | 0.094 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 8.047769e-01 | 0.094 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 8.060279e-01 | 0.094 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 8.063933e-01 | 0.093 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 8.066094e-01 | 0.093 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 8.081194e-01 | 0.093 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 8.081194e-01 | 0.093 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 8.081194e-01 | 0.093 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 8.081194e-01 | 0.093 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 8.081194e-01 | 0.093 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 8.082198e-01 | 0.092 | 1 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 8.092484e-01 | 0.092 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 8.092484e-01 | 0.092 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 8.099912e-01 | 0.092 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 8.119455e-01 | 0.090 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 8.119455e-01 | 0.090 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 8.119455e-01 | 0.090 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 8.145172e-01 | 0.089 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 8.168425e-01 | 0.088 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 8.168425e-01 | 0.088 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 8.168425e-01 | 0.088 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 8.172902e-01 | 0.088 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 8.178516e-01 | 0.087 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 8.197739e-01 | 0.086 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 8.201636e-01 | 0.086 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 8.201636e-01 | 0.086 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 8.201636e-01 | 0.086 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 8.207564e-01 | 0.086 | 0 | 0 |
| CASP4 inflammasome assembly | R-HSA-9948001 | 8.215560e-01 | 0.085 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 8.215560e-01 | 0.085 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 8.215560e-01 | 0.085 | 0 | 0 |
| TET1,2,3 and TDG demethylate DNA | R-HSA-5221030 | 8.215560e-01 | 0.085 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 8.215560e-01 | 0.085 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 8.215560e-01 | 0.085 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 8.215560e-01 | 0.085 | 0 | 0 |
| Arachidonate production from DAG | R-HSA-426048 | 8.215560e-01 | 0.085 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 8.215560e-01 | 0.085 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 8.215560e-01 | 0.085 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 8.215560e-01 | 0.085 | 0 | 0 |
| Sperm Motility And Taxes | R-HSA-1300642 | 8.215560e-01 | 0.085 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 8.215560e-01 | 0.085 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 8.215560e-01 | 0.085 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 8.215560e-01 | 0.085 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 8.215560e-01 | 0.085 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 8.215560e-01 | 0.085 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 8.229305e-01 | 0.085 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 8.264563e-01 | 0.083 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 8.264563e-01 | 0.083 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 8.264563e-01 | 0.083 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 8.264563e-01 | 0.083 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 8.264563e-01 | 0.083 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 8.272556e-01 | 0.082 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 8.273638e-01 | 0.082 | 1 | 1 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 8.273638e-01 | 0.082 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 8.273638e-01 | 0.082 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 8.273638e-01 | 0.082 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 8.273638e-01 | 0.082 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 8.281425e-01 | 0.082 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 8.283075e-01 | 0.082 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 8.292361e-01 | 0.081 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 8.296058e-01 | 0.081 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 8.296058e-01 | 0.081 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 8.296058e-01 | 0.081 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 8.311884e-01 | 0.080 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 8.315956e-01 | 0.080 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 8.334382e-01 | 0.079 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 8.334382e-01 | 0.079 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 8.334382e-01 | 0.079 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 8.388006e-01 | 0.076 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 8.388006e-01 | 0.076 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 8.394727e-01 | 0.076 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 8.396750e-01 | 0.076 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 8.403577e-01 | 0.076 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 8.416856e-01 | 0.075 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 8.416856e-01 | 0.075 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 8.416856e-01 | 0.075 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 8.416856e-01 | 0.075 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 8.431999e-01 | 0.074 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 8.437212e-01 | 0.074 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 8.437212e-01 | 0.074 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 8.437212e-01 | 0.074 | 0 | 0 |
| Regulation of gene expression in early pancreatic precursor cells | R-HSA-210747 | 8.437212e-01 | 0.074 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 8.437212e-01 | 0.074 | 0 | 0 |
| DAG1 core M3 glycosylations | R-HSA-8932505 | 8.437212e-01 | 0.074 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 8.437212e-01 | 0.074 | 0 | 0 |
| Inorganic anion exchange by SLC26 transporters | R-HSA-427601 | 8.437212e-01 | 0.074 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 8.437212e-01 | 0.074 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 8.437212e-01 | 0.074 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 8.437212e-01 | 0.074 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 8.460409e-01 | 0.073 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 8.474354e-01 | 0.072 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 8.485307e-01 | 0.071 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 8.495232e-01 | 0.071 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 8.495232e-01 | 0.071 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 8.495700e-01 | 0.071 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 8.498343e-01 | 0.071 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 8.510150e-01 | 0.070 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 8.522066e-01 | 0.069 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 8.549665e-01 | 0.068 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 8.574312e-01 | 0.067 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 8.584629e-01 | 0.066 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 8.592984e-01 | 0.066 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 8.631343e-01 | 0.064 | 0 | 0 |
| Anchoring fibril formation | R-HSA-2214320 | 8.631343e-01 | 0.064 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 8.631343e-01 | 0.064 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 8.631343e-01 | 0.064 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 8.631343e-01 | 0.064 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 8.631343e-01 | 0.064 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 8.631343e-01 | 0.064 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 8.631343e-01 | 0.064 | 0 | 0 |
| Proton-coupled monocarboxylate transport | R-HSA-433692 | 8.631343e-01 | 0.064 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 8.659435e-01 | 0.063 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 8.665049e-01 | 0.062 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 8.672623e-01 | 0.062 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 8.672623e-01 | 0.062 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 8.684282e-01 | 0.061 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 8.684282e-01 | 0.061 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 8.684282e-01 | 0.061 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 8.684282e-01 | 0.061 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 8.692700e-01 | 0.061 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 8.698146e-01 | 0.061 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 8.723547e-01 | 0.059 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 8.723547e-01 | 0.059 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 8.730907e-01 | 0.059 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 8.753396e-01 | 0.058 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 8.766057e-01 | 0.057 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 8.772768e-01 | 0.057 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 8.772768e-01 | 0.057 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 8.785958e-01 | 0.056 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 8.785958e-01 | 0.056 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 8.785958e-01 | 0.056 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 8.786290e-01 | 0.056 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 8.786290e-01 | 0.056 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 8.801368e-01 | 0.055 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 8.801368e-01 | 0.055 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 8.801368e-01 | 0.055 | 0 | 0 |
| Beta oxidation of palmitoyl-CoA to myristoyl-CoA | R-HSA-77305 | 8.801368e-01 | 0.055 | 0 | 0 |
| Beta oxidation of myristoyl-CoA to lauroyl-CoA | R-HSA-77285 | 8.801368e-01 | 0.055 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 8.801368e-01 | 0.055 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 8.801368e-01 | 0.055 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 8.801368e-01 | 0.055 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 8.801368e-01 | 0.055 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 8.801368e-01 | 0.055 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 8.801368e-01 | 0.055 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 8.801368e-01 | 0.055 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 8.801368e-01 | 0.055 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 8.813851e-01 | 0.055 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 8.828009e-01 | 0.054 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 8.840004e-01 | 0.054 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 8.849805e-01 | 0.053 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 8.849805e-01 | 0.053 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 8.849805e-01 | 0.053 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 8.849805e-01 | 0.053 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 8.849805e-01 | 0.053 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 8.880746e-01 | 0.052 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 8.880746e-01 | 0.052 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 8.880746e-01 | 0.052 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 8.891219e-01 | 0.051 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 8.903079e-01 | 0.050 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 8.935839e-01 | 0.049 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 8.950281e-01 | 0.048 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 8.950281e-01 | 0.048 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 8.950281e-01 | 0.048 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 8.950281e-01 | 0.048 | 0 | 0 |
| Microbial factors inhibit CASP4 activity | R-HSA-9956593 | 8.950281e-01 | 0.048 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 8.950281e-01 | 0.048 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 8.950281e-01 | 0.048 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 8.950281e-01 | 0.048 | 0 | 0 |
| rRNA modification in the mitochondrion | R-HSA-6793080 | 8.950281e-01 | 0.048 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 8.950281e-01 | 0.048 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 8.952920e-01 | 0.048 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 8.952920e-01 | 0.048 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 8.964403e-01 | 0.047 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 8.964403e-01 | 0.047 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 8.964403e-01 | 0.047 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 8.964403e-01 | 0.047 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 8.964403e-01 | 0.047 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 8.964403e-01 | 0.047 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 8.968998e-01 | 0.047 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 8.968998e-01 | 0.047 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 8.968998e-01 | 0.047 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 8.973499e-01 | 0.047 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 8.987948e-01 | 0.046 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 8.987948e-01 | 0.046 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 8.995431e-01 | 0.046 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 8.996101e-01 | 0.046 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 9.038944e-01 | 0.044 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 9.040312e-01 | 0.044 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.051064e-01 | 0.043 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 9.054927e-01 | 0.043 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 9.064506e-01 | 0.043 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 9.068288e-01 | 0.042 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 9.068288e-01 | 0.042 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 9.068288e-01 | 0.042 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 9.068288e-01 | 0.042 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 9.068288e-01 | 0.042 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 9.068288e-01 | 0.042 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 9.077004e-01 | 0.042 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 9.077004e-01 | 0.042 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 9.080700e-01 | 0.042 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 9.080700e-01 | 0.042 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 9.080700e-01 | 0.042 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 9.080700e-01 | 0.042 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 9.080700e-01 | 0.042 | 0 | 0 |
| Beta oxidation of octanoyl-CoA to hexanoyl-CoA | R-HSA-77348 | 9.080700e-01 | 0.042 | 0 | 0 |
| Beta oxidation of hexanoyl-CoA to butanoyl-CoA | R-HSA-77350 | 9.080700e-01 | 0.042 | 0 | 0 |
| Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA | R-HSA-77310 | 9.080700e-01 | 0.042 | 0 | 0 |
| Formation of the active cofactor, UDP-glucuronate | R-HSA-173599 | 9.080700e-01 | 0.042 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 9.080700e-01 | 0.042 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 9.080700e-01 | 0.042 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 9.107133e-01 | 0.041 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.107894e-01 | 0.041 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 9.115773e-01 | 0.040 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.127288e-01 | 0.040 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 9.139394e-01 | 0.039 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 9.158894e-01 | 0.038 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 9.162354e-01 | 0.038 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 9.162354e-01 | 0.038 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 9.162354e-01 | 0.038 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 9.162354e-01 | 0.038 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 9.162845e-01 | 0.038 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 9.194923e-01 | 0.036 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 9.194923e-01 | 0.036 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 9.194923e-01 | 0.036 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.198003e-01 | 0.036 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.198003e-01 | 0.036 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 9.198003e-01 | 0.036 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 9.198003e-01 | 0.036 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.200012e-01 | 0.036 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 9.231322e-01 | 0.035 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 9.234108e-01 | 0.035 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 9.234108e-01 | 0.035 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 9.234108e-01 | 0.035 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 9.246230e-01 | 0.034 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.247436e-01 | 0.034 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 9.247436e-01 | 0.034 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.247436e-01 | 0.034 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 9.247436e-01 | 0.034 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.247436e-01 | 0.034 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 9.247436e-01 | 0.034 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 9.247436e-01 | 0.034 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.247436e-01 | 0.034 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 9.252070e-01 | 0.034 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 9.263537e-01 | 0.033 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 9.294959e-01 | 0.032 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 9.294959e-01 | 0.032 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 9.294959e-01 | 0.032 | 0 | 0 |
| Activation of the phototransduction cascade | R-HSA-2485179 | 9.294959e-01 | 0.032 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 9.294959e-01 | 0.032 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 9.294959e-01 | 0.032 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 9.294959e-01 | 0.032 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 9.294959e-01 | 0.032 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 9.294959e-01 | 0.032 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 9.303112e-01 | 0.031 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.303112e-01 | 0.031 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 9.303112e-01 | 0.031 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.310250e-01 | 0.031 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 9.324205e-01 | 0.030 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.324205e-01 | 0.030 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 9.324314e-01 | 0.030 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 9.324314e-01 | 0.030 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 9.324314e-01 | 0.030 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 9.324314e-01 | 0.030 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.324314e-01 | 0.030 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 9.324314e-01 | 0.030 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 9.359128e-01 | 0.029 | 0 | 0 |
| Depurination | R-HSA-73927 | 9.366352e-01 | 0.028 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 9.366352e-01 | 0.028 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 9.367833e-01 | 0.028 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 9.369238e-01 | 0.028 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 9.369238e-01 | 0.028 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 9.380311e-01 | 0.028 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 9.382571e-01 | 0.028 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 9.382571e-01 | 0.028 | 0 | 0 |
| mitochondrial fatty acid beta-oxidation of unsaturated fatty acids | R-HSA-77288 | 9.382571e-01 | 0.028 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 9.382571e-01 | 0.028 | 0 | 0 |
| Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA | R-HSA-77346 | 9.382571e-01 | 0.028 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 9.382571e-01 | 0.028 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 9.382571e-01 | 0.028 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 9.393712e-01 | 0.027 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 9.393712e-01 | 0.027 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.393712e-01 | 0.027 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 9.393712e-01 | 0.027 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 9.399578e-01 | 0.027 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.411793e-01 | 0.026 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 9.424250e-01 | 0.026 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 9.424250e-01 | 0.026 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.424250e-01 | 0.026 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.424250e-01 | 0.026 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.437899e-01 | 0.025 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.450124e-01 | 0.025 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 9.456302e-01 | 0.024 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 9.456302e-01 | 0.024 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 9.456302e-01 | 0.024 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.456302e-01 | 0.024 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 9.459300e-01 | 0.024 | 0 | 0 |
| Sulfide oxidation to sulfate | R-HSA-1614517 | 9.459300e-01 | 0.024 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 9.459300e-01 | 0.024 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 9.459300e-01 | 0.024 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 9.459300e-01 | 0.024 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 9.459300e-01 | 0.024 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 9.459300e-01 | 0.024 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 9.477206e-01 | 0.023 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 9.477206e-01 | 0.023 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.489448e-01 | 0.023 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 9.499639e-01 | 0.022 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.500478e-01 | 0.022 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 9.500478e-01 | 0.022 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.500478e-01 | 0.022 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.500478e-01 | 0.022 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.500478e-01 | 0.022 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 9.512704e-01 | 0.022 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 9.512704e-01 | 0.022 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 9.524116e-01 | 0.021 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.524116e-01 | 0.021 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.525596e-01 | 0.021 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.525596e-01 | 0.021 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 9.526497e-01 | 0.021 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 9.526497e-01 | 0.021 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 9.526497e-01 | 0.021 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 9.526497e-01 | 0.021 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 9.526497e-01 | 0.021 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 9.526497e-01 | 0.021 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 9.526497e-01 | 0.021 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 9.526497e-01 | 0.021 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 9.526497e-01 | 0.021 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 9.526497e-01 | 0.021 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 9.526497e-01 | 0.021 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 9.529075e-01 | 0.021 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 9.536538e-01 | 0.021 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.550260e-01 | 0.020 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 9.551535e-01 | 0.020 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 9.563489e-01 | 0.019 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 9.563489e-01 | 0.019 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.563489e-01 | 0.019 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 9.564621e-01 | 0.019 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 9.564769e-01 | 0.019 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 9.569775e-01 | 0.019 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 9.569775e-01 | 0.019 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.569775e-01 | 0.019 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 9.580893e-01 | 0.019 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 9.585347e-01 | 0.018 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 9.585347e-01 | 0.018 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 9.585347e-01 | 0.018 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 9.585347e-01 | 0.018 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 9.585347e-01 | 0.018 | 0 | 0 |
| Methionine salvage pathway | R-HSA-1237112 | 9.585347e-01 | 0.018 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 9.585347e-01 | 0.018 | 0 | 0 |
| HDL remodeling | R-HSA-8964058 | 9.585347e-01 | 0.018 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 9.593531e-01 | 0.018 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 9.593905e-01 | 0.018 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.595680e-01 | 0.018 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 9.597434e-01 | 0.018 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 9.598726e-01 | 0.018 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 9.609182e-01 | 0.017 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 9.609182e-01 | 0.017 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 9.610074e-01 | 0.017 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 9.628113e-01 | 0.016 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 9.628446e-01 | 0.016 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.634594e-01 | 0.016 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 9.636615e-01 | 0.016 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.636615e-01 | 0.016 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 9.636885e-01 | 0.016 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 9.636885e-01 | 0.016 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 9.636885e-01 | 0.016 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 9.636885e-01 | 0.016 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 9.636885e-01 | 0.016 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.636885e-01 | 0.016 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 9.636885e-01 | 0.016 | 0 | 0 |
| Synthesis of Ketone Bodies | R-HSA-77111 | 9.636885e-01 | 0.016 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 9.636885e-01 | 0.016 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 9.636885e-01 | 0.016 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 9.642384e-01 | 0.016 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.646804e-01 | 0.016 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.649554e-01 | 0.015 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 9.650263e-01 | 0.015 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 9.650263e-01 | 0.015 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 9.650263e-01 | 0.015 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.650263e-01 | 0.015 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 9.667142e-01 | 0.015 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 9.680254e-01 | 0.014 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 9.682021e-01 | 0.014 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 9.682021e-01 | 0.014 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 9.682021e-01 | 0.014 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 9.682021e-01 | 0.014 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 9.682021e-01 | 0.014 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 9.682021e-01 | 0.014 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 9.682021e-01 | 0.014 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 9.682021e-01 | 0.014 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 9.687173e-01 | 0.014 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.687173e-01 | 0.014 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.687173e-01 | 0.014 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 9.697307e-01 | 0.013 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.697307e-01 | 0.013 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.701288e-01 | 0.013 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.710695e-01 | 0.013 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 9.717066e-01 | 0.012 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.720313e-01 | 0.012 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 9.721548e-01 | 0.012 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 9.721548e-01 | 0.012 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 9.721548e-01 | 0.012 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.721548e-01 | 0.012 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 9.721548e-01 | 0.012 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 9.721548e-01 | 0.012 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 9.721548e-01 | 0.012 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 9.721548e-01 | 0.012 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 9.721597e-01 | 0.012 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 9.723690e-01 | 0.012 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.730893e-01 | 0.012 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 9.738025e-01 | 0.012 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.738375e-01 | 0.012 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 9.748418e-01 | 0.011 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 9.750051e-01 | 0.011 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 9.756164e-01 | 0.011 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 9.756164e-01 | 0.011 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 9.756589e-01 | 0.011 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 9.756589e-01 | 0.011 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 9.756589e-01 | 0.011 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 9.756589e-01 | 0.011 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 9.762438e-01 | 0.010 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 9.767468e-01 | 0.010 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 9.767468e-01 | 0.010 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.767468e-01 | 0.010 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 9.771864e-01 | 0.010 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 9.771864e-01 | 0.010 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 9.772000e-01 | 0.010 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 9.772000e-01 | 0.010 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 9.774034e-01 | 0.010 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 9.779821e-01 | 0.010 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 9.786370e-01 | 0.009 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.786370e-01 | 0.009 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.786370e-01 | 0.009 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 9.786478e-01 | 0.009 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 9.786478e-01 | 0.009 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 9.786478e-01 | 0.009 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 9.786478e-01 | 0.009 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 9.786984e-01 | 0.009 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 9.787412e-01 | 0.009 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.791337e-01 | 0.009 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.791337e-01 | 0.009 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 9.796581e-01 | 0.009 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 9.800623e-01 | 0.009 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.800623e-01 | 0.009 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 9.802805e-01 | 0.009 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 9.802805e-01 | 0.009 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.806489e-01 | 0.008 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.807099e-01 | 0.008 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.812153e-01 | 0.008 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.812153e-01 | 0.008 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 9.813025e-01 | 0.008 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 9.813025e-01 | 0.008 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.822035e-01 | 0.008 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 9.822035e-01 | 0.008 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 9.822035e-01 | 0.008 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 9.824324e-01 | 0.008 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 9.827281e-01 | 0.008 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 9.836273e-01 | 0.007 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 9.836273e-01 | 0.007 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.836273e-01 | 0.007 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 9.836273e-01 | 0.007 | 0 | 0 |
| Beta-oxidation of pristanoyl-CoA | R-HSA-389887 | 9.836273e-01 | 0.007 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.836273e-01 | 0.007 | 0 | 0 |
| Fertilization | R-HSA-1187000 | 9.836273e-01 | 0.007 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 9.839717e-01 | 0.007 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 9.840031e-01 | 0.007 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.840031e-01 | 0.007 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.841207e-01 | 0.007 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.842936e-01 | 0.007 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.849275e-01 | 0.007 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 9.852580e-01 | 0.006 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 9.856631e-01 | 0.006 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 9.856631e-01 | 0.006 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 9.856631e-01 | 0.006 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 9.856631e-01 | 0.006 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.856631e-01 | 0.006 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 9.857305e-01 | 0.006 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 9.858364e-01 | 0.006 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 9.858364e-01 | 0.006 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.858364e-01 | 0.006 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 9.858370e-01 | 0.006 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 9.864015e-01 | 0.006 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.872342e-01 | 0.006 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 9.873711e-01 | 0.006 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 9.873711e-01 | 0.006 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.873711e-01 | 0.006 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 9.874459e-01 | 0.005 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 9.874459e-01 | 0.005 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 9.874459e-01 | 0.005 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 9.874459e-01 | 0.005 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 9.874459e-01 | 0.005 | 0 | 0 |
| Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane | R-HSA-83936 | 9.874459e-01 | 0.005 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.874459e-01 | 0.005 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.874459e-01 | 0.005 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.874459e-01 | 0.005 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.886215e-01 | 0.005 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.886215e-01 | 0.005 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.887432e-01 | 0.005 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.887496e-01 | 0.005 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 9.890071e-01 | 0.005 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 9.890071e-01 | 0.005 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 9.894120e-01 | 0.005 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 9.896095e-01 | 0.005 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.899695e-01 | 0.004 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.899695e-01 | 0.004 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.902345e-01 | 0.004 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 9.903743e-01 | 0.004 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 9.903743e-01 | 0.004 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 9.903743e-01 | 0.004 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 9.904074e-01 | 0.004 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 9.910073e-01 | 0.004 | 0 | 0 |
| Pyrimidine catabolism | R-HSA-73621 | 9.910650e-01 | 0.004 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 9.914140e-01 | 0.004 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 9.914140e-01 | 0.004 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 9.915714e-01 | 0.004 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 9.915714e-01 | 0.004 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 9.915714e-01 | 0.004 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.915714e-01 | 0.004 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.915714e-01 | 0.004 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 9.917313e-01 | 0.004 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 9.918750e-01 | 0.004 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 9.921646e-01 | 0.003 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.926198e-01 | 0.003 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 9.930589e-01 | 0.003 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.931075e-01 | 0.003 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.931332e-01 | 0.003 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 9.932119e-01 | 0.003 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 9.932119e-01 | 0.003 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.934420e-01 | 0.003 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.934669e-01 | 0.003 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 9.935378e-01 | 0.003 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 9.936955e-01 | 0.003 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.936955e-01 | 0.003 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.936955e-01 | 0.003 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.938981e-01 | 0.003 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 9.942554e-01 | 0.003 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.942713e-01 | 0.002 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 9.943416e-01 | 0.002 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.943904e-01 | 0.002 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 9.947487e-01 | 0.002 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.950456e-01 | 0.002 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 9.950456e-01 | 0.002 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.950745e-01 | 0.002 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 9.953923e-01 | 0.002 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.955770e-01 | 0.002 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 9.956619e-01 | 0.002 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 9.956619e-01 | 0.002 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.956619e-01 | 0.002 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 9.956619e-01 | 0.002 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.960413e-01 | 0.002 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.962017e-01 | 0.002 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 9.962017e-01 | 0.002 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.962017e-01 | 0.002 | 0 | 0 |
| Metabolism of ingested SeMet, Sec, MeSec into H2Se | R-HSA-2408508 | 9.962017e-01 | 0.002 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.962017e-01 | 0.002 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.962989e-01 | 0.002 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.964225e-01 | 0.002 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.964225e-01 | 0.002 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.964331e-01 | 0.002 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 9.964404e-01 | 0.002 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 9.965016e-01 | 0.002 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.966976e-01 | 0.001 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.967227e-01 | 0.001 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.967681e-01 | 0.001 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.968032e-01 | 0.001 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.969591e-01 | 0.001 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.970881e-01 | 0.001 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.970881e-01 | 0.001 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.971329e-01 | 0.001 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.974293e-01 | 0.001 | 0 | 0 |
| tRNA processing in the mitochondrion | R-HSA-6785470 | 9.974504e-01 | 0.001 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.974504e-01 | 0.001 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.974504e-01 | 0.001 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.974724e-01 | 0.001 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.974843e-01 | 0.001 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 9.975405e-01 | 0.001 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.976492e-01 | 0.001 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.976492e-01 | 0.001 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 9.976967e-01 | 0.001 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.977677e-01 | 0.001 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 9.977677e-01 | 0.001 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.977677e-01 | 0.001 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 9.980455e-01 | 0.001 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.980455e-01 | 0.001 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.980646e-01 | 0.001 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.981974e-01 | 0.001 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.982247e-01 | 0.001 | 1 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.982784e-01 | 0.001 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 9.984017e-01 | 0.001 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.984391e-01 | 0.001 | 0 | 0 |
| Heme biosynthesis | R-HSA-189451 | 9.985018e-01 | 0.001 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.987969e-01 | 0.001 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.987969e-01 | 0.001 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.987969e-01 | 0.001 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.987971e-01 | 0.001 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.988117e-01 | 0.001 | 0 | 0 |
| Defensins | R-HSA-1461973 | 9.988515e-01 | 0.000 | 0 | 0 |
| Synthesis of very long-chain fatty acyl-CoAs | R-HSA-75876 | 9.988515e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.988553e-01 | 0.000 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.988958e-01 | 0.000 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.989330e-01 | 0.000 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.989640e-01 | 0.000 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.989945e-01 | 0.000 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.989945e-01 | 0.000 | 0 | 0 |
| Methylation | R-HSA-156581 | 9.989945e-01 | 0.000 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.989945e-01 | 0.000 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.990676e-01 | 0.000 | 0 | 0 |
| mitochondrial fatty acid beta-oxidation of saturated fatty acids | R-HSA-77286 | 9.991197e-01 | 0.000 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 9.991197e-01 | 0.000 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.992293e-01 | 0.000 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.992561e-01 | 0.000 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 9.993253e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.993925e-01 | 0.000 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.993927e-01 | 0.000 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.994510e-01 | 0.000 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.994821e-01 | 0.000 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.995043e-01 | 0.000 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.995472e-01 | 0.000 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.995472e-01 | 0.000 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.995830e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.996017e-01 | 0.000 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.996036e-01 | 0.000 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.996036e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.996236e-01 | 0.000 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.996463e-01 | 0.000 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.996463e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.996603e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.996787e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.996812e-01 | 0.000 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.996812e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.996812e-01 | 0.000 | 0 | 0 |
| Glucuronidation | R-HSA-156588 | 9.997341e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.997775e-01 | 0.000 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.997787e-01 | 0.000 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 9.998127e-01 | 0.000 | 1 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.998141e-01 | 0.000 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.998154e-01 | 0.000 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.998182e-01 | 0.000 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.998216e-01 | 0.000 | 0 | 0 |
| Sialic acid metabolism | R-HSA-4085001 | 9.998633e-01 | 0.000 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.998633e-01 | 0.000 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.998697e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.998768e-01 | 0.000 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.998833e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.999022e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.999061e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.999083e-01 | 0.000 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.999083e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999151e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.999172e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.999224e-01 | 0.000 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.999551e-01 | 0.000 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.999551e-01 | 0.000 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.999604e-01 | 0.000 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.999626e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999657e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.999714e-01 | 0.000 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.999723e-01 | 0.000 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.999723e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.999758e-01 | 0.000 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 9.999769e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.999788e-01 | 0.000 | 0 | 0 |
| Transport of vitamins, nucleosides, and related molecules | R-HSA-425397 | 9.999814e-01 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.999838e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999881e-01 | 0.000 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.999891e-01 | 0.000 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.999894e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999898e-01 | 0.000 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.999903e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.999905e-01 | 0.000 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.999921e-01 | 0.000 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.999926e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999930e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999934e-01 | 0.000 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.999941e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999966e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999967e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.999969e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.999971e-01 | 0.000 | 0 | 0 |
| Classical antibody-mediated complement activation | R-HSA-173623 | 9.999975e-01 | 0.000 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.999975e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999976e-01 | 0.000 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.999980e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.999981e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.999987e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.999990e-01 | 0.000 | 0 | 0 |
| Scavenging of heme from plasma | R-HSA-2168880 | 9.999992e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999993e-01 | 0.000 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.999997e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.999998e-01 | 0.000 | 0 | 0 |
| Creation of C4 and C2 activators | R-HSA-166786 | 9.999998e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999999e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999999e-01 | 0.000 | 0 | 0 |
| Initial triggering of complement | R-HSA-166663 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 1.000000e+00 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 1.000000e+00 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 1.000000e+00 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 1.000000e+00 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 1.000000e+00 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 1.000000e+00 | 0.000 | 1 | 0 |
| Innate Immune System | R-HSA-168249 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | -0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | -0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Chromatin organization | R-HSA-4839726 | 5.714224e-10 | 9.243 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 7.011301e-09 | 8.154 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 2.276654e-08 | 7.643 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.105136e-07 | 6.957 | 1 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.467863e-07 | 6.833 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 9.342180e-07 | 6.030 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.866001e-06 | 5.729 | 1 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 3.904134e-06 | 5.408 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 5.314713e-06 | 5.275 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 9.257409e-06 | 5.034 | 1 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 4.477929e-05 | 4.349 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 4.280042e-05 | 4.369 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 4.280042e-05 | 4.369 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 4.739540e-05 | 4.324 | 1 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 4.739540e-05 | 4.324 | 1 | 1 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 3.552650e-05 | 4.449 | 1 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 4.739540e-05 | 4.324 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 6.024496e-05 | 4.220 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 5.956524e-05 | 4.225 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 6.076778e-05 | 4.216 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 9.564522e-05 | 4.019 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.954790e-04 | 3.709 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 2.262481e-04 | 3.645 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 2.582842e-04 | 3.588 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 3.276150e-04 | 3.485 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 3.542802e-04 | 3.451 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 3.710827e-04 | 3.431 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 4.403704e-04 | 3.356 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 4.437985e-04 | 3.353 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 5.235928e-04 | 3.281 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 5.721139e-04 | 3.243 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 6.430765e-04 | 3.192 | 1 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 7.579237e-04 | 3.120 | 1 | 1 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 7.782010e-04 | 3.109 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 7.579237e-04 | 3.120 | 1 | 1 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 9.092383e-04 | 3.041 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 9.092383e-04 | 3.041 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 9.092383e-04 | 3.041 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 9.092383e-04 | 3.041 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 9.128969e-04 | 3.040 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 9.483464e-04 | 3.023 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 9.483464e-04 | 3.023 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 1.117856e-03 | 2.952 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.111553e-03 | 2.954 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 1.084820e-03 | 2.965 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 1.117856e-03 | 2.952 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 1.111553e-03 | 2.954 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 1.139879e-03 | 2.943 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 1.219384e-03 | 2.914 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.180167e-03 | 2.928 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 1.265324e-03 | 2.898 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.297010e-03 | 2.887 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 1.246607e-03 | 2.904 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 1.327813e-03 | 2.877 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 1.327813e-03 | 2.877 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.390465e-03 | 2.857 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.506912e-03 | 2.822 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 1.568423e-03 | 2.805 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.775531e-03 | 2.751 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 2.012570e-03 | 2.696 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 2.062215e-03 | 2.686 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 2.601667e-03 | 2.585 | 1 | 1 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 2.601667e-03 | 2.585 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 2.506303e-03 | 2.601 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 2.506303e-03 | 2.601 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 2.495769e-03 | 2.603 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 2.601667e-03 | 2.585 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 2.620243e-03 | 2.582 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 2.898136e-03 | 2.538 | 1 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 2.902432e-03 | 2.537 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 3.066210e-03 | 2.513 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 3.066210e-03 | 2.513 | 0 | 0 |
| M Phase | R-HSA-68886 | 3.141638e-03 | 2.503 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 3.284476e-03 | 2.484 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 3.139552e-03 | 2.503 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 3.095954e-03 | 2.509 | 1 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 3.641693e-03 | 2.439 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 3.648039e-03 | 2.438 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 3.648039e-03 | 2.438 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 3.753383e-03 | 2.426 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 3.842114e-03 | 2.415 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 4.039821e-03 | 2.394 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 4.186849e-03 | 2.378 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 4.216433e-03 | 2.375 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 4.310998e-03 | 2.365 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 4.445679e-03 | 2.352 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 4.630417e-03 | 2.334 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 4.612624e-03 | 2.336 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 4.393506e-03 | 2.357 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 4.680758e-03 | 2.330 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 4.853746e-03 | 2.314 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 5.194429e-03 | 2.284 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 5.194429e-03 | 2.284 | 1 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 5.194429e-03 | 2.284 | 1 | 1 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 5.208042e-03 | 2.283 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 4.965537e-03 | 2.304 | 1 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 5.004678e-03 | 2.301 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 5.599102e-03 | 2.252 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 5.872856e-03 | 2.231 | 0 | 0 |
| S Phase | R-HSA-69242 | 6.355851e-03 | 2.197 | 1 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 6.428601e-03 | 2.192 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 6.445164e-03 | 2.191 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 7.068596e-03 | 2.151 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 7.278868e-03 | 2.138 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 6.783332e-03 | 2.169 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 7.416908e-03 | 2.130 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 7.239045e-03 | 2.140 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 7.347993e-03 | 2.134 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 7.532467e-03 | 2.123 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 7.538989e-03 | 2.123 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 7.538989e-03 | 2.123 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 7.538989e-03 | 2.123 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 7.538989e-03 | 2.123 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 7.538989e-03 | 2.123 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 7.538989e-03 | 2.123 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 7.969318e-03 | 2.099 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 8.363076e-03 | 2.078 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 1.002959e-02 | 1.999 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 1.002959e-02 | 1.999 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 9.418649e-03 | 2.026 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 1.016247e-02 | 1.993 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 1.037232e-02 | 1.984 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 1.070358e-02 | 1.970 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 1.076827e-02 | 1.968 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 1.104256e-02 | 1.957 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 1.130569e-02 | 1.947 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 1.173621e-02 | 1.930 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.188853e-02 | 1.925 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 1.215980e-02 | 1.915 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 1.236070e-02 | 1.908 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.314431e-02 | 1.881 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 1.383383e-02 | 1.859 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 1.383383e-02 | 1.859 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 1.383383e-02 | 1.859 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 1.383383e-02 | 1.859 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.383383e-02 | 1.859 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 1.280962e-02 | 1.892 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 1.383383e-02 | 1.859 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 1.349646e-02 | 1.870 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.230192e-02 | 1.910 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 1.405308e-02 | 1.852 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 1.405308e-02 | 1.852 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.407795e-02 | 1.851 | 1 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.432420e-02 | 1.844 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.432420e-02 | 1.844 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 1.533979e-02 | 1.814 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 1.665344e-02 | 1.778 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 1.665344e-02 | 1.778 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 1.457750e-02 | 1.836 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 1.626544e-02 | 1.789 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 1.665344e-02 | 1.778 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 1.626386e-02 | 1.789 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.467985e-02 | 1.833 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.561530e-02 | 1.806 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 1.514643e-02 | 1.820 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 1.654955e-02 | 1.781 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 1.654955e-02 | 1.781 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 1.835357e-02 | 1.736 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.947695e-02 | 1.710 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 1.957206e-02 | 1.708 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 2.052193e-02 | 1.688 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 2.052193e-02 | 1.688 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 2.052193e-02 | 1.688 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 2.084711e-02 | 1.681 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 2.176840e-02 | 1.662 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 2.226171e-02 | 1.652 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 2.275160e-02 | 1.643 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 2.389922e-02 | 1.622 | 1 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 2.389922e-02 | 1.622 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 2.389922e-02 | 1.622 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 2.428464e-02 | 1.615 | 1 | 0 |
| Signaling by EGFR | R-HSA-177929 | 2.428955e-02 | 1.615 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 2.428955e-02 | 1.615 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 2.456357e-02 | 1.610 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 2.503447e-02 | 1.601 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 2.523633e-02 | 1.598 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 2.729977e-02 | 1.564 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 2.729977e-02 | 1.564 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 2.876277e-02 | 1.541 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 2.729977e-02 | 1.564 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 3.007058e-02 | 1.522 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 2.711307e-02 | 1.567 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 3.038048e-02 | 1.517 | 1 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 3.052516e-02 | 1.515 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 3.115563e-02 | 1.506 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 3.145873e-02 | 1.502 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 3.145873e-02 | 1.502 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 3.240888e-02 | 1.489 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 3.379898e-02 | 1.471 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 3.390007e-02 | 1.470 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 3.469370e-02 | 1.460 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 3.469370e-02 | 1.460 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 3.522761e-02 | 1.453 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 3.522761e-02 | 1.453 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 3.586884e-02 | 1.445 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 3.628554e-02 | 1.440 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 3.726034e-02 | 1.429 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 4.301335e-02 | 1.366 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 4.301335e-02 | 1.366 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 4.578053e-02 | 1.339 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 4.083251e-02 | 1.389 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 4.083251e-02 | 1.389 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 4.083251e-02 | 1.389 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 4.163341e-02 | 1.381 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 3.972586e-02 | 1.401 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 3.972586e-02 | 1.401 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 3.889622e-02 | 1.410 | 1 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 4.177931e-02 | 1.379 | 1 | 1 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 4.301335e-02 | 1.366 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 4.153164e-02 | 1.382 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 4.462026e-02 | 1.350 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 4.301335e-02 | 1.366 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 4.449934e-02 | 1.352 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 4.449934e-02 | 1.352 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 4.587073e-02 | 1.338 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 4.618267e-02 | 1.336 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 4.627881e-02 | 1.335 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 4.769232e-02 | 1.322 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 4.769232e-02 | 1.322 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 4.769232e-02 | 1.322 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 4.815380e-02 | 1.317 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 4.862675e-02 | 1.313 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 5.128928e-02 | 1.290 | 0 | 0 |
| Deletions in the AMER1 gene destabilize the destruction complex | R-HSA-5467343 | 6.207888e-02 | 1.207 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 6.207888e-02 | 1.207 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 6.207888e-02 | 1.207 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 5.742135e-02 | 1.241 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 5.742135e-02 | 1.241 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 5.742135e-02 | 1.241 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 5.742135e-02 | 1.241 | 1 | 1 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 5.223369e-02 | 1.282 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 6.232191e-02 | 1.205 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 6.232191e-02 | 1.205 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 6.232191e-02 | 1.205 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 6.232191e-02 | 1.205 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 5.716877e-02 | 1.243 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 5.730611e-02 | 1.242 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 5.304308e-02 | 1.275 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 6.128053e-02 | 1.213 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 5.953051e-02 | 1.225 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 6.316007e-02 | 1.200 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 5.730611e-02 | 1.242 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 5.716877e-02 | 1.243 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 5.285466e-02 | 1.277 | 1 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 5.285466e-02 | 1.277 | 1 | 1 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 5.202592e-02 | 1.284 | 1 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 6.435940e-02 | 1.191 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 5.582434e-02 | 1.253 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 5.346662e-02 | 1.272 | 1 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 5.223369e-02 | 1.282 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 6.082717e-02 | 1.216 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 6.248599e-02 | 1.204 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 5.582434e-02 | 1.253 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 6.123231e-02 | 1.213 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 6.450338e-02 | 1.190 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 6.228973e-02 | 1.206 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 6.123231e-02 | 1.213 | 1 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 6.053975e-02 | 1.218 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 5.730611e-02 | 1.242 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 5.704450e-02 | 1.244 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 6.646077e-02 | 1.177 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 6.659056e-02 | 1.177 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 6.688556e-02 | 1.175 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 6.754149e-02 | 1.170 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 6.838705e-02 | 1.165 | 1 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 7.003719e-02 | 1.155 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 7.017193e-02 | 1.154 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 7.017193e-02 | 1.154 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 7.037286e-02 | 1.153 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 7.037286e-02 | 1.153 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 7.158687e-02 | 1.145 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 7.158687e-02 | 1.145 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 7.158687e-02 | 1.145 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 7.323893e-02 | 1.135 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 7.323893e-02 | 1.135 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 7.323893e-02 | 1.135 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 7.353239e-02 | 1.134 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 7.500692e-02 | 1.125 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 7.500692e-02 | 1.125 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 7.500692e-02 | 1.125 | 1 | 1 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 7.500692e-02 | 1.125 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 7.500692e-02 | 1.125 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 7.500692e-02 | 1.125 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 7.500692e-02 | 1.125 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 7.702109e-02 | 1.113 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 7.848295e-02 | 1.105 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 8.076879e-02 | 1.093 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 8.368513e-02 | 1.077 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 9.404228e-02 | 1.027 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 9.404228e-02 | 1.027 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 8.494073e-02 | 1.071 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 8.494073e-02 | 1.071 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 8.494073e-02 | 1.071 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 8.494073e-02 | 1.071 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 8.494073e-02 | 1.071 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 8.494073e-02 | 1.071 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 8.494073e-02 | 1.071 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 1.105047e-01 | 0.957 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 8.805278e-02 | 1.055 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 8.805278e-02 | 1.055 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 8.436580e-02 | 1.074 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 9.479432e-02 | 1.023 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 1.010480e-01 | 0.995 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.616289e-02 | 1.017 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 8.494073e-02 | 1.071 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 8.494073e-02 | 1.071 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 8.484837e-02 | 1.071 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 8.494073e-02 | 1.071 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 1.118699e-01 | 0.951 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 9.404228e-02 | 1.027 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 9.737952e-02 | 1.012 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 1.074065e-01 | 0.969 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 1.105047e-01 | 0.957 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 9.840454e-02 | 1.007 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 9.206543e-02 | 1.036 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 9.206543e-02 | 1.036 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 8.805278e-02 | 1.055 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 8.550251e-02 | 1.068 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 8.681238e-02 | 1.061 | 1 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 1.085000e-01 | 0.965 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 1.010480e-01 | 0.995 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 1.090267e-01 | 0.962 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 1.113521e-01 | 0.953 | 1 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.062649e-01 | 0.974 | 1 | 0 |
| Signaling by WNT | R-HSA-195721 | 8.952160e-02 | 1.048 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 9.149002e-02 | 1.039 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 9.762032e-02 | 1.010 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 1.085000e-01 | 0.965 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 9.232796e-02 | 1.035 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 9.737952e-02 | 1.012 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 1.060548e-01 | 0.974 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 1.122395e-01 | 0.950 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 1.142800e-01 | 0.942 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.147368e-01 | 0.940 | 1 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 1.158148e-01 | 0.936 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.172175e-01 | 0.931 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 1.172175e-01 | 0.931 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 1.172895e-01 | 0.931 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.187423e-01 | 0.925 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 1.203075e-01 | 0.920 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 1.211124e-01 | 0.917 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 1.242639e-01 | 0.906 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 1.242639e-01 | 0.906 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.242639e-01 | 0.906 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 1.242639e-01 | 0.906 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 1.242639e-01 | 0.906 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 1.262552e-01 | 0.899 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 1.290170e-01 | 0.889 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 1.290170e-01 | 0.889 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 1.307641e-01 | 0.884 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.313046e-01 | 0.882 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 1.354979e-01 | 0.868 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 1.354979e-01 | 0.868 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 1.354979e-01 | 0.868 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 1.354979e-01 | 0.868 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 1.354979e-01 | 0.868 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 1.354979e-01 | 0.868 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 1.354979e-01 | 0.868 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.386035e-01 | 0.858 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 1.386035e-01 | 0.858 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.386035e-01 | 0.858 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 1.386035e-01 | 0.858 | 1 | 1 |
| TGFBR3 expression | R-HSA-9839394 | 1.403114e-01 | 0.853 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.418170e-01 | 0.848 | 1 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 1.449229e-01 | 0.839 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 1.452458e-01 | 0.838 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 1.460216e-01 | 0.836 | 1 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 1.464561e-01 | 0.834 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.464654e-01 | 0.834 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.466509e-01 | 0.834 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.473768e-01 | 0.832 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 1.480499e-01 | 0.830 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.507676e-01 | 0.822 | 0 | 0 |
| Defective MMADHC causes MMAHCD | R-HSA-3359473 | 1.749244e-01 | 0.757 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 2.261534e-01 | 0.646 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 2.261534e-01 | 0.646 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 2.261534e-01 | 0.646 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 2.261534e-01 | 0.646 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 2.261534e-01 | 0.646 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 2.261534e-01 | 0.646 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 2.261534e-01 | 0.646 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 2.261534e-01 | 0.646 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 2.261534e-01 | 0.646 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 2.261534e-01 | 0.646 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 2.261534e-01 | 0.646 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 2.261534e-01 | 0.646 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 2.261534e-01 | 0.646 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 2.261534e-01 | 0.646 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 1.574964e-01 | 0.803 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 1.574964e-01 | 0.803 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 1.800972e-01 | 0.744 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 1.800972e-01 | 0.744 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 2.031410e-01 | 0.692 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 2.031410e-01 | 0.692 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 1.534694e-01 | 0.814 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 1.688075e-01 | 0.773 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 1.845646e-01 | 0.734 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 2.006880e-01 | 0.697 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 1.763593e-01 | 0.754 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 1.763593e-01 | 0.754 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 1.890153e-01 | 0.724 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.813401e-01 | 0.742 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 2.005482e-01 | 0.698 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 2.104216e-01 | 0.677 | 1 | 1 |
| mRNA Splicing | R-HSA-72172 | 1.976674e-01 | 0.704 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.845646e-01 | 0.734 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.897257e-01 | 0.722 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 1.865318e-01 | 0.729 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 1.574964e-01 | 0.803 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 1.845646e-01 | 0.734 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 2.006880e-01 | 0.697 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 2.151366e-01 | 0.667 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 1.519826e-01 | 0.818 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 2.031410e-01 | 0.692 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 2.199456e-01 | 0.658 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 2.072942e-01 | 0.683 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 1.750177e-01 | 0.757 | 0 | 0 |
| ARL13B-mediated ciliary trafficking of INPP5E | R-HSA-5624958 | 1.749244e-01 | 0.757 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 2.261534e-01 | 0.646 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 1.800972e-01 | 0.744 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 1.845646e-01 | 0.734 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.586689e-01 | 0.800 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 2.001243e-01 | 0.699 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.934513e-01 | 0.713 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 1.800972e-01 | 0.744 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 2.171266e-01 | 0.663 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 1.890153e-01 | 0.724 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 2.019496e-01 | 0.695 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 2.244946e-01 | 0.649 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.800972e-01 | 0.744 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 2.031410e-01 | 0.692 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 1.688075e-01 | 0.773 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.845646e-01 | 0.734 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 2.082678e-01 | 0.681 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.678216e-01 | 0.775 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.728636e-01 | 0.762 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 1.540187e-01 | 0.812 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 1.865318e-01 | 0.729 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 1.688075e-01 | 0.773 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.619052e-01 | 0.791 | 1 | 0 |
| Tie2 Signaling | R-HSA-210993 | 1.845646e-01 | 0.734 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 1.667542e-01 | 0.778 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 1.800972e-01 | 0.744 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 1.845646e-01 | 0.734 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 1.750177e-01 | 0.757 | 1 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 1.750177e-01 | 0.757 | 1 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.574964e-01 | 0.803 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 2.031410e-01 | 0.692 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 2.199456e-01 | 0.658 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.738825e-01 | 0.760 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 2.019496e-01 | 0.695 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 2.198567e-01 | 0.658 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 2.264857e-01 | 0.645 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 2.285511e-01 | 0.641 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 2.285511e-01 | 0.641 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 2.314704e-01 | 0.636 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 2.314913e-01 | 0.635 | 1 | 0 |
| Signalling to RAS | R-HSA-167044 | 2.338305e-01 | 0.631 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 2.338305e-01 | 0.631 | 0 | 0 |
| Defective MMACHC causes MAHCC | R-HSA-3359474 | 2.742045e-01 | 0.562 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 2.742045e-01 | 0.562 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 2.742045e-01 | 0.562 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 2.742045e-01 | 0.562 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 3.192746e-01 | 0.496 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 3.192746e-01 | 0.496 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 3.192746e-01 | 0.496 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 3.192746e-01 | 0.496 | 0 | 0 |
| IRS activation | R-HSA-74713 | 3.615485e-01 | 0.442 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 3.615485e-01 | 0.442 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 2.500054e-01 | 0.602 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 2.500054e-01 | 0.602 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 2.735885e-01 | 0.563 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 2.735885e-01 | 0.563 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 4.011996e-01 | 0.397 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 4.011996e-01 | 0.397 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 4.011996e-01 | 0.397 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 4.011996e-01 | 0.397 | 1 | 1 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 4.011996e-01 | 0.397 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 3.205632e-01 | 0.494 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 3.205632e-01 | 0.494 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 4.383903e-01 | 0.358 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 4.383903e-01 | 0.358 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 4.383903e-01 | 0.358 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 2.850650e-01 | 0.545 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 2.850650e-01 | 0.545 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 4.732733e-01 | 0.325 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 4.732733e-01 | 0.325 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 4.732733e-01 | 0.325 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 4.732733e-01 | 0.325 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 4.732733e-01 | 0.325 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 4.732733e-01 | 0.325 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 4.732733e-01 | 0.325 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 2.699086e-01 | 0.569 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 2.699086e-01 | 0.569 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 2.669898e-01 | 0.574 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 3.544182e-01 | 0.450 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 3.544182e-01 | 0.450 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 3.544182e-01 | 0.450 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 4.116848e-01 | 0.385 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 3.716935e-01 | 0.430 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 3.716935e-01 | 0.430 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 3.888791e-01 | 0.410 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 3.888791e-01 | 0.410 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 3.554849e-01 | 0.449 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 3.554849e-01 | 0.449 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 2.855573e-01 | 0.544 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 3.409035e-01 | 0.467 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 3.534222e-01 | 0.452 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 3.155685e-01 | 0.501 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 3.951029e-01 | 0.403 | 1 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 3.951029e-01 | 0.403 | 1 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 4.160483e-01 | 0.381 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 4.160483e-01 | 0.381 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 4.550362e-01 | 0.342 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 4.689041e-01 | 0.329 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 4.654612e-01 | 0.332 | 1 | 1 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 4.059468e-01 | 0.392 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 2.372880e-01 | 0.625 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 3.888791e-01 | 0.410 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 3.534222e-01 | 0.452 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 2.620721e-01 | 0.582 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 4.059468e-01 | 0.392 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 2.500054e-01 | 0.602 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 4.732733e-01 | 0.325 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 2.699086e-01 | 0.569 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 2.981640e-01 | 0.526 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 2.981640e-01 | 0.526 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 3.192746e-01 | 0.496 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 3.192746e-01 | 0.496 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 2.735885e-01 | 0.563 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 4.011996e-01 | 0.397 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 3.267480e-01 | 0.486 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 3.554849e-01 | 0.449 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 3.370838e-01 | 0.472 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 3.563639e-01 | 0.448 | 1 | 1 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 3.842117e-01 | 0.415 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 3.197230e-01 | 0.495 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 2.467299e-01 | 0.608 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 2.735885e-01 | 0.563 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 4.511611e-01 | 0.346 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 3.500603e-01 | 0.456 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 3.615485e-01 | 0.442 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 2.735885e-01 | 0.563 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 4.732733e-01 | 0.325 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 4.335532e-01 | 0.363 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 3.358809e-01 | 0.474 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 3.171217e-01 | 0.499 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 4.689041e-01 | 0.329 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 4.059468e-01 | 0.392 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 3.872747e-01 | 0.412 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 2.971366e-01 | 0.527 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 3.370838e-01 | 0.472 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 3.437928e-01 | 0.464 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 3.667595e-01 | 0.436 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 4.732733e-01 | 0.325 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 4.116848e-01 | 0.385 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 3.666268e-01 | 0.436 | 1 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 2.500054e-01 | 0.602 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 3.895427e-01 | 0.409 | 1 | 0 |
| Parasite infection | R-HSA-9664407 | 3.097376e-01 | 0.509 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 3.097376e-01 | 0.509 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 3.097376e-01 | 0.509 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 4.335532e-01 | 0.363 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 4.063661e-01 | 0.391 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 2.742045e-01 | 0.562 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 3.615485e-01 | 0.442 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 2.500054e-01 | 0.602 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 2.500054e-01 | 0.602 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 2.421678e-01 | 0.616 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 3.023710e-01 | 0.519 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 3.544182e-01 | 0.450 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 4.335532e-01 | 0.363 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 4.549766e-01 | 0.342 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 4.228703e-01 | 0.374 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 3.081420e-01 | 0.511 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 4.577253e-01 | 0.339 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 4.335532e-01 | 0.363 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 3.409035e-01 | 0.467 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 3.437928e-01 | 0.464 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 3.370838e-01 | 0.472 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 4.232412e-01 | 0.373 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 3.667595e-01 | 0.436 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 3.667595e-01 | 0.436 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 3.894064e-01 | 0.410 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 4.059468e-01 | 0.392 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 4.059468e-01 | 0.392 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 3.203281e-01 | 0.494 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 3.575168e-01 | 0.447 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 3.256995e-01 | 0.487 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 4.063661e-01 | 0.391 | 1 | 1 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 4.634687e-01 | 0.334 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 4.615789e-01 | 0.336 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 3.192746e-01 | 0.496 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 4.011996e-01 | 0.397 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 4.011996e-01 | 0.397 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 2.678447e-01 | 0.572 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 2.431631e-01 | 0.614 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 3.975982e-01 | 0.401 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 4.408836e-01 | 0.356 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 3.205632e-01 | 0.494 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 3.054984e-01 | 0.515 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 3.847232e-01 | 0.415 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 3.894064e-01 | 0.410 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 4.388757e-01 | 0.358 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 4.256196e-01 | 0.371 | 0 | 0 |
| Sensory perception of sour taste | R-HSA-9729555 | 3.192746e-01 | 0.496 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 4.011996e-01 | 0.397 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 4.383903e-01 | 0.358 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 2.850650e-01 | 0.545 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 2.421678e-01 | 0.616 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 4.732733e-01 | 0.325 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 2.411985e-01 | 0.618 | 1 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 2.431631e-01 | 0.614 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 2.768962e-01 | 0.558 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 4.327736e-01 | 0.364 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 2.859860e-01 | 0.544 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 3.872747e-01 | 0.412 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 2.675598e-01 | 0.573 | 1 | 1 |
| L1CAM interactions | R-HSA-373760 | 3.248981e-01 | 0.488 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 3.054984e-01 | 0.515 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 3.205632e-01 | 0.494 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 3.544182e-01 | 0.450 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 4.549766e-01 | 0.342 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 3.437928e-01 | 0.464 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 3.894064e-01 | 0.410 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 4.288321e-01 | 0.368 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 3.527635e-01 | 0.453 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 4.550362e-01 | 0.342 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 2.945090e-01 | 0.531 | 0 | 0 |
| The NLRP1 inflammasome | R-HSA-844455 | 2.742045e-01 | 0.562 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 4.383903e-01 | 0.358 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 4.383903e-01 | 0.358 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 4.732733e-01 | 0.325 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 4.732733e-01 | 0.325 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 3.411078e-01 | 0.467 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 3.888791e-01 | 0.410 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 3.409035e-01 | 0.467 | 1 | 1 |
| Mitochondrial biogenesis | R-HSA-1592230 | 3.331740e-01 | 0.477 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 3.544182e-01 | 0.450 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 3.025853e-01 | 0.519 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 2.735885e-01 | 0.563 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 4.725459e-01 | 0.326 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 3.411078e-01 | 0.467 | 0 | 0 |
| Protein folding | R-HSA-391251 | 3.324318e-01 | 0.478 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 3.562431e-01 | 0.448 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 2.735885e-01 | 0.563 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 2.507519e-01 | 0.601 | 1 | 1 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 4.335532e-01 | 0.363 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 3.910424e-01 | 0.408 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 2.850650e-01 | 0.545 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 3.667595e-01 | 0.436 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 2.678873e-01 | 0.572 | 1 | 1 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 4.116848e-01 | 0.385 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 3.287288e-01 | 0.483 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 4.011996e-01 | 0.397 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 2.678447e-01 | 0.572 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 3.437928e-01 | 0.464 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 2.431631e-01 | 0.614 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 2.854422e-01 | 0.544 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 3.500603e-01 | 0.456 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 4.561909e-01 | 0.341 | 1 | 1 |
| Specification of primordial germ cells | R-HSA-9827857 | 4.116848e-01 | 0.385 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 4.005542e-01 | 0.397 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 4.335532e-01 | 0.363 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 2.678873e-01 | 0.572 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 4.284929e-01 | 0.368 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 3.230305e-01 | 0.491 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 4.627008e-01 | 0.335 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 4.550362e-01 | 0.342 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 2.735885e-01 | 0.563 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 3.554849e-01 | 0.449 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 4.732892e-01 | 0.325 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 4.759259e-01 | 0.322 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 4.759259e-01 | 0.322 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 4.759259e-01 | 0.322 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 4.759259e-01 | 0.322 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 4.776283e-01 | 0.321 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 4.776283e-01 | 0.321 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 4.795498e-01 | 0.319 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 4.826409e-01 | 0.316 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 4.886727e-01 | 0.311 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 4.886727e-01 | 0.311 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 4.886727e-01 | 0.311 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 4.962343e-01 | 0.304 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 4.962343e-01 | 0.304 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 4.963774e-01 | 0.304 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 5.028456e-01 | 0.299 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 5.034413e-01 | 0.298 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 5.059765e-01 | 0.296 | 1 | 1 |
| MET receptor recycling | R-HSA-8875656 | 5.059916e-01 | 0.296 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 5.059916e-01 | 0.296 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 5.059916e-01 | 0.296 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 5.059916e-01 | 0.296 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 5.059916e-01 | 0.296 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 5.059916e-01 | 0.296 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 5.059916e-01 | 0.296 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 5.059916e-01 | 0.296 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 5.059916e-01 | 0.296 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 5.059916e-01 | 0.296 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 5.059916e-01 | 0.296 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 5.059916e-01 | 0.296 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 5.059916e-01 | 0.296 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 5.135340e-01 | 0.289 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 5.163121e-01 | 0.287 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 5.163121e-01 | 0.287 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 5.163121e-01 | 0.287 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 5.163121e-01 | 0.287 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 5.163121e-01 | 0.287 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 5.163121e-01 | 0.287 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 5.163121e-01 | 0.287 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 5.201784e-01 | 0.284 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 5.214482e-01 | 0.283 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 5.273542e-01 | 0.278 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 5.355298e-01 | 0.271 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 5.357154e-01 | 0.271 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 5.357154e-01 | 0.271 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 5.357154e-01 | 0.271 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 5.357154e-01 | 0.271 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 5.357154e-01 | 0.271 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 5.357154e-01 | 0.271 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 5.357154e-01 | 0.271 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 5.360471e-01 | 0.271 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 5.360471e-01 | 0.271 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 5.366794e-01 | 0.270 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 5.366794e-01 | 0.270 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 5.366794e-01 | 0.270 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 5.366794e-01 | 0.270 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 5.366794e-01 | 0.270 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 5.366794e-01 | 0.270 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 5.366794e-01 | 0.270 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 5.366794e-01 | 0.270 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 5.366794e-01 | 0.270 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 5.379007e-01 | 0.269 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 5.423831e-01 | 0.266 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 5.489637e-01 | 0.260 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 5.489637e-01 | 0.260 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 5.519542e-01 | 0.258 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 5.545763e-01 | 0.256 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 5.545763e-01 | 0.256 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 5.545763e-01 | 0.256 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 5.580446e-01 | 0.253 | 1 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 5.581372e-01 | 0.253 | 1 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 5.597254e-01 | 0.252 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 5.597254e-01 | 0.252 | 1 | 1 |
| Translation initiation complex formation | R-HSA-72649 | 5.616894e-01 | 0.251 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 5.622523e-01 | 0.250 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 5.653735e-01 | 0.248 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 5.653735e-01 | 0.248 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 5.654626e-01 | 0.248 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 5.654626e-01 | 0.248 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 5.654626e-01 | 0.248 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 5.654626e-01 | 0.248 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 5.654626e-01 | 0.248 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 5.654626e-01 | 0.248 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 5.654626e-01 | 0.248 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 5.654626e-01 | 0.248 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 5.654626e-01 | 0.248 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 5.654626e-01 | 0.248 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 5.654626e-01 | 0.248 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 5.667100e-01 | 0.247 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 5.667100e-01 | 0.247 | 1 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 5.728874e-01 | 0.242 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 5.728874e-01 | 0.242 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 5.728874e-01 | 0.242 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 5.728874e-01 | 0.242 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 5.741792e-01 | 0.241 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 5.742168e-01 | 0.241 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 5.742168e-01 | 0.241 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 5.798476e-01 | 0.237 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 5.798476e-01 | 0.237 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 5.798476e-01 | 0.237 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 5.798476e-01 | 0.237 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 5.798476e-01 | 0.237 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 5.798476e-01 | 0.237 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 5.798476e-01 | 0.237 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 5.804817e-01 | 0.236 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 5.828896e-01 | 0.234 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 5.865397e-01 | 0.232 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 5.865397e-01 | 0.232 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 5.865397e-01 | 0.232 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 5.890042e-01 | 0.230 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 5.906442e-01 | 0.229 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 5.906442e-01 | 0.229 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 5.906442e-01 | 0.229 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 5.906442e-01 | 0.229 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 5.924593e-01 | 0.227 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 5.924593e-01 | 0.227 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 5.924593e-01 | 0.227 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 5.924593e-01 | 0.227 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 5.924593e-01 | 0.227 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 5.924593e-01 | 0.227 | 0 | 0 |
| Inorganic anion exchange by SLC26 transporters | R-HSA-427601 | 5.924593e-01 | 0.227 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 5.924593e-01 | 0.227 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 5.928776e-01 | 0.227 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 5.928776e-01 | 0.227 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 5.940134e-01 | 0.226 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 5.940134e-01 | 0.226 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 6.036162e-01 | 0.219 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 6.036162e-01 | 0.219 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 6.078448e-01 | 0.216 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 6.078651e-01 | 0.216 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 6.105493e-01 | 0.214 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 6.141915e-01 | 0.212 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 6.177802e-01 | 0.209 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 6.177802e-01 | 0.209 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 6.177802e-01 | 0.209 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 6.177802e-01 | 0.209 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 6.177802e-01 | 0.209 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 6.213981e-01 | 0.207 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 6.213981e-01 | 0.207 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 6.222267e-01 | 0.206 | 1 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 6.244898e-01 | 0.204 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 6.244898e-01 | 0.204 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 6.244898e-01 | 0.204 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 6.346090e-01 | 0.197 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 6.346090e-01 | 0.197 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 6.348379e-01 | 0.197 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 6.405819e-01 | 0.193 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 6.415294e-01 | 0.193 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 6.415294e-01 | 0.193 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 6.415294e-01 | 0.193 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 6.415294e-01 | 0.193 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 6.415294e-01 | 0.193 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 6.415294e-01 | 0.193 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 6.415294e-01 | 0.193 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 6.415294e-01 | 0.193 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 6.415294e-01 | 0.193 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 6.449078e-01 | 0.191 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 6.449078e-01 | 0.191 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 6.474952e-01 | 0.189 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 6.559057e-01 | 0.183 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 6.561255e-01 | 0.183 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 6.561255e-01 | 0.183 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 6.561255e-01 | 0.183 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 6.561255e-01 | 0.183 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 6.600551e-01 | 0.180 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 6.600551e-01 | 0.180 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 6.600551e-01 | 0.180 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 6.600551e-01 | 0.180 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 6.638043e-01 | 0.178 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 6.638043e-01 | 0.178 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 6.638043e-01 | 0.178 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 6.638043e-01 | 0.178 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 6.638043e-01 | 0.178 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 6.638043e-01 | 0.178 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 6.638043e-01 | 0.178 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 6.645037e-01 | 0.178 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 6.711266e-01 | 0.173 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 6.722881e-01 | 0.172 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 6.815269e-01 | 0.167 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 6.846963e-01 | 0.165 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 6.846963e-01 | 0.165 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 6.846963e-01 | 0.165 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 6.846963e-01 | 0.165 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 6.846963e-01 | 0.165 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 6.846963e-01 | 0.165 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 6.846963e-01 | 0.165 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 6.846963e-01 | 0.165 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 6.846963e-01 | 0.165 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 6.855926e-01 | 0.164 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 6.957747e-01 | 0.158 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 7.042912e-01 | 0.152 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 7.042912e-01 | 0.152 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 7.042912e-01 | 0.152 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 7.042912e-01 | 0.152 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 7.042912e-01 | 0.152 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 7.042912e-01 | 0.152 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 7.042912e-01 | 0.152 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 7.042912e-01 | 0.152 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 7.042912e-01 | 0.152 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 7.042912e-01 | 0.152 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 7.074017e-01 | 0.150 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 7.103415e-01 | 0.149 | 1 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 7.129545e-01 | 0.147 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 7.129545e-01 | 0.147 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 7.129545e-01 | 0.147 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 7.129545e-01 | 0.147 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 7.129545e-01 | 0.147 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 7.179647e-01 | 0.144 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 7.226695e-01 | 0.141 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 7.226695e-01 | 0.141 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 7.226695e-01 | 0.141 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 7.226695e-01 | 0.141 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 7.226695e-01 | 0.141 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 7.226695e-01 | 0.141 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 7.258704e-01 | 0.139 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 7.258704e-01 | 0.139 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 7.258704e-01 | 0.139 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 7.309666e-01 | 0.136 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 7.354898e-01 | 0.133 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 7.356416e-01 | 0.133 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 7.382908e-01 | 0.132 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 7.382908e-01 | 0.132 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 7.382908e-01 | 0.132 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 7.388776e-01 | 0.131 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 7.399066e-01 | 0.131 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 7.399066e-01 | 0.131 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 7.399066e-01 | 0.131 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 7.399066e-01 | 0.131 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 7.399066e-01 | 0.131 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 7.399066e-01 | 0.131 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 7.443879e-01 | 0.128 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 7.443879e-01 | 0.128 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 7.446550e-01 | 0.128 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 7.450115e-01 | 0.128 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 7.502274e-01 | 0.125 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 7.502274e-01 | 0.125 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 7.502274e-01 | 0.125 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 7.530560e-01 | 0.123 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 7.560733e-01 | 0.121 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 7.560733e-01 | 0.121 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 7.560733e-01 | 0.121 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 7.560733e-01 | 0.121 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 7.560733e-01 | 0.121 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 7.560733e-01 | 0.121 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 7.560733e-01 | 0.121 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 7.560733e-01 | 0.121 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 7.585413e-01 | 0.120 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 7.614962e-01 | 0.118 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 7.616441e-01 | 0.118 | 1 | 0 |
| HSF1 activation | R-HSA-3371511 | 7.616923e-01 | 0.118 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 7.616923e-01 | 0.118 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 7.616923e-01 | 0.118 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 7.616923e-01 | 0.118 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 7.616923e-01 | 0.118 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 7.616923e-01 | 0.118 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 7.616923e-01 | 0.118 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 7.630111e-01 | 0.117 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 7.688602e-01 | 0.114 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 7.712361e-01 | 0.113 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 7.712361e-01 | 0.113 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 7.712361e-01 | 0.113 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 7.712361e-01 | 0.113 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 7.712361e-01 | 0.113 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 7.712361e-01 | 0.113 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 7.712361e-01 | 0.113 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 7.712361e-01 | 0.113 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 7.726980e-01 | 0.112 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 7.726980e-01 | 0.112 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 7.769904e-01 | 0.110 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 7.769904e-01 | 0.110 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 7.771175e-01 | 0.110 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 7.777013e-01 | 0.109 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 7.795914e-01 | 0.108 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 7.832573e-01 | 0.106 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 7.832573e-01 | 0.106 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 7.832573e-01 | 0.106 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 7.854572e-01 | 0.105 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 7.854572e-01 | 0.105 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 7.854572e-01 | 0.105 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 7.854572e-01 | 0.105 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 7.854572e-01 | 0.105 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 7.854572e-01 | 0.105 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 7.854572e-01 | 0.105 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 7.854572e-01 | 0.105 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 7.880405e-01 | 0.103 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 7.951123e-01 | 0.100 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 7.987950e-01 | 0.098 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 7.987950e-01 | 0.098 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 7.987950e-01 | 0.098 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 7.987950e-01 | 0.098 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 7.987950e-01 | 0.098 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 7.987950e-01 | 0.098 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 7.987950e-01 | 0.098 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 8.003604e-01 | 0.097 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 8.098803e-01 | 0.092 | 0 | 0 |
| Kinesins | R-HSA-983189 | 8.104084e-01 | 0.091 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 8.113044e-01 | 0.091 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 8.113044e-01 | 0.091 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 8.113044e-01 | 0.091 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 8.113044e-01 | 0.091 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 8.113044e-01 | 0.091 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 8.113044e-01 | 0.091 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 8.113044e-01 | 0.091 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 8.123868e-01 | 0.090 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 8.123868e-01 | 0.090 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 8.123868e-01 | 0.090 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 8.123868e-01 | 0.090 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 8.144023e-01 | 0.089 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 8.180708e-01 | 0.087 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 8.180708e-01 | 0.087 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 8.186959e-01 | 0.087 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 8.212908e-01 | 0.086 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 8.230367e-01 | 0.085 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 8.230367e-01 | 0.085 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 8.230367e-01 | 0.085 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 8.230367e-01 | 0.085 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 8.230367e-01 | 0.085 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 8.250427e-01 | 0.084 | 1 | 0 |
| Signaling by FGFR | R-HSA-190236 | 8.266141e-01 | 0.083 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 8.285191e-01 | 0.082 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 8.298136e-01 | 0.081 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 8.324193e-01 | 0.080 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 8.340403e-01 | 0.079 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 8.340403e-01 | 0.079 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 8.340403e-01 | 0.079 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 8.340403e-01 | 0.079 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 8.379683e-01 | 0.077 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 8.379683e-01 | 0.077 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 8.383559e-01 | 0.077 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 8.383559e-01 | 0.077 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 8.394929e-01 | 0.076 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 8.424771e-01 | 0.074 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 8.443602e-01 | 0.073 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 8.443602e-01 | 0.073 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 8.443602e-01 | 0.073 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 8.443602e-01 | 0.073 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 8.443602e-01 | 0.073 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 8.443602e-01 | 0.073 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 8.443602e-01 | 0.073 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 8.443602e-01 | 0.073 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 8.457676e-01 | 0.073 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 8.461328e-01 | 0.073 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 8.461328e-01 | 0.073 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 8.469250e-01 | 0.072 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 8.488885e-01 | 0.071 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 8.495749e-01 | 0.071 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 8.532242e-01 | 0.069 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 8.540391e-01 | 0.069 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 8.540391e-01 | 0.069 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 8.540391e-01 | 0.069 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 8.540391e-01 | 0.069 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 8.540391e-01 | 0.069 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 8.586994e-01 | 0.066 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 8.603505e-01 | 0.065 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 8.603505e-01 | 0.065 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 8.603505e-01 | 0.065 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 8.625547e-01 | 0.064 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 8.631165e-01 | 0.064 | 0 | 0 |
| Defects in cobalamin (B12) metabolism | R-HSA-3296469 | 8.631165e-01 | 0.064 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 8.631165e-01 | 0.064 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 8.631165e-01 | 0.064 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 8.631165e-01 | 0.064 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 8.631165e-01 | 0.064 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 8.631165e-01 | 0.064 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 8.631165e-01 | 0.064 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 8.631165e-01 | 0.064 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 8.646387e-01 | 0.063 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 8.671588e-01 | 0.062 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 8.671588e-01 | 0.062 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 8.678693e-01 | 0.062 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 8.703573e-01 | 0.060 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 8.713581e-01 | 0.060 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 8.716300e-01 | 0.060 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 8.716300e-01 | 0.060 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 8.716300e-01 | 0.060 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 8.716300e-01 | 0.060 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 8.716300e-01 | 0.060 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 8.758614e-01 | 0.058 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 8.758614e-01 | 0.058 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 8.789975e-01 | 0.056 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 8.796144e-01 | 0.056 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 8.796144e-01 | 0.056 | 0 | 0 |
| Cobalamin (Cbl) metabolism | R-HSA-9759218 | 8.796144e-01 | 0.056 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 8.796144e-01 | 0.056 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 8.796144e-01 | 0.056 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 8.796144e-01 | 0.056 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 8.796144e-01 | 0.056 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 8.796144e-01 | 0.056 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 8.796144e-01 | 0.056 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 8.798688e-01 | 0.056 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 8.798688e-01 | 0.056 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 8.821410e-01 | 0.054 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 8.821410e-01 | 0.054 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 8.821410e-01 | 0.054 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 8.862510e-01 | 0.052 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 8.871027e-01 | 0.052 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 8.871027e-01 | 0.052 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 8.871027e-01 | 0.052 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 8.871027e-01 | 0.052 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 8.871027e-01 | 0.052 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 8.871027e-01 | 0.052 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 8.914224e-01 | 0.050 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 8.914469e-01 | 0.050 | 1 | 1 |
| Co-inhibition by PD-1 | R-HSA-389948 | 8.938604e-01 | 0.049 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 8.938604e-01 | 0.049 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 8.941256e-01 | 0.049 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 8.941256e-01 | 0.049 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 8.941256e-01 | 0.049 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 8.941256e-01 | 0.049 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 8.941256e-01 | 0.049 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 8.968392e-01 | 0.047 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 8.968392e-01 | 0.047 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 8.982440e-01 | 0.047 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.003811e-01 | 0.046 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 9.007120e-01 | 0.045 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 9.007120e-01 | 0.045 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.007120e-01 | 0.045 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.053181e-01 | 0.043 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 9.068891e-01 | 0.042 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.068891e-01 | 0.042 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.068891e-01 | 0.042 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 9.112139e-01 | 0.040 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.115548e-01 | 0.040 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 9.122887e-01 | 0.040 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 9.122887e-01 | 0.040 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 9.126822e-01 | 0.040 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 9.126822e-01 | 0.040 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 9.129088e-01 | 0.040 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 9.148044e-01 | 0.039 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 9.181152e-01 | 0.037 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 9.181152e-01 | 0.037 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 9.181152e-01 | 0.037 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 9.181867e-01 | 0.037 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 9.181867e-01 | 0.037 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 9.181867e-01 | 0.037 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 9.202464e-01 | 0.036 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 9.205198e-01 | 0.036 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.232104e-01 | 0.035 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 9.232104e-01 | 0.035 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 9.242054e-01 | 0.034 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 9.246533e-01 | 0.034 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 9.257303e-01 | 0.034 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 9.274922e-01 | 0.033 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 9.277287e-01 | 0.033 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.279889e-01 | 0.032 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 9.279889e-01 | 0.032 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.279889e-01 | 0.032 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 9.279889e-01 | 0.032 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 9.279889e-01 | 0.032 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 9.279889e-01 | 0.032 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.281292e-01 | 0.032 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.317890e-01 | 0.031 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 9.324704e-01 | 0.030 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.324704e-01 | 0.030 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.324704e-01 | 0.030 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 9.324704e-01 | 0.030 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.324704e-01 | 0.030 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 9.324704e-01 | 0.030 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 9.332043e-01 | 0.030 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 9.337611e-01 | 0.030 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.352719e-01 | 0.029 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 9.366731e-01 | 0.028 | 1 | 1 |
| GPVI-mediated activation cascade | R-HSA-114604 | 9.366731e-01 | 0.028 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.384908e-01 | 0.028 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.405798e-01 | 0.027 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.406146e-01 | 0.027 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 9.406146e-01 | 0.027 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 9.406146e-01 | 0.027 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.406146e-01 | 0.027 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 9.414219e-01 | 0.026 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 9.438593e-01 | 0.025 | 0 | 0 |
| Depurination | R-HSA-73927 | 9.443110e-01 | 0.025 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.443110e-01 | 0.025 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.443110e-01 | 0.025 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 9.443110e-01 | 0.025 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 9.443110e-01 | 0.025 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 9.447364e-01 | 0.025 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.462037e-01 | 0.024 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.463400e-01 | 0.024 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 9.475874e-01 | 0.023 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.477774e-01 | 0.023 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 9.477774e-01 | 0.023 | 1 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.477774e-01 | 0.023 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 9.484582e-01 | 0.023 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 9.490483e-01 | 0.023 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 9.506258e-01 | 0.022 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 9.510284e-01 | 0.022 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.522281e-01 | 0.021 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 9.527094e-01 | 0.021 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 9.527094e-01 | 0.021 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 9.527094e-01 | 0.021 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.540771e-01 | 0.020 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 9.548249e-01 | 0.020 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.553225e-01 | 0.020 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.560250e-01 | 0.020 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 9.566359e-01 | 0.019 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 9.566359e-01 | 0.019 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.566359e-01 | 0.019 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 9.569362e-01 | 0.019 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.569362e-01 | 0.019 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 9.569362e-01 | 0.019 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.569362e-01 | 0.019 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 9.569362e-01 | 0.019 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 9.584842e-01 | 0.018 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.585662e-01 | 0.018 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.596174e-01 | 0.018 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 9.598589e-01 | 0.018 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.598589e-01 | 0.018 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 9.599518e-01 | 0.018 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 9.602595e-01 | 0.018 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.604975e-01 | 0.018 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 9.609336e-01 | 0.017 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 9.619582e-01 | 0.017 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.619582e-01 | 0.017 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.621319e-01 | 0.017 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.639518e-01 | 0.016 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 9.644899e-01 | 0.016 | 1 | 1 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.644899e-01 | 0.016 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.644899e-01 | 0.016 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.644899e-01 | 0.016 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.644899e-01 | 0.016 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.667013e-01 | 0.015 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 9.667013e-01 | 0.015 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 9.708463e-01 | 0.013 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 9.708463e-01 | 0.013 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.709095e-01 | 0.013 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.709095e-01 | 0.013 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 9.709672e-01 | 0.013 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.718927e-01 | 0.012 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.725037e-01 | 0.012 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 9.725435e-01 | 0.012 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.725435e-01 | 0.012 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 9.726258e-01 | 0.012 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.739616e-01 | 0.011 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 9.742537e-01 | 0.011 | 1 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 9.742537e-01 | 0.011 | 1 | 1 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 9.745216e-01 | 0.011 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 9.745216e-01 | 0.011 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.753690e-01 | 0.011 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 9.756469e-01 | 0.011 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 9.758575e-01 | 0.011 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 9.766565e-01 | 0.010 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 9.770002e-01 | 0.010 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.773615e-01 | 0.010 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.773615e-01 | 0.010 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 9.778823e-01 | 0.010 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.779008e-01 | 0.010 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 9.779500e-01 | 0.010 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 9.779500e-01 | 0.010 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.800945e-01 | 0.009 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.800945e-01 | 0.009 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 9.800945e-01 | 0.009 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.809929e-01 | 0.008 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 9.811937e-01 | 0.008 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 9.813347e-01 | 0.008 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.816278e-01 | 0.008 | 1 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.822810e-01 | 0.008 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.841218e-01 | 0.007 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 9.841823e-01 | 0.007 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 9.849776e-01 | 0.007 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.855702e-01 | 0.006 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 9.857885e-01 | 0.006 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.878393e-01 | 0.005 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 9.879739e-01 | 0.005 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.880558e-01 | 0.005 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.881038e-01 | 0.005 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 9.886267e-01 | 0.005 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.890644e-01 | 0.005 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 9.892450e-01 | 0.005 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.892450e-01 | 0.005 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 9.895408e-01 | 0.005 | 1 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 9.901928e-01 | 0.004 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 9.901928e-01 | 0.004 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 9.903847e-01 | 0.004 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 9.909094e-01 | 0.004 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 9.909094e-01 | 0.004 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 9.914061e-01 | 0.004 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 9.914061e-01 | 0.004 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.916589e-01 | 0.004 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.918763e-01 | 0.004 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 9.918763e-01 | 0.004 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 9.923443e-01 | 0.003 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 9.924195e-01 | 0.003 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.927424e-01 | 0.003 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.927712e-01 | 0.003 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 9.935179e-01 | 0.003 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.935525e-01 | 0.003 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.937512e-01 | 0.003 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.938747e-01 | 0.003 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 9.943669e-01 | 0.002 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.945065e-01 | 0.002 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.945151e-01 | 0.002 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.945314e-01 | 0.002 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 9.945942e-01 | 0.002 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.948447e-01 | 0.002 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.948492e-01 | 0.002 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.951705e-01 | 0.002 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.951913e-01 | 0.002 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.956814e-01 | 0.002 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 9.963479e-01 | 0.002 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.976148e-01 | 0.001 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.976229e-01 | 0.001 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 9.979939e-01 | 0.001 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.981633e-01 | 0.001 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.982779e-01 | 0.001 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.985525e-01 | 0.001 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.986226e-01 | 0.001 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.986695e-01 | 0.001 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 9.987293e-01 | 0.001 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.987960e-01 | 0.001 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.989036e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.989721e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.990749e-01 | 0.000 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.992059e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.992311e-01 | 0.000 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 9.992556e-01 | 0.000 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.994264e-01 | 0.000 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.994900e-01 | 0.000 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 9.994900e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.994938e-01 | 0.000 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.995558e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.996623e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.996958e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.997516e-01 | 0.000 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 9.997615e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.997817e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.998314e-01 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.998559e-01 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.998702e-01 | 0.000 | 1 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.998856e-01 | 0.000 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.998970e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999224e-01 | 0.000 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.999362e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999391e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999801e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.999817e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999825e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999872e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999896e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999927e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.999958e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.999958e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999970e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999979e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999983e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.999989e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.999990e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.999997e-01 | 0.000 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.999999e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999999e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | -0.000 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 1.000000e+00 | 0.000 | 1 | 1 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
